Ê Ë Ì Ì Ë Ê °ê ° Ì Ì Ì Í Ë Ë¡ Í Í © ('20.08)

국내·외 의료기기 임상시험 등록현황
1. 의료기기 임상시험 단계별 진행 현황(총 512건)

- 피험자 등록 전(Not yet recruiting) : 356건
- 피험자 등록 중(Recruiting), 등록(Enrolling) : 148건
- 임상시험 종료(Completed) : 0건
- 기타(임상시험 중단(Terminated , Withdrawn), 유예(Suspended) 등) : 6건
2. 모니터링 기간 : 2020.8.1. ~ 2020.8.31.
3. 키워드 검색 : 기타 용어(Other terms)에 device ; 학습시작(Study Start)에 08/01/2020 ~ 08/31/2020
4. 정보출처 : ClinicalTrials.gov
각 임상시험 정보는 사이트를 참고하시길 바라며 임상시험 등록번호를 통해 찾을 수 있습니다
번호 임상시험 등록번호
1 NCT04059640
2 NCT04378270
3 NCT04482556
4 NCT04445129
5 NCT04468204
6 NCT04500288
7 NCT04459559
8 NCT04327154
9 NCT04496505
10 NCT04522778
11 NCT04482166
12 NCT04498598
13 NCT04530591
14 NCT04502017
15 NCT04513730
16 NCT04497129
17 NCT04422795
18 NCT04478188
19 NCT04404036
20 NCT04471584
21 NCT04471896
22 NCT04396379
23 NCT03636230
24 NCT04508153
25 NCT04092790
26 NCT04516109
27 NCT04370340
28 NCT04440982
29 NCT04395911
30 NCT04426344
31 NCT03429582
32 NCT03648450
33 NCT04338295
34 NCT04374851
35 NCT04519190
36 NCT04365465
37 NCT04110717
38 NCT04478890
39 NCT04228367
40 NCT04471623
41 NCT04229563
42 NCT04468321
43 NCT04358302
44 NCT04454970
45 NCT04529239
46 NCT04514861
47 NCT03988699
48 NCT04485858
49 NCT03330067
50 NCT03772717
51 NCT04444453
52 NCT04342091
53 NCT04405583
54 NCT04498026
55 NCT04476628
56 NCT04229316
57 NCT04311970
58 NCT04485897
59 NCT04496518
60 NCT04474574
61 NCT04500106
62 NCT04197284
63 NCT04530201
64 NCT04470258
65 NCT04131725
66 NCT04152668
67 NCT04008563
68 NCT04500314
69 NCT04379505
70 NCT04524416
71 NCT04275089
72 NCT04103554
73 NCT04349046
74 NCT04033692
75 NCT04432727
76 NCT04381013
77 NCT04369638
78 NCT04225520
79 NCT04495062
80 NCT04485455
81 NCT04508556
82 NCT04505579
83 NCT04107662
84 NCT04159454
85 NCT04363489
86 NCT04309513
87 NCT04488224
88 NCT04473443
89 NCT04182555
90 NCT04338893
91 NCT04337554
92 NCT04352127
93 NCT04223570
94 NCT04511793
95 NCT04093076
96 NCT04445220
97 NCT04413032
98 NCT04452149
99 NCT04480385
100 NCT04352140
101 NCT04269681
102 NCT04333810
103 NCT03811405
104 NCT02725554
105 NCT04218019
106 NCT04327076
107 NCT04476927
108 NCT04212780
109 NCT04478071
110 NCT04515498
111 NCT03458325
112 NCT04410237
113 NCT04306848
114 NCT04398654
115 NCT04430660
116 NCT04494867
117 NCT04014998
118 NCT04301986
119 NCT04341948
120 NCT04505007
121 NCT04425720
122 NCT04437914
123 NCT04016662
124 NCT04396444
125 NCT04430218
126 NCT04049383
127 NCT04129515
128 NCT04502654
129 NCT04480645
130 NCT04519138
131 NCT04139564
132 NCT04525573
133 NCT04416555
134 NCT04418830
135 NCT04506333
136 NCT04099342
137 NCT04476472
138 NCT04529655
139 NCT04086615
140 NCT04018092
141 NCT04232163
142 NCT04312256
143 NCT04506502
144 NCT04291404
145 NCT04423679
146 NCT04341363
147 NCT04481490
148 NCT04480437
149 NCT04471844
150 NCT04332003
151 NCT04323670
152 NCT04392167
153 NCT04525924
154 NCT04448171
155 NCT04507802
156 NCT04431817
157 NCT04396860
158 NCT04506866
159 NCT04329767
160 NCT03780452
161 NCT03708809
162 NCT04338776
163 NCT03870217
164 NCT04242810
165 NCT04464993
166 NCT04494178
167 NCT04483154
168 NCT04341350
169 NCT04384679
170 NCT04159571
171 NCT04531358
172 NCT04468633
173 NCT04500392
174 NCT04104126
175 NCT04505618
176 NCT03892980
177 NCT03947307
178 NCT04474548
179 NCT04477187
180 NCT04511247
181 NCT04511234
182 NCT04423796
183 NCT04463121
184 NCT04524364
185 NCT04526925
186 NCT04236856
187 NCT04322994
188 NCT04491136
189 NCT04118764
190 NCT04327687
191 NCT04261478
192 NCT04320849
193 NCT04489628
194 NCT04520568
195 NCT04507490
196 NCT04482855
197 NCT04476862
198 NCT03045055
199 NCT04501133
200 NCT04302896
201 NCT04466826
202 NCT04403789
203 NCT04261686
204 NCT04445675
205 NCT04490655
206 NCT04479618
207 NCT04373070
208 NCT04343209
209 NCT04404465
210 NCT02022969
211 NCT04500119
212 NCT04411810
213 NCT04309682
214 NCT04449510
215 NCT04391504
216 NCT04368858
217 NCT04393207
218 NCT04441164
219 NCT04091594
220 NCT04472286
221 NCT04478344
222 NCT03660891
223 NCT04524481
224 NCT04496258
225 NCT04230876
226 NCT04443556
227 NCT04463225
228 NCT04496908
229 NCT04499807
230 NCT04462224
231 NCT04466072
232 NCT04054323
233 NCT04267588
234 NCT04412954
235 NCT04526730
236 NCT04411849
237 NCT04340063
238 NCT04420182
239 NCT04021238
240 NCT04382924
241 NCT04480138
242 NCT04028752
243 NCT04515082
244 NCT04500418
245 NCT04315363
246 NCT04376255
247 NCT04469114
248 NCT04231773
249 NCT04436796
250 NCT04494685
251 NCT04531241
252 NCT04524039
253 NCT04523584
254 NCT04511208
255 NCT04509453
256 NCT04509349
257 NCT04507880
258 NCT04504929
259 NCT04499222
260 NCT04492397
261 NCT04490200
262 NCT04482816
263 NCT04481802
264 NCT04466332
265 NCT04460482
266 NCT04449263
267 NCT04448327
268 NCT04437498
269 NCT04431427
270 NCT04404725
271 NCT04398537
272 NCT04381923
273 NCT04350255
274 NCT04317742
275 NCT04293744
276 NCT04279574
277 NCT04273919
278 NCT04248010
279 NCT04238546
280 NCT04191031
281 NCT04188288
282 NCT04170322
283 NCT04170062
284 NCT04168489
285 NCT03899753
286 NCT04532879
287 NCT04532762
288 NCT04530955
289 NCT04530084
290 NCT04529837
291 NCT04529408
292 NCT04522999
293 NCT04522609
294 NCT04521062
295 NCT04520906
296 NCT04519515
297 NCT04518033
298 NCT04517695
299 NCT04517019
300 NCT04514718
301 NCT04513483
302 NCT04512690
303 NCT04510805
304 NCT04510779
305 NCT04510506
306 NCT04509960
307 NCT04507295
308 NCT04506476
309 NCT04505761
310 NCT04504890
311 NCT04504422
312 NCT04504344
313 NCT04503174
314 NCT04502290
315 NCT04499664
316 NCT04495049
317 NCT04493775
318 NCT04490824
319 NCT04489914
320 NCT04489407
321 NCT04489082
322 NCT04486924
323 NCT04484220
324 NCT04481360
325 NCT04480970
326 NCT04479228
327 NCT04477005
328 NCT04473495
329 NCT04473469
330 NCT04471636
331 NCT04468178
332 NCT04467736
333 NCT04466956
334 NCT04466384
335 NCT04466228
336 NCT04456569
337 NCT04453020
338 NCT04451889
339 NCT04451109
340 NCT04449770
341 NCT04449055
342 NCT04439409
343 NCT04438759
344 NCT04437537
345 NCT04437173
346 NCT04437082
347 NCT04434820
348 NCT04434729
349 NCT04420819
350 NCT04418505
351 NCT04408482
352 NCT04407039
353 NCT04402294
354 NCT04398966
355 NCT04393272
356 NCT04385732
357 NCT04384094
358 NCT04375085
359 NCT04369599
360 NCT04364217
361 NCT04362787
362 NCT04346537
363 NCT04339439
364 NCT04336644
365 NCT04322448
366 NCT04307680
367 NCT04146987
368 NCT04303533
369 NCT04300075
370 NCT04274296
371 NCT04262323
372 NCT04257227
373 NCT04251897
374 NCT04242134
375 NCT04237974
376 NCT04227054
377 NCT04203381
378 NCT04202666
379 NCT04166630
380 NCT04162496
381 NCT04150653
382 NCT04129580
383 NCT04124341
384 NCT04086927
385 NCT04076696
386 NCT04049656
387 NCT03973814
388 NCT03621397
389 NCT03616041
390 NCT04472637
391 NCT03192007
392 NCT03071484
393 NCT04524143
394 NCT04485091
395 NCT04520880
396 NCT04491760
397 NCT04416269
398 NCT04279834
399 NCT04501198
400 NCT04443153
401 NCT04436627
402 NCT04289051
403 NCT04440579
404 NCT04352192
405 NCT04524182
406 NCT04395274
407 NCT04497779
408 NCT04269239
409 NCT04529681
410 NCT04516200
411 NCT04509817
412 NCT04506775
413 NCT04504019
414 NCT04497922
415 NCT04496232
416 NCT04475315
417 NCT04473430
418 NCT04460612
419 NCT04440358
420 NCT04431596
421 NCT04411277
422 NCT04380454
423 NCT04364126
424 NCT04361799
425 NCT04179981
426 NCT04063267
427 NCT04046991
428 NCT04010266
429 NCT03598816
430 NCT04533295
431 NCT04515121
432 NCT04507009
433 NCT02828761
434 NCT04122001
435 NCT03979664
436 NCT04508725
437 NCT04505163
438 NCT04486859
439 NCT04467437
440 NCT04444492
441 NCT04416724
442 NCT04388332
443 NCT04322370
444 NCT04258618
445 NCT04136912
446 NCT04416113
447 NCT03159598
448 NCT04000880
449 NCT04236908
450 NCT04205136
451 NCT04525599
452 NCT04303689
453 NCT03832985
454 NCT04026776
455 NCT04464538
456 NCT03699865
457 NCT04396808
458 NCT04271436
459 NCT04407702
460 NCT04515095
461 NCT04424394
462 NCT04410146
463 NCT04260412
464 NCT04247867
465 NCT04076618
466 NCT04011150
467 NCT04200508
468 NCT04410783
469 NCT04480918
470 NCT04529473
471 NCT04429321
472 NCT03935295
473 NCT04321655
474 NCT03982004
475 NCT04472312
476 NCT04413747
477 NCT04497805
478 NCT04372745
479 NCT04097054
480 NCT04522284
481 NCT04480684
482 NCT04417179
483 NCT04458324
484 NCT04503499
485 NCT04528693
486 NCT04511364
487 NCT04238013
488 NCT04375280
489 NCT04455139
490 NCT04353063
491 NCT04276233
492 NCT04508114
493 NCT04478981
494 NCT04531618
495 NCT04199481
496 NCT04396405
497 NCT04103255
498 NCT04464720
499 NCT04492475
500 NCT02468219
501 NCT03043469
502 NCT04411446
503 NCT04276259
504 NCT04397796
505 NCT04480931
506 NCT04513470
507 NCT04509284
508 NCT04358276
509 NCT04465513
510 NCT04477330
511 NCT04487886
512 NCT04492241
임상시험 등록현황(2020.08)
험 단계별 진행 현황(총 512건)

Not yet recruiting) : 356건
ecruiting), 등록(Enrolling) : 148건
ompleted) : 0건
단(Terminated , Withdrawn), 유예(Suspended) 등) : 6건
2020.8.1. ~ 2020.8.31.
타 용어(Other terms)에 device ; 학습시작(Study Start)에 08/01/2020 ~ 08/31/2020
alTrials.gov
사이트를 참고하시길 바라며 임상시험 등록번호를 통해 찾을 수 있습니다
연구명 임상시험 진행 상태
PMCF Study of LiquiBand FIX8짰 OHMF Device Not yet recruiting
Validation of a Novel Foot Offloading Device Not yet recruiting
Comparison of the Q-NRG+ Indirect Calorimetry Device Versus the V(Max)

Not yet recruiting
Encore Device in Mechanically Ventilated Children
Wake and Sleep State Transitions on a Portable Electroencephalogram

Recruiting
(EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants
Use of Novel Sinusonic Device for Prevention of Community Acquired

Not yet recruiting
Upper Respiratory Infection (URI)
The Effect of Positional Therapy on Symptoms of Gastroesophageal Reflux

Not yet recruiting
Disease: A Prospective Pilot Study
Usability of a Novel Cueing Device for Patients With Parkinson's Disease Not yet recruiting
TISSIUM??Nerve Coaptation Device First-in-Human Clinical Trial Not yet recruiting
Neuromodulation Device Use in Patients With Major Depressive Disorder Not yet recruiting
Innovative Central Line Securement Device in the Pediatric Population Not yet recruiting
Learning Curve of Fiberoptic Intubation Through Supraglottic Airway Device Not yet recruiting
Structural Modification In Supraglottic Airway Device Not yet recruiting
User Acceptability of a Device-Based Opioid Overdose Intervention Recruiting
Efficacy of Different Anti-Thrombotic Strategies on Device-Related

Recruiting
Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
Positional Device Aimed at Patients With Low Back Pain Recruiting
ROMTECH PortableConnect Rehabilitation Device Usage Post Unilateral

Not yet recruiting
Total Knee Arthroplasty (TKA)
The Evaluation of External Thermomechanical Stimulation for Pain

Not yet recruiting
Reduction in Patients Undergoing Nail Injection
Pressure Volume Loop Not yet recruiting
Treatment of Eustachian Tube Dysfunction (ETD) and Facial Pain With

Not yet recruiting
Combined Acoustic Vibration and Oscillating Expiratory Pressure
Comparative Analysis in Detection of Atrial Arrhythmia and ECG Quality in
Not yet recruiting
Three Different Insertable Cardiac Monitors
Joovvin' for Your Skin Health Study Not yet recruiting
Epicardial Mitral Touch System for Mitral Insufficiency Not yet recruiting
Remote Patient Management of CIEDs - Brady Devices Not yet recruiting
Pelvic Floor Muscle Training With a Digital Therapeutic Device to Standard

Not yet recruiting
Exercises for Stress Urinary Incontinence
Sarcopenia in Older Patients in the Acute Hospital Setting Not yet recruiting
Improvements and Modifications of Devices for Hip Arthroscopy Enrolling by invitation
Application of a Perineal Protection Device in Vacuum-assisted Births Not yet recruiting
Feasibility Study of Intraoperative Detection of Residual Cancer in Breast

Not yet recruiting
Cancer Patients Receiving Neoadjuvant Therapy
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-
Not yet recruiting
19 Infections
Core Warming of COVID-19 Patients Not yet recruiting

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal
Not yet recruiting
Ablation Device
Feasibility and Acceptability of the Propeller Monitoring System in Children

Recruiting
With Persistent Asthma
Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of

Not yet recruiting
Micro-needling
A Comparative Clinical Investigation of Two Hearing Instrument Digital

Enrolling by invitation
Signal Processing
Screening for Atrial Fibrillation With Prolonged Continuous Single-lead ECG

Not yet recruiting
Devices in High-risk Patients
BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control Recruiting
Vestibular Nerve Stimulation Compared to Sham Control as a Means of

Not yet recruiting
Reducing Excess Body Weight
Hemodynamic Assessment of the Right Ventricle Using Pressure-volume

Loop Catheter and Pulmonary Artery Catheter in Patients Undergoing Left Not yet recruiting
Ventricular Assist Device Placement
JuggerStitch Post Market Clinical Follow-up Study Not yet recruiting
Decentralized Trial in Atrial Fibrillation Patients Not yet recruiting

Post-Market Registry of AURYON??Atherectomy Device in Subjects Affected
Not yet recruiting
With Infrainguinal Peripheral Artery Disease
Effect of Wearable Devices on Patient-Reported Outcomes and Clinical

Not yet recruiting
Utilization
Individual Patient Exposure and Response in Pediatric Lupus Not yet recruiting
Safe Access for Bladder Entry in Transgender Men Following Penile

Not yet recruiting
Reconstruction
Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose

Not yet recruiting
Monitoring System
Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee

Recruiting
Oxygen Platform in Correlation to TcPO2
Novel Tinnitus Implant System for the Treatment of Chronic Severe Tinnitus Not yet recruiting
First in Human (FIH) Study to Assess Safety and Efficacy of the CorNeat
Not yet recruiting
KPro for the Treatment of Corneal Blindness
Warm and Humidified vs Cold and Dry Carbon Dioxide (CO2)

Not yet recruiting
Pneumoperitoneum
Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic

Not yet recruiting
Inflammatory Demyelinating Polyneuropathy (CIDP)
Early Ambulation to Reduce Hospital Length of Stay Not yet recruiting
Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling Not yet recruiting
The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of
Not yet recruiting
the Occlutech AFR in Heart Failure Patients
Adherus??Dural Sealant in Spinal Procedures Not yet recruiting
Efficacy of Budesonide Via Delayed Release vs Immediate Release Not yet recruiting
Safety And Efficacy Assessment of the zLock Facet Fusion System- A Pilot
Recruiting
Study
Pilot Study of Esocheck in Eosinophilic Esophagitis Not yet recruiting
Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal

Not yet recruiting
Monitoring
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval
Recruiting
Study (iATP PAS)
How Differences in Oximeter Performance May Affect Clinical Decision Not yet recruiting
Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-

Assisted Telenursing in Adult Participants With Parkinson's Disease Treated Not yet recruiting
With Levodopa-Carbidopa Intestinal Gel
Determination of the Effectiveness of Certain Physical Methods in the

Recruiting
Treatment of Knee Osteoarthritis
CASUS: Validation for Detection of Precursor Lesions Recruiting
Elmo Respiratory Support Project - COVID-19 Not yet recruiting
Cardiac Function Non-Invasive Monitoring System Evaluation Trial Not yet recruiting
Non-surgical Treatment of Peri-implantitis With and Without Erythritol Air-

Not yet recruiting
polishing
Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and

Not yet recruiting
Grade 1 Cancer of the Endometrium
Efficacy of Whole-body Vibration on Balance Control, Postural Stability and

Not yet recruiting
Mobility After Thermal Burn Injuries.
Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT) Not yet recruiting
MINIject Global Long-Term Follow-up Study Recruiting
Early Feasibility Study of the Reia Vaginal Pessary Recruiting
Sacubitril/Valsartan in Left Ventricular Assist Device Recipients Not yet recruiting

Exception Cementless Hip Stem Not yet recruiting
MDR-JuggerKnot Mini Soft Anchor in Maxillofacial TMJ Not yet recruiting
Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30

Recruiting
Patients With Breast Cancer-Related Lymphedema.
Emergency Ventilator Splitting Between Two or More Patients (COVID-19) Not yet recruiting
Fabrication of Naso-alveolar Molding (NAM) Appliance in Cleft Lip and

Not yet recruiting
Palate (CLP) From Digital Magnetic Resonance Imaging (MRI) Face Scan
Mechanical Dyssynchrony in CRT Not yet recruiting
The Use of Wearable Technology to Acquire Signals for COPD Research Not yet recruiting
iTBS for Adolescent Depression: An Open Label Study Evaluating Safety

Recruiting
and Efficacy of Treatment
Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-
Not yet recruiting
CoV-2 Study
The Tether??- Vertebral Body Tethering System Post Approval Study Not yet recruiting
Biomarkers of Traumatic Brain Injury With Tbit System Not yet recruiting
PITA-HF: Feasibility, Safety, and Tolerability Not yet recruiting
The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare

Not yet recruiting
Workers)
Evaluation of the Personal Activity Intelligence (PAI) Score Not yet recruiting
Nano-X Image Guidance: CBCT With Gravity-induced Motion Not yet recruiting
Addition of Computer Simulations to Minimize Adverse Events After
Not yet recruiting
Transcatheter Aortic Valve Implantation
Identification of Jaundice in Newborns Using Smartphones Recruiting
ROSA Total Knee Post Market Study EMEA Not yet recruiting
Exoskeleton Footwear to Improve Walking Recruiting
Visual and Electromyography Assessments in Response to Train-of-Four

Stimulation of the Ulnar Nerve
Portable Measurement of Protoporphyrin IX in the Skin During

Not yet recruiting
Photodynamic Therapy
Hepatic Artery Infusion (HAI) Program at Duke University Not yet recruiting
Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500
Not yet recruiting
in Healthy Volunteers in Ghana
A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury

Not yet recruiting
Who Are Receiving Renal Replacement Therapy
DreaMS - Digital Biomarkers for Multiple Sclerosis Not yet recruiting
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart

Not yet recruiting
Failure
REmote Data Acquisition After SURgery Not yet recruiting
Electromyographic and Acceleromyographic Monitoring in Restricted Arm

Movement Surgical Setting
RENOVATE Palliative: HFNC vs. Standard Respiratory Support in Patients

Not yet recruiting
With Do-Not-Intubate Order and ARF
Remote Physiologic Monitoring to Detect Inflammatory Bowel Disease (IBD)

Not yet recruiting
Flares: A Feasibility Study
Physiology, Imaging and Modeling of Essential Tremor Not yet recruiting
Study of Wireless Nerve Stimulation in the Treatment of Chronic Migraine Not yet recruiting
Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation Not yet recruiting
Magnetically Guided Endotracheal Intubation and Airway Cleaning Robot

Not yet recruiting
System
Detection of COVID-19 Subjects Using DiaNose Exhalation Test Not yet recruiting
Dual Lead Thalamic Deep Brain Recording (DBR)-DBS Interface for Closed
Not yet recruiting
Loop Control of Severe Essential Tremor
Vadadustat for the Prevention and Treatment of Acute Respiratory Distress

Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 Not yet recruiting
(COVID-19)
A Prospective Clinical Study of the CloudCath System During In-home

Peritoneal Dialysis
Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart

Not yet recruiting
Failure
Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque

Not yet recruiting
Psoriasis With a Novel Needle-free Drug-delivery System
Temporary Use of a Continuous Glucose Monitoring System as an Adjunct

Not yet recruiting
to Lifestyle Medicine Education
Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart

Not yet recruiting
Failure (HF) Outcomes
Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic
Not yet recruiting
Complications in Diabetic Patients
COVID-19 Core Warming Recruiting
Effectiveness of Virtual Reality in Patients With Chronic Neck Pain Not yet recruiting
Patient Acceptance and Preference Among Screening Modalities for

Recruiting
Detection of Barrett's Esophagus
Treatment of Post-Operative Pain Following Orthopedic Surgery With

Recruiting
SPRINT짰 Peripheral Nerve Stimulation (PNS) System
Guideline-Directed Medical Therapy in Patients After Implantation of

Not yet recruiting
Implantable Cardioverter Defibrillators to Improve Long-Term Outcomes
Use of Remote Monitoring for COVID-19 Patient Not yet recruiting
Accuracy of Cardiac Arrhythmias and Conduction Disorders Diagnosis Using

Not yet recruiting
a Smartwatch
Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D) Not yet recruiting
Lavender Aromasticks for Pain Control Recruiting

Peripheral Interfaces in Amputees for Sensorimotor Integration Not yet recruiting
CAR-20/19-T Cells in Pediatric Patients With Relapsed/Refractory B Cell ALL Not yet recruiting
NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis Recruiting
Rehabilitation for Thoracoscopic Lobectomy Not yet recruiting
CivaDerm(TM) Surface Therapy Pilot Study Not yet recruiting
Investigation to Evaluate Safety and Efficacy of the Endodrill Model X

Not yet recruiting
Biopsy Instrument
EaseVRx for the Reduction of Chronic Pain and Opioid Use Not yet recruiting
Effects of a Red/Gold/IR LED Combination Light on Reduction of Fat Recruiting
Virtual Reality Distraction for Reduction Not yet recruiting
Lumbar Interbody Implant Study Not yet recruiting
Validation of A&D UA-651 in Children Not yet recruiting
Enhanced Spatial Targeting in ECT Utilizing FEAST Not yet recruiting

Omnipod Horizon??Automated Glucose Control System Preschool Cohort Not yet recruiting
Digital Capillary Refill for Monitoring of Sepsis Recruiting
Trial of Neurostimulation and Blood Flow Restriction for PFPS in Active

Recruiting
Duty
The Revitalize Study Not yet recruiting
Arm Boot Camp Study: Evaluation of a Program to Increase Upper Limb

Recruiting
Recovery After Stroke
Thumb vs Great Toe Recovery Enrolling by invitation
Functional Change With MMS Enrolling by invitation
Virtual Reality-based Distraction to Reduce Pain and Distress in the

Not yet recruiting
Pediatric Emergency Department
The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening
Not yet recruiting
From Self-collected Samples
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling Not yet recruiting
A Study to Objectively Measure Physical Activity and Sedentary Behavior
Not yet recruiting
During Cardiac Rehabilitation
Multi-parametric Breast Ultrasound Imaging as a Potential Biomarker for

Not yet recruiting
Breast Cancer
Pivotal, Randomized, Open-label Study of Optune짰 Concomitant With RT

Not yet recruiting
& TMZ for the Treatment of Newly Diagnosed GBM
Evaluating Remote Ischemic Conditioning (RIC) and Standard of Care vs.

Not yet recruiting
Sham Therapy and Standard Care
Master Study Investigating the Guiding Catheter Selectra 3D Not yet recruiting
a/LCI-OCT Pilot in Esophagus Not yet recruiting
Feasibility of Adjunctive BLT for Amelioration of Fatigue in Chinese Cancer

Recruiting
Patients Admitted to a Palliative Care Unit
TENS Used for Pain Management During Office Cystoscopy Botox

Not yet recruiting
Injections
Helmet vs Face Mask in Patients With Acute Respiratory Distress Syndrome Not yet recruiting
KinetiGait- Analysis of Depth Camera to Assist Gait Analysis for Unilateral

Not yet recruiting
Transtibial/Transfemoral Amputees
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab

Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide
Recruiting
and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated
Glioblastoma
InterStim Micro Post Market Clinical Follow-up Study Recruiting
A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a

Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Not yet recruiting
Surgical Planning and Intra-operative Navigation for Nephrectomy
Compression Nail for Tibiocalcaneal Arthrodesis Not yet recruiting
Immediate Versus Delayed Initiation of Intrauterine System Not yet recruiting
Comparing UroLift Experience Against Rez큰m Not yet recruiting
Comparing Site-selection Strategies Recruiting
Effects of rTMS on Human Brain Activity Not yet recruiting
StandUPTV: Reducing Sedentary Screen Time in Adults Not yet recruiting
G-PUR짰 for Reduced Dietary Fumonisin Bioavailability Not yet recruiting
Perry Virtual - A Prospective and Observational Rural Health Trial Recruiting

Comparison of an Inhaled Sedation Strategy to an Intravenous Sedation
Strategy in Intensive Care Unit Patients Treated With Invasive Mechanical Recruiting
Ventilation
Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With

Not yet recruiting
Potassium Ferrate for Hemostasis Following Nail Surgery
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce

Suspended
Smoking Directly Following a Quit Attempt
Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin

Nasal Spray in Comparison to Untreated Subjects and Subjects Treated
Recruiting
With Vis Alpin짰 Alpensalz Nasal Spray, All Suffering From Grass Pollen
Induced Rhinitis/Rhinoconjunctivitis
The Baerveldt Versus ClearPath Comparison Study Not yet recruiting
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated

Not yet recruiting
Gastrointestinal Endoscopes in Obesity
Blood Flow Restriction Therapy in Achilles Injury Recruiting
Optical Coherence Tomography Angiography in Subjects With Retinal

Recruiting
Vascular Disease
Da Vinci Xi NSM IDE Study Not yet recruiting
Kinesiotape Treatment for Postoperative Edema After Joint Replacement

Recruiting
Surgery of the Knee- The KNEETAPE Study
Postplacental LNG-IUD Ultrasound Use Study Not yet recruiting
Clinical Assessment of Skin Tightening and Contour Change of Submental

Not yet recruiting
Tissue Using Bipolar Radiofrequency Microneedling
SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial
Recruiting
Disease
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal
Not yet recruiting
Artery Disease
Robotic Assisted Early Mobilization in Ventilated ICU Patients Not yet recruiting
Preload and Autonomic Responses With Cardiac Neuromodulation Therapy

Recruiting
(CNT) (CS-06)
A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field
Not yet recruiting
Ablation (PFA) System With Irreversible Electroporation (IRE)
The Effects of Filter During CPET on WOB and Aerosol Particle

Recruiting
Concentrations
CorPath짰 GRX Neuro Study Not yet recruiting
THRIVE Use in Pediatric Populations- Multi Site Not yet recruiting
Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With

Not yet recruiting
ICD or CRT-D
Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients

Recruiting
Using Focused Ultrasound
Remote Ischemic Conditioning for Parkinson's Disease Recruiting
Endovascular Acute Stroke Intervention - Tandem OCclusion Trial Not yet recruiting
Human Use Condition Study- Evaluation of Implanted Leads in Humans Not yet recruiting
Tele-health Enabled Clinical Trial for COVID-19 Not yet recruiting
High Flow Nasal Cannula Oxygen During Sedation for Video-assisted

Recruiting
Thoracoscopic Surgery
Analysis of Balance and Mobility for Parkinson Disease After Whole Body
Recruiting
Vibration
Low-Level Laser in Head and Neck Chronic Lymphedema Not yet recruiting
Cerliponase Alfa Observational Study in the US Not yet recruiting
Remote Ischemic Conditioning Paired With Endovascular Treatment for

Not yet recruiting
Acute Ischemic Stroke
Sensory-specific Peripheral Stimulation for Tremor Management Recruiting
Development of a Urine-Based Point-of-Care Test for Adherence to

Recruiting
Antiretroviral Drugs
Transnasal Sphenopalatine Ganglia Block for Management of Chronic

Not yet recruiting
Migraines in Pediatric Patients
A Workplace Exercise Intervention in Dubai to Improve Cardio-metabolic
Not yet recruiting
Health
Post Approval Study of the BARD짰 COVERA??Arteriovenous (AV) Stent

Recruiting
Graft
The Effect of Breastfeeding Support on Hospitalization Due to Jaundice Not yet recruiting
Active Sensory Exercise for Chronic Stroke Not yet recruiting
Test of the Safety, Effectiveness, & Acceptability of An Improvised Dressing

Not yet recruiting
for Sickle Cell Leg Ulcers in the Tropics
Quality-of-Life Management for COPD Patients Recruiting

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in
Recruiting
Patients With Known or Suspected CAD (Ammonia MAP)
Health eHeart BEAT-AFib - Health eHeart Biomarkers of Early Atrial

Not yet recruiting
Transformation in Atrial Fibrillation
Detection of SpO2-oscillations of Low Ventilated Areas Not yet recruiting
Neuronal Mechanisms of Human Episodic Memory Enrolling by invitation
SpotCheck: Comparison of Enhanced Telemedicine Versus In-person

Recruiting
Evaluation for the Diagnosis of Skin Cancer
Evaluation of Implants Placed Without Bone Grafts in Two Different Sinus

Not yet recruiting
Floor Elevation Techniques.
Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH Not yet recruiting
Intracardiac Versus Transesophageal Echocardiography for Left Atrial

Not yet recruiting
Appendage Occlusion Combined With Radiofrequency Ablation
Towards the Use of Instrumented Tests for Screening the Risk of Falling in
Recruiting
Patients With Chronic Illness.
TAP Block Using Liposomal Bupivacaine for Post-cesarean Delivery

Recruiting
Analgesia- Walking Towards Recovery
VERARE : Effectiveness of Virtual Motor Actions for Improving Walking in
Not yet recruiting
Patients With Post-resuscitation Muscle Weakness
Investigating the Effects of Sensory Input Orthotics in Disorders of Posture

and Movement
Maximizing Bone Health for Life Not yet recruiting
Ultrasound Localization and Guided Injection for Superior Cluneal Nerve

Not yet recruiting
Entrapment
OS NMB Depth Measured by Central and Peripheral Monitor. Not yet recruiting
Osteoporosis and Haemophilia Not yet recruiting
Investigating the Neural Systems That Support the Beneficial Effects of

Not yet recruiting
Positive Emotion on Stress Regulation
Auditory Training and Hearing Aid Satisfaction Recruiting
Effect of Continue RISS Block in Thoracotomy Recruiting
The Network Study: Soldiers Connecting for Work and Health Not yet recruiting
Early Versus Delayed Artificial Rupture of Membranes (AROM Trial) Not yet recruiting
Accuracy of Rhythm Detection by a Wearable Smart Watch for Cardiac

Not yet recruiting
Arrhythmias (The WATCH-RHYTHM Study)
Improving Control Measures and Revolutionizing Asthma Care Using

Not yet recruiting
mHealth
Gut Microbiome and Ventricular Arrhythmias Not yet recruiting
The Efficacy of Physical Activity on Improving Health Outcomes for Renal

Not yet recruiting
Transplant Patients and Their Caregivers
Using Technology to Track Pain and Pain-related Outcomes Recruiting
Improving Cardiovascular Risk Factors in Black Young Adults Not yet recruiting
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination

Recruiting
With Nivo. in Melanoma Patients
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer

Not yet recruiting
Screening Among Women in Appalachia
Amplify Gait to Improve Locomotor Engagement in Spinal Cord Injury Not yet recruiting
COVID-19 Virtual Care at Home Recruiting
Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging Recruiting
Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized

Recruiting
Patient With Confirmed COVID-19 Disease
Pegylated Interferon - 慣2b With SARSCoV- 2 (COVID-19) Recruiting
A 3D Hydrogel Model to Assess Endothelial Cell-macrophage Interactions

Not yet recruiting
in Simulated Microgravity (OR-DRPD-SRI2019)
Colorectal Cancer Screening Using Stool DNA-based SDC2 and SFRP2

Not yet recruiting
Methylation Test in China
Charit챕 Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients Recruiting
Daily Activity Study of Health Recruiting
AR Vs In-Person Simulation Assessment of Medical Personnel Enrolling by invitation
Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia Not yet recruiting
The Effect of Inhaled Nitric Oxide on Maximal Oxygen Consumption During

Recruiting
Exercise in Hypoxia
The International Diabetes Closed Loop (iDCL) Trial: Protocol 4 Recruiting
Effects of Robotic Rehabilitation in Post-Stroke Patients Not yet recruiting
Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel

Recruiting
Manufacturing Technology
iTBS Study for Depression in Patients With Multiple Sclerosis Not yet recruiting
Ultrasound Quantification of Liver Fat Recruiting
Cooling Vest May Reduce Heat Stress During Surgery Not yet recruiting
McGRATH vs Macintosh Laryngoscopy Comparison in LMA Insertion Not yet recruiting
Alternating Current Stimulation for Essential Tremor Not yet recruiting
A 2-Year Prospective Follow-up Study of the Global Unite Reverse Fracture

Not yet recruiting
Shoulder System for Proximal Humerus Fractures
The Effectiveness of Dynamic Taping in Preventing Muscle Fatigue Not yet recruiting
Assessment of Tube Position According to the Changes of Neck Position
Not yet recruiting
Between Two Different Types of Nasotracheal Tubes
Comparing The Performance Of Two Different Daily Disposable Lenses

Not yet recruiting
(MIKI)
Effectiveness of a Novel Respirator With Chitosan Nanoparticles Not yet recruiting
Physiological vs Right Ventricular Pacing in Patients With Normal

Not yet recruiting
Ventricular Function Post-TAVI
The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation

Not yet recruiting
Dermatitis in Breast Cancer Patients
Comparison of Two ECG Guided PICC Insertion Techniques Not yet recruiting
Near-infrared Spectroscopy Guided Percutaneous Coronary Intervention in

Not yet recruiting
Patients With Acute Myocardial Infarction
Comparing the Performance of 1 Day Multifocal Contact Lenses Not yet recruiting
Impact of Transcutaneous Vagal Nerve Stimulation on Stress Response in
Not yet recruiting
Major Depression
Vagal Nerve Stimulation in mTBI Not yet recruiting
Partially Covered Metal Stents Efficacy in Biliary Drainage of Malignant

Not yet recruiting
Extra-hepatic Biliary Obstruction
Comparing Biofinity Toric Multifocal to Ultra Multifocal for Astigmatism Not yet recruiting
The Role of Pre-deployment Retraction in Decreasing Biopsy Clip Migration

Recruiting
During Stereotactic Breast Biopsies
COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia Not yet recruiting
A Register Based Prospective Study During Implementation of a New Cup Not yet recruiting
eHealth Insomnia Intervention for Adult Survivors of Childhood Cancer Not yet recruiting
Acute Kidney Injury After Cardiac Surgery; A Prospective Randomized Study

Not yet recruiting
of Dextran Based and Crystalloid Priming Solutions
Clinical Performance of Chairside CAD/CAM Restorations Not yet recruiting
Virtual Reality for the Treatment of Chronic Low Back Pain Recruiting
Mechanistic Clinical Trial of Individualized tDCS for Hallucinations in

Not yet recruiting
Schizophrenia
Major Adverse Limb Events in Patients With Femoro-popliteal and Below-

the-knee Peripheral Arterial Disease Treated With Either Sirolimus-coated Not yet recruiting
Balloon or Standard Uncoated Balloon Angioplasty
Study to Evaluate Iovera짰째 in Adult Patients Undergoing Total Knee
Not yet recruiting
Arthroplasty
Neurofeedback in Individuals With Substance Use Disorders Not yet recruiting
Comparing Pvc or Silicone Gastric Calibration Tube During Sleeve

Not yet recruiting
Gastrectomy
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At
Not yet recruiting
Rest
Evaluation of the Effect of TMS on Primary Dysmenorrhea Not yet recruiting
Closure After Total Shoulder Arthroplasty: Prineo vs Dermabond Not yet recruiting
HygiRelief Procedure and HygiSample Evaluation for Functional

Not yet recruiting
Constipation
Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to

Recruiting
Saline Nasal Spray.
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) Not yet recruiting
A Single Center Proof Of Concept Study To Assess Intra And Perioperative

Recruiting
Safety Profile Of OMNI Surgical System
Ultrasound Evaluation of Cervical Dilation Using DILAPAN-S (USE-Dilapan) Not yet recruiting
EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19
Recruiting
Follow up
Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry

Recruiting
Age-Related Macular Degeneration
Electrostimulation of Skeletal Muscles in Patients Listed for a Heart

Recruiting
Transplant
Dilapan-S짰 for Induction of Labor The Feasibility Study Recruiting
To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in

Not yet recruiting
Patients With Primary Liver Cancer
Vollure for the Correction of Atrophic Facial Scarring Recruiting
Quantifying Respiratory Particle Production in Children Not yet recruiting

Blood Volume Assessment in COVID-19 ICU Patients - BVAC19 Recruiting
Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout

Recruiting
During Radiotherapy
Low Energy HoLEP on IPSS Not yet recruiting
CPAP in AF Patients With OSA Recruiting
Spinal Cord Stimulation for Restoration of Arm and Hand Function in

Recruiting
People With Subcortical Stroke
Effectiveness of NextDose for Warfarin Dose Individualization Not yet recruiting
Apple Watch Heart Failure Study Not yet recruiting
Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal

Not yet recruiting
Evaluation
Different Ways of Airway Management in Elective Minor Surgeries in

Not yet recruiting
Geriatric Patients
Cerebral Blood Flow in Neonates During Thoracoscopic Surgeries Not yet recruiting
Trial Evaluating the Benefit of a Fitness Tracker Based Workout During

Recruiting
Adjuvant Radiotherapy of Breast Cancer
The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation
Recruiting
From COVID-19
Ocular-vestibular Biomarker Identification for ADHD Recruiting
tDCS for Dual-task Performance in Patients With PD Not yet recruiting
Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function

Not yet recruiting
After Anterior Cruciate Ligament Reconstruction
Control-IQ Observational (CLIO) Post-Approval Study Enrolling by invitation
Synchronized Brain and Hand Stimulation After Stroke Not yet recruiting
Autonomic Cardiovascular Control in Response to Blood Volume Reduction

Recruiting
in Blood Donors
Vivity Insight: A Study of Patient Satisfaction and Visual Performance Not yet recruiting
Smartphone-based Brainwave Entrainment (BWE) Technology in Chronic

Not yet recruiting
Pain
Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals Recruiting
Observational Study on the Application of High-Flow Therapy After

Not yet recruiting
Percutaneous Transfemoral Aortic Valve Replacement
Can Remote Photoplethysmography Be Used for Contactless Vital Sign

Not yet recruiting
Acquisition in a Healthcare Setting? A Prospective Comparative Study.
Near-Infrared Laser Stimulation for Various Neurological Conditions Enrolling by invitation
Performance of the Globe짰 Positioning System for Left Atrial Mapping

Not yet recruiting
During Cardiac Ablation for the Treatment of AF
Ellipsys Vascular Access System Post Market Surveillance (PS) Study Not yet recruiting
Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia

Not yet recruiting
in Assiut University Hospital
Placement of Nasogastric Tubes for Gastric Decompression in Patients With

Not yet recruiting
Bronchiolitis
Plastic Stents vs. NAGI Bi-flanged Metal Stent for Endoscopic Ultrasound
Not yet recruiting
Guided Drainage of Walled-off Necrosis
Archimedes Bio-degradable Bile Duct Stent Study Not yet recruiting
The Impact of Video Information on Preoperative Anxiety in Interventional

Not yet recruiting
Cardiology Patients.
Previously Implanted Pudendal Nerve Stimulation Recruiting

Telemedicine in Outpatient Covid-19 Patients Not yet recruiting
Clinical Results and RSA Migration Analysis of the GLOBAL ICON - Stemless
Not yet recruiting
Anatomic Shoulder
Wound Healing With Hyaluronic Acid After Alveolar Ridge Preservation Not yet recruiting
Virtual Reality as a Distraction Technique for the Management of Acute

Not yet recruiting
Pain and Anxiety During Manual Vacuum Aspiration for Miscarriage
Bispectral Index and Levels of Sedation With Propofol With/Without

Recruiting
Remifentanil in Healthy Volunteers (SONORA)
Non-invasive Transcranial Electrical Stimulation in MS Not yet recruiting
Geniculate Artery Embolization for Osteoarthritis Not yet recruiting
Deep Brain Stimulation Effects in Patients With Chronic Refractory Obesity Not yet recruiting
Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19

Recruiting
Patients
Dilapan-S짰: A Multicenter US E-registry Enrolling by invitation
Height-based Formula for Predicting the Insertion Depth of Left-sided

Recruiting
Double and the Role of Fiberoptic Bronchoscopy
Pilot TMS for Methamphetamine Use Disorder Not yet recruiting
Variability of the Autonomic Nervous System (ANS) During Cluster

Not yet recruiting
Headache (CH).
Clinical Efficacy of Virtual Reality During Office Hysteroscopy and

Not yet recruiting
Endometrial Biopsy in Subfertility
Pilot Study of PHOENIX Impact on Wound Microbiome Not yet recruiting
Pain Procedures and Anxiolysis Via Distraction With Virtual Reality Not yet recruiting
Performance Evaluation of OCT and OCT Angiography-based Ocular

Not yet recruiting
Measurements (Optical Coherence Tomography)
External Negative Pressure Dressing System vs. Traditional Wound Dressing

Not yet recruiting
for Cesarean Section Incision in Obese Women.
Fetal Treatment of Galenic Malformations Recruiting

Effects of Ischemic Preconditioning on Muscle Damage Induced by
Not yet recruiting
Excentric Exercise
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms Recruiting
Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic

Recruiting
Sphincterotomy for Difficult Cannulation?
Establishment and Evaluation of Multimodal Image Recognition System of

Not yet recruiting
Glioma Based on Deep Learning
Individualized Closed Loop TMS for Working Memory Enhancement Suspended
Prostatic Artery Embolization vs Medication for Benign Prostatic

Recruiting
Hyperplasia
Digital Intelligent Assistant for Nursing Application Not yet recruiting
Melanoma Surveillance Photography (MSP) to Improve Early Detection of

Not yet recruiting
Melanoma in Ultra-high and High Risk Patients
Defining the Operating Parameters for a Rebound-esthesiometer Not yet recruiting
DESyne X2 Post Market Follow-up Study Not yet recruiting

Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for
COVID-19
Pain and Itch Reduction in Burn Scars Treated With Fractional CO2 Laser Not yet recruiting
High Pressure Non Invasive Ventilation in Hypercapnic Respiratory Failure Not yet recruiting
INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study Recruiting
Does Addition of a Vessel Loop in Wound Closure Improve Suture

Recruiting
Removal?
Continuous Versus Intermittent cARdiac Electrical moNitorinG Not yet recruiting
Mechanomyography for Predictor of Prognosis in CuTS and PND Patients Recruiting
Evaluation and Comparison of Efficacy Between Extracorporeal Magnetic

Innervation and High-intensity Kegel Exercise Regimen in Treatment of Recruiting
Stress Urinary Incontinence in Female
Cost-Effectiveness of Rotator Cuff Repair Methods Not yet recruiting
Regulation of Amygdala Via Neurofeedback in PTSD After Childhood

Not yet recruiting
Sexual Abuse
The CUSA Clarity Bone Tip Study Not yet recruiting
Advisory Lead ARDS Respirator Management Not yet recruiting
A Novel Mobile Phone Application ( OptiBP) for Blood Pressure Monitoring Not yet recruiting
Transcranial Magnetic Stimulation for Psychological Distress in Patients

Not yet recruiting
With Advanced Illness
Novel Support Surface to Alleviate Pressure Ulcer Recruiting
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions Not yet recruiting
Prognostic Tools in Patients With Acute Pulmonary Thromboembolism. Not yet recruiting
Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks Recruiting
Skeletal Health and Bone Marrow Composition Among Youth Recruiting
The Role of Convex Skin Barrier in Prevention of Peristomy Skin

Not yet recruiting
Complication-Randomized Controlled Trial
Diagnosing Intensive Care Unit (ICU) Acquired Weakness Suspended

Restylane Refyne for Correction of Horizontal Neck Rhytides Recruiting
Non-invasive Aortic Aneurysm Tissue Characterization Using Wall

Not yet recruiting
Viscoelasticity
reSET-O RCT (Randomized Controlled Trial) Not yet recruiting
EpCS in Severe Treatment Resistant Depression Not yet recruiting
Unna Boots for Ankle Fracture Swelling Not yet recruiting
Clinical Evaluation of Primary Sampling Scatter Correction for Chest

Recruiting
Tomosynthesis
Confirmatory Study of HFVI Guided Analgesic Administration in Surgical

Not yet recruiting
Subjects
Hypothermia Risk With Continuous Renal Replacement Therapy Not yet recruiting
Online Spanish Cognitive Intervention Program for Spanish-Speaking

Recruiting
Latino/Hispanic Subarachnoid Hemorrhage Patients
Capsule Endoscopy for Severe Hematochezia Not yet recruiting
Atorvastatin Effects On Arterial Stiffness In Hemodialysis Not yet recruiting
Multi-Parametric MRI for Renal Transplantation Not yet recruiting

Efficacy of Transcranial Direct Current Stimulation in Treatment of Cognitive
Recruiting
Deficits in Early Stages of Psychosis
The Acute Effect of Cervical Mobilization in Parkinson's Disease Not yet recruiting
Association of Trichloroacetic Acid Peel With Photobiomodulation in the

Not yet recruiting
Treatment of Cutaneous Hand Photoaging.
Antibodies Responses to COVID-19 Infection in Hospitalized Patients Not yet recruiting
Inspiratory Muscle Training in Patients With Acute Myocardial Infarction Not yet recruiting
Oral Anti Diabetic Agents in the Hospital Recruiting

Improving Outcomes for Patients With SDB and Insufficient Sleep Not yet recruiting
Moxibustion Combined With Characteristic Lifestyle Intervention of

Not yet recruiting
Traditional Chinese Medicine in the Treatment of Abdominal Obesity
Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes Not yet recruiting
Protocol Design of Hand Robotics Assisted Therapy in Patients With

Not yet recruiting
Different Severity of Stroke
Clinical Evaluation of Oral Rinse for Xerostomia Enrolling by invitation
Utilization of PTNS During Office-Based Cystoscopy Not yet recruiting
Effect of Kinesiotaping on Muscle Activity Not yet recruiting
The Acute Effect of Lumbosacral Mobilization in Parkinson's Disease Not yet recruiting
Respiratory Effects of E-Cigarettes Among Youth / Young Adults Not yet recruiting
Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma Not yet recruiting
Effectiveness of Healthy Habits for Hospitalized Older Adults to Optimize

Not yet recruiting
Rehabilitation
Effectiveness of Stroke Riskometer Apps In Improving Awareness and
Recruiting
Stroke Risk Probability
Effect of Transcranial Direct Current Stimulation on Sensory Integration Not yet recruiting
Acupuncture for Oligomenorrhea Due to Polycystic Ovary Syndrome Not yet recruiting
Comparison of Non-invasive and Invasive Blood Pressure Monitors Not yet recruiting
Clinical Outcomes of USCTR vs. mOCTR Not yet recruiting
Virtual White Boards for Patient Satisfaction Not yet recruiting
Strategies for Reducing Sperm DNA Fragmentation in ICSI Semen Samples:

Not yet recruiting
a Prospective Randomized Controlled Trial
Ventricular Sling for Heart Failure With Reduced Ejection Fraction Not yet recruiting
Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease

Not yet recruiting
(ESRD) Patients With Type 2 Diabetes
Infrared Socks Effect on Oxygenation of Diabetics Feet and Lower Leg Not yet recruiting
Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment

Not yet recruiting
of rGBM
Military Alerting System for Monitoring Body Temperature During Active

Not yet recruiting
Cooling
Time in Range (TIR) and Time Below Range (TBR) in Insulin-Treated Elderly
Not yet recruiting
Patients With Type 2 Diabetes
Biomechanical and Neural Mechanisms of Post-stroke Gait Training Not yet recruiting
Home Blood Pressure Monitoring in Kidney Transplant Recipients Not yet recruiting
Perioperative Closed-loop Glucose Control Not yet recruiting
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older

Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Not yet recruiting
Obstructive Sleep Apnea (Overlap Syndrome)
Electronic Cigarettes as a Harm Reduction Strategy in Individuals With

Not yet recruiting
Substance Use Disorder
Treating Primary Progressive Aphasia (PPA) Using High-definition tDCS Recruiting
RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute
Not yet recruiting
Postoperative Pain and Opioid Use
PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine

Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Withdrawn
Carcinoma
The Effect of Acupuncture on IVF Pregnancy Outcomes for Women With

Active, not recruiting
RIF
High-definition Transcranial Electrical Stimulation for Lower Limb Stroke

Recruiting
Rehabilitation
Clinical Investigation of the Efficacy of CGF and Ozone in the Treatment of
Active, not recruiting
Alveolar Osteitis
Coronary Calcium Scoring Versus Standard Care for Emergency Department

Not yet recruiting
Chest Pain Patients
Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical

Recruiting
Alzheimer's Disease
Iontophoresis in Psoriasis Not yet recruiting
Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC) Not yet recruiting
Left Atrial Posterior Wall and PV Isolation Using Cryoballoon for Treatment
Not yet recruiting
of Persistent AF
A Prospective, Multicenter, Randomized Controlled Study of Postoperative

Not yet recruiting
Thrombosis Prevention in Patients With Cushing's Disease
Transcutaneous Stimulation for Neurological Populations Recruiting
Combination of Ranibizumab and Targeted Laser Photocoagulation Not yet recruiting
Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation

Not yet recruiting
Glaucoma
ACDF Using Structural Allograft vs. Tritanium C Recruiting

Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for
Not yet recruiting
Zone 2 Flexor Tendon Injuries.
Cognitive Behavioral Therapy for Insomnia With rTMS Recruiting
3-D Super Resolution Ultrasound Microvascular Imaging Not yet recruiting
Photodynamic Therapy for the Treatment of COVID-19 Not yet recruiting
Drain-Less Abdominally Based Breast Reconstruction Using Lysine-Derived

Not yet recruiting
Urethane Adhesive
Adapting Multiple Behavior Interventions That Effectively Improve Cancer

Not yet recruiting
Survivor Health Cancer Survivor Health
Accessible Acupuncture for the Warrior With Acute Low Back Pain Recruiting
Spironolactone to Improve Apnea and Cardiovascular Markers in

Not yet recruiting
Obstructive Sleep Apnea Patients
A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772,

a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Recruiting
Comparison to an Active Comparator
Repurposing Colchicine to Improve Vascular Function in Hypertension Recruiting
Pediatric Reporting of Adult-Onset Genomic Results Recruiting

Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm Recruiting
Reducing Sedentary Behaviour and Cognition in Older People Recruiting
Young Adults and Low Nicotine Cigarettes Suspended

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR)
Not yet recruiting
for Men With Newly Diagnosed Favorable Risk Prostate Cancer
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT Not yet recruiting
Control of Pain Due to Dentin Hypersensitivity in Individuals With Molar-

Not yet recruiting
incisor Hypomineralization
Water-only Fasting in the Treatment of Hypertension Patients Enrolling by invitation
DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly

Not yet recruiting
for Erectile Dysfunction
The SQUID Trial for the Embolization of the Middle Meningeal Artery for
Not yet recruiting
Treatment of Chronic Subdural Hematoma (STEM)
The Effect of Combining Medium Cut Off Dialysis Membrane and Diet
Not yet recruiting
Modification on Reducing of Inflammation Response
Combination of Medium Cut-off Dialyzer Membrane and Diet Modification

Not yet recruiting
to Alleviate Residual Uremic Syndrome of Dialysis Patients
Incorporating Nutrition, Vests, Education, and Strength Training in Bone
Recruiting
Health (INVEST in Bone Health)
Development of Variable Volume Automated Mandatory Boluses for

Not yet recruiting
Patient-controlled Epidural Analgesia During Labour
Targeted Gown and Glove Intervention in Nursing Homes Not yet recruiting
The Emergency Department Sedation Pilot Trial Not yet recruiting
University of Iowa Interventional Psychiatry Service Patient Registry Not yet recruiting
Efficacy and Safety of 12-weeks Supplementation of Eubacterium Hallii on

Recruiting
Insulin Sensitivity and Glycaemic Control
Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4

Not yet recruiting
Renal Cell Carcinoma With Unresected Primary
Dysport 짰 as an Adjunctive Treatment to Bracing in the Management of

Not yet recruiting
Adolescent Idiopathic Scoliosis
Reduce Pain and Improve Quality of Life in Patient With Knee

Not yet recruiting
Osteoarthritis by Light, Sound and Brain Stimulation
Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for

Not yet recruiting
Cutaneous Metastatic Breast Cancer
Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in

Recruiting
Cirrhotic Patients Undergoing Liver Transplantation
Yoga Pranayama Adjuvant to Treat Burden COVID-19 Not yet recruiting
Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade

Not yet recruiting
II Foot Ulcers
Home Pregnancy Test Evaluation, Lay User Study Not yet recruiting
The 3P Trial: Preoperative Planning and Preparation of Complex and Rare

Not yet recruiting
Procedures in GI Surgery
PRECISE CURATE.AI Pilot Clinical Trial Recruiting
The Effect of Perineal Wound Infection on the Anal Sphincter Not yet recruiting
Erector Spinae Block Versus Transversus Abdominis Plane Block In

Not yet recruiting
Laparoscopic Bariatric Surgery
Hybrid Functional Electrical Stimulation Exercise to Prevent

Not yet recruiting
Cardiopulmonary Declines in High-level Spinal Cord Injury
Effect of Thoracic Manual Therapy in Hemiplegic Patients Not yet recruiting
The Effect of 12-week Circuit Training on Insulin Sensitivity and Endothelial

Recruiting
Function in Women With Insulin Resistance
Long-term Follow-up of AGN1 Treated Patients Not yet recruiting
Neuromodulation of Ankle Muscles in Persons With SCI Recruiting
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort Recruiting
A Prospective International Multicenter Clinical Trial for Eyes With Relapsed

Not yet recruiting
Retinoblastoma
Muscle Wasting in Children and Adolescents With Cancer Not yet recruiting
Phase 4 Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in

Indian Subjects Aged >=18 Years With Severe Eosinophilic Asthma Not yet recruiting
Requiring Maintenance Oral Corticosteroids
Technology-assisted Index on Improving Hand Hygiene of Registered
Not yet recruiting
Nurses
The Natural History of Patients With Mutations in SEPN1 (SELENON) or

Recruiting
LAMA2
Mother-infant Bonding During COVID-19 Recruiting
Univation XM France Withdrawn
Investigation of Factors Affecting Cardiorespiratory Fitness in Individuals

Not yet recruiting
With Systemic Hypertension
High Frequency and Intensive Prevention Program Recruiting
AIM to Improve Asthma: Airflow Improvements During Meal-Prep Not yet recruiting
Adaptive COVID-19 Treatment Trial 3 (ACTT-3) Recruiting
Cardiovascular Rehabilitation in Patients With Severe Aortic Stenosis

Not yet recruiting
Submitted to Valvar Correction
Dysfunctional Breathing: Characterisation and Assessment Not yet recruiting
Cholecalciferol to Improve the Outcomes of COVID-19 Patients Recruiting

Rapid Antidepressant Improvement Secondary to Excitatory Brain
Not yet recruiting
Responses
Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in

Recruiting
Adults With COVID-19 Infection Requiring Mechanical Ventilation
Pilot Testing a Mobile App to Designed to Increase Physical Activity Among

Not yet recruiting
Pregnant and Postpartum Women
Allocetra-OTS in COVID-19 Recruiting
Resistance Training for Breast Cancer Survivors Recruiting
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell

Not yet recruiting
Transplant Survivors
Investigation and
of Safety Their
and Primary
Efficacy Care Providers,
of CARDIO SoftgelsTEACH Study
in Former Smokers
Not yet recruiting
and Asthma Patients With COVID-19 Infection
Cortical Priming to Optimize Gait Rehabilitation in Stroke: a Renewal Not yet recruiting
Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel
Not yet recruiting
Coronavirus
Ginkgo Leaf Infection (COVID-19)
Extract and Armillariella Mellea Powder Oral Solution for the
Recruiting
Treatment of Motoric Cognitive Risk Syndrome
연구 결과 공개 대상질환
No Results Available Inguinal Hernia
Plantar Fasciitis, Chronic|Heel Pain Syndrome|Fat Pad

No Results Available
Syndrome
Calorimetry, Indirect|Oxygen Consumption|Metabolism|

Mechanical Ventilation
No Results Available Healthy Volunteers|Narcolepsy Type 1
No Results Available Upper Respiratory Infection
No Results Available Gastro Esophageal Reflux
No Results Available Freezing of Gait|Parkinson Disease

No Results Available Digital Nerve Injury
No Results Available Clinical Depression
Central Line Complication|Central Line Infection|Central

No Results Available Line-Associated Infection|Central Line Sepsis|Short Gut
Syndrome|Quality of Life|Pediatric Disorder
No Results Available Intubation;Difficult
Airway Complication of Anesthesia|Ventilation Therapy;

Complications|Hypoxia|Hypoventilation
Opioid Overdose|Opioid-use Disorder|Substance Use

Disorders
Device-Related Thrombosis|Atrial Fibrillation|Left Atrial

Appendage Occlusion
No Results Available Low Back Pain
Knee Osteoarthritis|Knee Arthritis|Knee Pain Chronic|Knee

No Results Available Disease|Joint Pain|Osteo Arthritis Knee|Osteoarthritis,
Knee
No Results Available Nail Diseases
No Results Available Cardiogenic Shock|Decompensated Heart Failure
No Results Available Eustachian Tube Dysfunction|Facial Pain

No Results Available Arrhythmias, Cardiac
Skin Inflammation|Acne|Skin Diseases|Dermatological

Non-Disease|Skin Condition|Eczema
Ischemic Mitral Regurgitation|Functional Mitral

Regurgitation
No Results Available Pacemaker
No Results Available Stress Urinary Incontinence
No Results Available Sarcopenia|Frailty
No Results Available Hip Arthroscopy
No Results Available Vaginal Tear|Perineal Tear
No Results Available Breast Cancer|Neoadjuvant Therapy
No Results Available AKI|ARDS|COVID
No Results Available COVID 19

No Results Available Cervical Intraepithelial Neoplasia
No Results Available Asthma
No Results Available Alopecia Areata
No Results Available Hearing Loss
No Results Available Atrial Fibrillation
No Results Available Opioid-use Disorder|Pain, Postoperative
Overweight|Obesity|Overweight and Obesity|Overweight

or Obesity|Metabolic Syndrome
No Results Available Right Ventricular Dysfunction
No Results Available Meniscus Tear, Tibial|Meniscus Lesion

Infrainguinal Peripheral Artery Disease|Peripheral Arterial
Disease|PAD
No Results Available Cardioversion|Atrial Fibrillation
No Results Available Systemic Lupus Erythematosus
No Results Available Transgenderism|Catheter Related Complication
No Results Available Healthy|Type 2 Diabetes Mellitus
No Results Available Peripheral Artery Disease
No Results Available Tinnitus

No Results Available Corneal Disease|Corneal Opacity|Corneal Injuries
No Results Available Pneumoperitoneum
No Results Available Chronic Inflammatory Demyelinating Polyneuropathy
No Results Available Ambulation|Wearable Devices
Fibrosing Alopecia|Frontal Fibrosing Alopecia|Central

Centrifugal Cicatricial Alopecia
No Results Available Heart Failure
No Results Available Spinal Duraplasty
No Results Available Chronic Rhinosinusitis (Diagnosis)
No Results Available Low Back Pain
No Results Available Eosinophilic Esophagitis|Diagnoses Disease
No Results Available Intraocular Pressure

No Results Available Ventricular Tachycardia
Sleep Apnea|Alveolar Hypoventilation|Nocturnal

Hypoxemia
No Results Available Parkinson's Disease
No Results Available Osteoarthritis, Knee

Cervical Cancer|Cervical Intraepithelial Neoplasia|Human
Papilloma Virus|HPV-Related Cervical Carcinoma|Urine
No Results Available COVID-19|Respiratory Failure With Hypoxia
No Results Available Cardiac Disease
No Results Available Peri-Implantitis
Endometrial Cancer|Atypical Hyperplasia|Bariatric Surgery

Candidate
No Results Available Thermal Burn
No Results Available Head and Neck Cancer
No Results Available Open Angle Glaucoma|Ocular Hypertension
No Results Available Pelvic Organ Prolapse|Prolapse

Osteoarthritis, Hip|Rheumatoid Arthritis|Inflammatory
No Results Available Arthritis|Congenital Hip Dysplasia|Avascular Necrosis of
Hip|Femoral Neck Fractures
TMJ Disc Disorder|TMJ Pain|TMJ Sounds on

Opening/Closing the Jaw|TMJ Disease
No Results Available Breast Cancer Lymphedema
No Results Available COVID-19
No Results Available Cleft Lip and Palate
Left Ventricular Dyssynchrony|Heart Failure|

Cardiomyopathy, Dilated|Cardiac Remodeling, Ventricular
No Results Available Pulmonary Disease, Chronic Obstructive
No Results Available Depression

No Results Available Covid19
No Results Available Scoliosis Idiopathic
No Results Available Brain Injuries, Traumatic
No Results Available Heart Failure|Dilated Cardiomyopathy
No Results Available Physical Activity
No Results Available Cancer

No Results Available Aortic Valve Stenosis|Bicuspid Cardiac Valve
No Results Available Jaundice, Neonatal|Hyperbilirubinemia, Neonatal
Knee Pain|Chronic Osteoarthritis|Avascular Necrosis of the

No Results Available Femoral Condyle|Moderate Varus, Valgus or Flexion
Deformities|Rheumatoid Arthritis
No Results Available Peripheral Arterial Disease
No Results Available Residual Neuromuscular Blockade
No Results Available Photochemotherapy|Actinic Keratoses
Metastatic Colon Cancer|Liver Cancer|Intrahepatic

Cholangiocarcinoma
No Results Available Lassa Fever
No Results Available COVID-19|Acute Kidney Injury
No Results Available Multiple Sclerosis
No Results Available Heart Failure NYHA Class II|Heart Failure NYHA Class III
No Results Available Visceral and Digestive Surgery
No Results Available Care, Palliative|Respiratory Failure
No Results Available Inflammatory Bowel Diseases
No Results Available Essential Tremor|Parkinson Disease|Dystonia
No Results Available Migraine

No Results Available Newly Diagnosed Glioblastoma in Patients ??0 Years
No Results Available General Anesthesia
No Results Available Essential Tremor
Acute Respiratory Distress Syndrome|Coronavirus

Infection
No Results Available Peritoneal Dialysis-associated Peritonitis
No Results Available Psoriasis
No Results Available Blood Glucose Profile

No Results Available Diabetes|Hypoglycemia
No Results Available Pain, Neck|Virtual Reality|Proprioception|Balance
No Results Available Barrett Esophagus|GERD
Postoperative Pain|Total Knee Replacement|Total Knee

Arthroplasty
No Results Available Heart Failure|ICD
No Results Available COVID
Cardiovascular Diseases|Cardiac Arrhythmia|Conduction

Disturbance
No Results Available Type 1 Diabetes Mellitus
No Results Available Pain Perception|Patient Satisfaction

No Results Available Upper Extremity Amputee
Acute Lymphoblastic Leukemia, in Relapse|Acute
Lymphoblastic Leukemia With Failed Remission|Acute
Lymphoblastic Leukemia Recurrent|Acute Lymphoblastic
Leukemia Not Having Achieved Remission|Acute
Lymphoblastic Leukemia, Pediatric|Acute Lymphoblastic
Leukemia
No Results Available Metastatic Melanoma|Melanoma Brain Metastasis
Lung Neoplasms|Rehabilitation|Exercise|Pain,
Postoperative|Post Discharge
Basal Cell Carcinoma|Squamous Cell Carcinoma of the

Skin
No Results Available Tumor Sampling
No Results Available Chronic Low-back Pain
No Results Available Body Image|Diabetes Mellitus, Type 2
No Results Available Postoperative Pain
Degenerative Disc Disease|Degenerative

Spondylolisthesis|Degenerative Scoliosis
No Results Available Blood Pressure
No Results Available Treatment Resistant Depression

No Results Available Type 1 Diabetes Mellitus
No Results Available Sepsis
No Results Available Patellofemoral Pain Syndrome
No Results Available Cognitive Aging|Alzheimer Disease, Protection Against
Stroke|Cerebral Infarction|Brain Diseases|Central Nervous

System Diseases|Cerebrovascular Disorders|Brain
Ischemia|Brain Infarction|Vascular Diseases|Infarction|
Nervous System Diseases|Cardiovascular Diseases
No Results Available Muscle Weakness
No Results Available Children Requiring IV Placement
No Results Available Human Papilloma Virus|Cervical Cancer|CIN 2/3
No Results Available Androgenic Alopecia

Cardiac Disease|Myocardial Infarction|Cardiac Valve
Disease|Coronary Artery Disease
No Results Available Breast Cancer
No Results Available Glioblastoma Multiforme
No Results Available Diabetic Foot Ulcer
No Results Available Pacemaker DDD
No Results Available Barrett Esophagus
No Results Available Fatigue|Cancer
No Results Available Overactive Bladder
Acute Respiratory Distress Syndrome|Noninvasive

Ventilation|Corona Virus Disease|Acute Respiratory Failure
No Results Available Lower Limb Amputation
No Results Available Gliosarcoma|MGMT-Unmethylated Glioblastoma

Overactive Bladder|Fecal Incontinence|Non-obstructive
Urinary Retention
No Results Available Kidney Cancer
No Results Available Subtalar Arthritis|Ankle Arthritis
No Results Available Contraception
No Results Available Benign Prostatic Hyperplasia
No Results Available Deafness
No Results Available Repetitive Transcranial Magnetic Stimulation (rTMS)
No Results Available Sedentary Behavior|Screen Time|Physical Activity|Sleep
No Results Available Reduction of Dietary Fumonisin Bioavailability
No Results Available COPD|Arrhythmia|Murmur, Heart|Chronic Disease

No Results Available Prevention of Delirium
No Results Available Nail Diseases
Smoking|Smoking Cessation|Craving|Addiction|Addiction
Nicotine|Nicotine Dependence|Cigarette Smoking
No Results Available Allergic Rhinitis|Allergic Rhinoconjunctivitis
No Results Available Glaucoma
Hypoxia|Gastric Cancer|Esophagus Cancer|Polyp of Colon|

Colon Cancer
No Results Available Achilles Injuries Tendon
Diabetic Retinopathy|Retinal Vein Occlusion|

Hypertension,Essential|Retinal Vascular Disorder
No Results Available Nipple Sparing Mastectomy
No Results Available Postoperative Edema
No Results Available IUD Insertion Complication
No Results Available Skin Laxity
Peripheral Artery Disease|Atherosclerosis|Arterial Disease

of Legs
No Results Available Peripheral Artery Disease|Atherosclerosis|Arterial Disease
Critical Illness Polyneuromyopathy|Critical Illness|Early

Ambulation|Rehabilitation
No Results Available Bradycardia|Hypertension, Systolic

No Results Available Transmission, Patient-Professional
Intracranial Aneurysm|Subarachnoid Hemorrhage|

Headache
Oxygen Deficiency|Desaturation of Blood|Hypoventilation|

Anesthesia; Adverse Effect
No Results Available Alzheimer Disease
No Results Available Parkinson's Disease
No Results Available Stroke, Acute|Carotid Stenosis|Carotid Artery Diseases
No Results Available Human Use Study

No Results Available SARS-CoV Infection
Chronic Obstructive Pulmonary Disease|Respiratory

Failure
No Results Available Parkinson Disease
No Results Available Head and Neck Cancer|Lymphedema|Fibrosis
No Results Available Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2
No Results Available Acute Stroke
No Results Available Parkinson's Disease|Essential Tremor
No Results Available Medication Adherence|HIV
No Results Available Migraine in Children|Pain, Neuropathic

Cardiovascular Risk Factor|Pre Diabetes|High Blood
Pressure|Elevated LDL Cholesterol
No Results Available Arteriovenous Fistula
No Results Available Hyperbilirubinemia, Neonatal|Jaundice, Neonatal
No Results Available Stroke
No Results Available Sickle Cell Leg Ulcer
No Results Available Copd|Chronic Respiratory Disease

Myocardial Ischemia|Coronary Disease|Coronary Artery
Disease|Heart Diseases|Cardiovascular Diseases|
Arteriosclerosis|Arterial Occlusive Diseases|Vascular
Diseases
No Results Available Atelectasis
No Results Available Epilepsy Intractable
No Results Available Skin Cancer
No Results Available Dental Implant Placement
No Results Available Cardiovascular Risk Factor|Nicotine Dependence
Joint Osteoarthritis|Atherosclerosis of the Distal Arteries,

No Results Available Without Gangrene|Parkinson Disease|Chronic Obstructive
Pulmonary Disease, Unspecified|Obesity, Unspecified
No Results Available Opioid Use|Pain, Acute

No Results Available Weakness of the Lower Limbs
No Results Available Cerebral Palsy
Acute Lymphoblastic Leukemia, Pediatric|Pediatric ALL|

Pediatric Lymphoma|Bone Loss|Metabolic Syndrome|
No Results Available Habitual Physical Activity|Precursor Cell Lymphoblastic
Leukemia|Lymphoma|Leukemia|Lymphoid Leukemia|
Pediatric|Osteoporosis|Osteoporosis Risk
No Results Available Low Back Pain|Nerve Entrapment Syndrome
No Results Available Neuromuscular Blockade
No Results Available Osteoporosis|Haemophilia|Bone Mass
No Results Available Behavior
No Results Available Hearing Impairment, Sensorineural
No Results Available Postoperative Pain|Thoracotomy
No Results Available Alcohol Use Disorder|Depression

No Results Available Induction of Labor Affected Fetus / Newborn
Ventricular Tachycardia|Ventricular Fibrillation|Gut

Microbiome
No Results Available Chronic Kidney Diseases
No Results Available Pain, Chronic
No Results Available Obesity
No Results Available Melanoma
No Results Available Cervical Carcinoma|Human Papillomavirus Infection

No Results Available Incomplete Spinal Cord Injury
No Results Available Covid-19
No Results Available Kidney Cancer

No Results Available Cardiovascular Diseases
Colorectal Neoplasm|Colorectal Cancer|Adenomatous

Polyps|Adenoma|Advanced Adenoma|Serrated Polyp
No Results Available Aging
No Results Available Educational Problems
No Results Available Hypoxia

No Results Available Type 1 Diabetes
No Results Available Visual Acuity

No Results Available Multiple Sclerosis|Depression, Anxiety
No Results Available Non-Alcoholic Fatty Liver Disease
No Results Available Body Temperature Changes
No Results Available Intubation Complication|Intubation;Difficult|Anesthesia
No Results Available Essential Tremor
No Results Available Shoulder Fractures
No Results Available Fatigue; Muscle, Heart|Shoulder Pain|Sport Injury

No Results Available Nasotracheal Intubation
No Results Available Myopia
Covid19|SARS-CoV Infection|Worker-Patient Transmission,

Healthcare
Transcatheter Aortic Valve Implantation|Physiological

Pacing|Right Ventricular Pacing|AV Block
No Results Available Breast Cancer|Radiation Dermatitis
Central Venous Access|Long Term Antibiotics|

Chemotherapy|Total Parenteral Nutrition
Myocardial Infarction|Coronary Artery Disease|Myocardial

No Results Available Ischemia|Atherosclerosis|Lipid-Rich Atherosclerosis of
Coronary Artery|Vascular Diseases|Infarct Ischemia
No Results Available Presbyopia

No Results Available Major Depressive Disorder
No Results Available PTSD|mTBI
No Results Available Biliary Obstruction
No Results Available Astigmatism|Presbyopia
No Results Available Breast Biopsy
Severe Acute Respiratory Syndrome Coronavirus 2|

Hypoxemic Respiratory Failure|Pneumonia, Viral|COVID
No Results Available Prospective

Childhood Cancer|Insomnia|Neurocognitive Impairment|
Survivorship|Late Effect|Sleep
Cardiac Surgical Procedures|Extracorporeal Circulation;

Complications|Acute Kidney Injury
No Results Available Dental Cements|Caries,Dental
No Results Available Back Pain Lower Back Chronic
No Results Available Schizophrenia and Related Disorders
No Results Available Peripheral Arterial Disease

No Results Available Post-Operative Pain Management
No Results Available Opioid-Related Disorders
No Results Available Surgery|Calibration Tube
Pulmonary Disease, Chronic Obstructive|Lung Diseases,

No Results Available Interstitial|Pulmonary Fibrosis|Hypoxemia|Dyspnea|Oxygen
Inhalation Therapy
No Results Available Primary Dysmenorrhea
Shoulder Arthritis|Shoulder Arthropathy Associated With

Other Conditions
No Results Available Rome IV Functional Constipation
No Results Available Allergic Rhinitis|Allergic Rhinoconjunctivitis
Injuries, Spinal Cord|CVA (Cerebrovascular Accident)|

No Results Available Traumatic Brain Injury|MS (Multiple Sclerosis)|Muscle
Spasticity|Cerebral Palsy, Spastic
No Results Available Open Angle Glaucoma
No Results Available Cervical Dilation|Induction of Labor|Ultrasound Evaluation

No Results Available Covid19|Pulmonary Disease
No Results Available Age Related Macular Degeneration
No Results Available Sarcopenia|Heart Failure, Systolic
No Results Available Induction of Labor Affected Fetus / Newborn
No Results Available Hepatocellular Carcinoma
No Results Available Atrophic Scar
No Results Available Droplet Spread

No Results Available Covid19|Acute Respiratory Distress Syndrome
Bronchial Carcinoma|Esophageal Carcinoma|Tumor of the

No Results Available Brain|Head and Neck Cancer|Pancreas Cancer|Sarcoma|
Cervix Uteri Cancer
Prostate Hyperplasia|Prostatic Hypertrophy|Surgery|

No Results Available Bladder Outlet Obstruction|Quality of Life|Complication of
Surgical Procedure
No Results Available Atrial Fibrillation|Sleep Apnea
Stroke|Brain Diseases|Central Nervous System Diseases|

Nervous System Diseases|Cardiovascular Diseases
No Results Available Thrombosis Embolism
No Results Available Type 1 Diabetes
Comparison of Different Laryngeal Mask Wearing

Methods
Tracheo Esophageal Fistula|Congenital Diaphragmatic

Hernia

No Results Available Coronavirus|Post Intensive Care Unit Syndrome
ADHD - Combined Type|ADHD|ADHD Predominantly

No Results Available Inattentive Type|ADHD, Predominantly Hyperactive -
Impulsive
No Results Available Parkinson Disease
Anterior Cruciate Ligament Reconstruction|Quadriceps

Muscle Weakness|Transcranial Direct Current Stimulation
No Results Available Diabetes Mellitus, Type 1
No Results Available Stroke|Upper Extremity Paresis
No Results Available Autonomic Dysfunction|Autonomic Imbalance|Blood Loss
No Results Available Cataract
No Results Available Chronic Pain

No Results Available Transcatheter Aortic Valve Replacement
Coronavirus|Cardiac Disease|Respiratory Disease|Vascular

Diseases
Refractory Depression|Anxiety Disorders|

No Results Available Neurodegenerative Diseases|Traumatic Brain Injury|
Chronic Traumatic Encephalopathy
Renal Disease, End Stage|Kidney Disease, End-Stage|AV

Fistula|Fistulas Arteriovenous
No Results Available Coronavirus
No Results Available Bronchiolitis
No Results Available Acute Necrotizing Pancreatitis|Walled Off Necrosis
Bile Leak|Common Bile Duct Stone With Chronic

Cholecystitis
No Results Available Coronary Artery Disease|Atrial Fibrillation|Atrial Flutter
No Results Available Urinary Retention|Underactive Bladder

No Results Available Covid-19|Cardiovascular Risk Factor
No Results Available Osteoarthritis of the Shoulder
No Results Available Healing Wound
No Results Available Miscarriage
No Results Available Anesthesia
No Results Available Multiple Sclerosis|Cognitive Impairment
Osteo Arthritis Knee|Arthritis|Osteoarthritis|Osteoarthritis,

Knee
Post Term Pregnancy|Premature Rupture of Membrane|

No Results Available Fetal Growth Retardation|Oligohydramnios|Gestational
Diabetes|High Blood Pressure in Pregnancy
No Results Available Thoracic Anesthesia

Stimulant Dependence|Methamphetamine-dependence|
Addiction, Drug
No Results Available Cluster Headache
No Results Available Infertility, Female
No Results Available Virtual Reality|Anxiety|Pain
No Results Available Normal Eyes and Ocular Pathology
No Results Available Wound Dehiscence
No Results Available Vein of Galen Malformations

No Results Available Healthy
No Results Available Endoscopic Retrograde Cholangiopancreatography
No Results Available Glioma
No Results Available Working Memory in Healthy Participants
No Results Available BPH|Enlarged Prostate (BPH)|Prostatic Hyperplasia
Frailty Syndrome|Fall in Nursing Home|Dementia|Delirium

in Old Age|Incontinence, Urinary|Incontinence Bowel
No Results Available Melanoma|Skin Cancer|Anxiety and Fear
Corneal Sensation Reduced|Corneal Dystrophy|Corneal

Degeneration|Corneal Transplant Failure|Herpetic Keratitis
No Results Available Coronary Artery Disease

No Results Available Acute Respiratory Distress Syndrome|COVID-19
No Results Available Hypertrophic Scar|Burn Scar
No Results Available Acute Hypercapnic Respiratory Failure
No Results Available Bradycardia
No Results Available Patient Satisfaction|Suture, Complication
No Results Available Torsades de Pointe Caused by Drug|Long QT Syndrome
No Results Available Cubital Tunnel Syndrome|Peroneal Nerve Entrapment
No Results Available Stress Urinary Incontinence
Rotator Cuff Injuries|Shoulder Pain|Shoulder

No Results Available Impingement|Shoulder Injuries|Shoulder Bursitis|Shoulder
Tendinitis|Shoulder Lesions
No Results Available PTSD

No Results Available Cranial Skull Base Bone Removal
No Results Available ARDS, Human
No Results Available Technology
Depressive Symptoms|Depression, Anxiety|Psychological

Distress|Terminal Illness
No Results Available Immobility Syndrome|Pressure Ulcer|Pressure Injury
No Results Available Coronary Artery Disease
No Results Available Pulmonary Embolism
No Results Available Abdominal Aortic Aneurysm
No Results Available Gender Dysphoria in Children|Puberty|Bone Development
No Results Available Stoma Colostomy|Stoma Ileostomy
No Results Available ICU Acquired Weakness

No Results Available Aging|Wrinkle|Rhytides
No Results Available Abdominal Aortic Aneurysm Without Rupture
No Results Available Opioid-use Disorder
No Results Available Treatment Resistant Depression
No Results Available Ankle Fractures
No Results Available Pulmonary Nodule, Solitary|Pulmonary Nodule, Multiple
No Results Available Analgesia
No Results Available Acute Kidney Injury|Hypothermia
Subarachnoid Hemorrhage|Cognitive Impairment|Quality

of Life|Depression, Anxiety
No Results Available Hematochezia
No Results Available Arterial Stiffness
No Results Available Renal Transplant Rejection

No Results Available Schizophrenia
No Results Available Idiopathic Parkinson Disease
No Results Available Skin Aging
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-

No Results Available CoV 2 Infection)|Hospitalized Patients|Laboratory-
confirmed SARS-CoV 2 Infection
No Results Available Acute Myocardial Infarction
No Results Available Diabetes Mellitus

Sleep Apnea|Insufficient Sleep Syndrome|Sleep|
Hypertension
No Results Available Diabetes Mellitus, Type 1
No Results Available Xerostomia
No Results Available Cystoscopy
No Results Available Healthy
No Results Available Idiopathic Parkinson Disease
No Results Available E Cig Use
Asymptomatic COVID-19 Infection Laboratory-Confirmed|

Symptomatic COVID-19 Infection Laboratory-Confirmed
No Results Available Insomnia|Pain|Osteoarthritis, Knee|Osteoarthritis, Hip

No Results Available Stroke|Cardiovascular Diseases|Risk Factor, Cardiovascular
No Results Available Diabetic Polyneuropathy
No Results Available Polycystic Ovary Syndrome|Oligomenorrhea
No Results Available Blood Pressure|Surgery|Intensive Care Unit
No Results Available Carpal Tunnel
Satisfaction, Patient|Covid19|Emergencies|Satisfaction|
Information Disclosure
No Results Available Male Infertility

No Results Available Heart Failure|Cardiomyopathy, Dilated
No Results Available End-Stage Renal Disease|Type 2 Diabetes
No Results Available Diabetes
No Results Available Recurrent Glioblastoma
No Results Available Hyperthermia

No Results Available Continuous Glucose Monitoring
Hypertension|Cardiovascular Diseases|Kidney Transplant;

Complications
Perioperative Hyperglycaemia|Insulin Therapy|Elective

Surgery|Closed-Loop Glucose Control|Artificial Pancreas
Sleep Apnea Syndrome|Obstructive Sleep Apnea|COPD|

No Results Available Overlap Syndrome|Quality of Life|Neurocognitive
Function|Sleepiness|Elderly|Positive Airway Pressure
No Results Available Cigarette Smoking|Addiction|E Cig Use
No Results Available Primary Progressive Aphasia
No Results Available Opioid Use|Arthropathy of Knee|Pain, Postoperative
No Results Available Renal Cell Carcinoma
No Results Available Repeated Implantation Failure

No Results Available Alveolar Osteitis
No Results Available Chest Pain
Alzheimer Disease, Early Onset|Atypical Alzheimer's

Disease|Logopenic Progressive Aphasia
No Results Available Psoriasis|Psoriasis Vulgaris|Skin Diseases
Kidney Cancer|Renal Cell Carcinoma|Metastatic Renal Cell

Carcinoma
No Results Available Persistent Atrial Fibrillation
No Results Available Cushing Disease|DVT|Pulmonary Embolism
No Results Available Neurological Disorder|Cerebral Palsy
No Results Available Central Retinal Vein Occlusion With Macular Edema
No Results Available Pseudoexfoliation Glaucoma
No Results Available Degenerative Disc Disease

No Results Available Flexor Tendon
No Results Available Depression|Insomnia
No Results Available Breast Cancer|Thyroid Cancer
Photodynamic Therapy& Low Level Laser in Management

of COVID 19
Breast Cancer|Colorectal Cancer|Endometrial Cancer|

No Results Available Kidney Cancer|Multiple Myeloma|Ovary Cancer|Prostate
Cancer
No Results Available Acupuncture|Low Back Pain
No Results Available Obstructive Sleep Apnea
No Results Available Healthy Volunteers|Pneumococcal Disease
No Results Available Essential Hypertension
Hereditary Breast and Ovarian Cancer Syndrome|Lynch

Syndrome|Familial Hypercholesterolemia
No Results Available Salt; Excess|Blood Pressure Disorders
No Results Available Mild Cognitive Impairment
No Results Available Smoking

No Results Available Prostate Cancer
No Results Available Cancer
No Results Available Dentin Sensitivity|Molar Incisor Hypomineralization
No Results Available Hypertension
No Results Available Erectile Dysfunction
No Results Available Subdural Hematoma, Chronic
End Stage Renal Disease|Haemodialysis|Diet, Healthy|

Chronic Inflammation
No Results Available End Stage Renal Disease|Haemodialysis|Diet, Healthy

No Results Available Weight Loss|Bone Health
No Results Available Labor Pain|Breakthrough Pain
Staphylococcus Aureus|Carbapenem Resistant Gram

Negative Bacteria
No Results Available Mechanical Ventilation|Respiratory Failure
Treatment Resistant Depression|Major Depressive

No Results Available Episode|Major Depression|Major Depressive Disorder|
Bipolar Disorder|Bipolar Depression
Pre Diabetes|Impaired Glucose Tolerance|Insulin

No Results Available Sensitivity|Insulin Resistance|Glucose Metabolism
Disorders|Metabolic Syndrome
No Results Available Renal Cell Carcinoma|Renal Cell Carcinoma Stage IV
No Results Available Adolescent Idiopathic Scoliosis
No Results Available Knee Osteoarthritis
No Results Available Metastatic Breast Cancer
Liver Transplantation|Portal Hypertension|Blood

Transfusion|Blood Loss, Surgical
No Results Available Coronavirus Infection|Cytokine Storm|Mental Disorder
No Results Available Pregnancy Related
No Results Available Surgical Procedures, Operative
No Results Available Solid Tumor
Obstetric Trauma|Perineum; Injury|Perineal Infection|Anal

Sphincter Injury
No Results Available Erector Spinae Block|Bariatric Surgery Candidate
No Results Available Spinal Cord Injuries
No Results Available Insulin Resistance

No Results Available Osteoporosis
No Results Available Spinal Cord Injuries|Spastic Gait|Foot Drop
Joint Osteoarthritis|Atherosclerosis of the Distal Arteries,

No Results Available Without Gangrene|Parkinson Disease|Chronic Obstructive
Pulmonary Disease, Unspecified|Obesity, Unspecified
No Results Available Eye Cancer, Retinoblastoma
Cachexia; Cancer|Muscle Wasting|Child Development|

Adolescent Development

No Results Available Hand Hygiene
No Results Available MDC1A|SELENON-related Myopathy
No Results Available Child Development|Mother-Infant Interaction|COVID-19
Osteoarthritis, Knee|Osteoarthrosis of Knee|Arthritis Knee|

Unicompartmental Knee Arthroplasty
Systemic Hypertension|Muscle Weakness|Vascular

Stiffness
No Results Available Parkinson Disease|Mild Cognitive Impairment
No Results Available Asthma in Children|Pollution; Exposure
No Results Available Aortic Valve Stenosis
Respiration Disorder|Hyperventilation Syndrome|

Breathlessness|Breath Shortness

No Results Available Major Depressive Disorder|Depression
No Results Available Pregnancy|Postpartum
Breast Cancer|Surgery|Chemotherapy Effect|Radiotherapy

Side Effect|Pain, Chronic
No Results Available Skin Carcinoma

No Results Available Asthma; Eosinophilic|COVID|Covid-19
Motoric Cognitive Risk Syndrome|Mild Cognitive
Impairment|Aging|Locomotive Syndrome
중재방법
Device: LiquiBand FIX8 Open Hernia Mesh

Fixation Device
Device: PopSole??Offloading Device
Device: Q-NRG+ Indirect Calorimetry Device|

Device: V(max) Encore Indirect Calorimetry
Device
Device: Portable EEG Device|Device: Portable

ECG Device|Device: Accelerometry
Device: SinuSonic Device|Device: Sham

SinuSonic Device
Device: LEFT Device
Device: Tactile Cueing Device

Device: TISSIUM??Nerve Coaptation Device
Device: SANA Device|Device: Sham SANA

Device
Device: Wearable Central Line Securement

Device (Vest)|Other: Traditional Securement
Dressing
Other: Training|Device: supraglottic airway

device
Device: A/Z Supraglottic airway
Other: Survey|Other: Interview
Drug: ASA plus Clopidogrel|Drug: Genetic-

Tailored AntiThrombotic Strategy|Drug: Half-
Dose of novel OAC
Other: Rehabilitation
Device: ROMTech PortableConnect|Device:

Traditional Rehabilitation and CPM Device
Device: External thermomechanical device

delivering cold and vibration stimuli|Device:
External thermomechanical device without
delivering cold and vibration stimuli
Other: Measuring Pressure Volume Loop Pre

and Post Device Placement
Device: SinuSonic Device

Device: Insertion of ILR device
Device: Joovv Mini
Device: Implant an epicardial device to

reshape the mitral valve annulus
Device: Remote Monitoring|Other: Standard of

care
Device: Leva Pelvic Digital Health System|

Other: Kegel exercises
Device: Virtual Gate Device (VGD)
Device: Modified hip capsule side fixed slotted

cannula|Device: Modified bone graft delivery
tool set
Device: BabySlide
Combination Product: Study Device Arm
Device: SCD
Device: ensoETM device

Device: Standard C02 Cryotherapy|Device:
Single Tip Thermoablation|Device: Multiple Tip
Thermoablation
Other: Hailie Smart Inhaler EMD
Device: Tattoo machine (SOL Nova Device)
Device: Polaris miniRITE BTE|Device: Viron

miniRiTE BTE
Diagnostic Test: Prolonged continuous single-

lead ECG monitor|Diagnostic Test: Intermittent
ECG monitor|Diagnostic Test: Routine practice
Device: NSS-2 Bridge|Device: Inactive NSS-2

Bridge|Other: Active control
Device: Vestal Device|Device: Control Device|

Behavioral: Hypocaloric Diet
Diagnostic Test: Hemodynamic assessment
Device: JuggerStitch Meniscal Repair Device
Device: DeTAP App and Home Devices

Device: AURYON??System
Device: Apple Watch|Device: Fitbit Inspire
Behavioral: Pillsy
Device: Urethrotech Urethral catheterisation

device (UCD)|Device: Bardia Aquafil long term
catheter
Device: Abbott Freestyle Libre Pro
Device: Wireless Lumee Oxygen Platform
Device: Tinnitus Implant System

Device: CorNeat KPro
Device: Cold and dry CO2

pneumoperitoneum|Device: Warm and
humidified CO2 pneumoperitoneum
Device: Vital EMS+|Drug: Standard of Care
Device: Wearable Pedometer
Device: SOL Nova Device
Device: Occlutech Atrial Flow Regulator
Device: Adherus Dural Sealant System|Device:

DuraSeal Exact Dural Sealant System
Drug: Budesonide|Device: Mucosal

Atomization Device|Device: NeilMed squeeze
bottle for Impregnated Nasal Saline Irrigation
Device: zLOCK Facet Fusion System
Device: EsoCheck
Device: icare HOME device (Icare Oy, Vanda,

Finland)
Device: Intrinsic Antitachycardia Pacing (iATP)
Therapy
Device: Simultaneous recording of nocturnal

SpO2
Device: Biofeedback, Myomed 632|Device:

device for electrical stimulation, BTL 4000
Smart|Other: kinesitherapy
Device: Colli-Pee Small Volumes (10 mL)
device
Other: ELMO PROJECT AT COVID-19: STUDY

IN HUMANS|Device: ELMO PROJECT AT
COVID-19: PROOF OF CONCEPT AND
USABILITY
Device: Cardiac Performance System (NSR)
Procedure: Titanium curette.|Procedure:

Ultrasonic|Procedure: Air-polishing
Procedure: Bariatric Surgery
Device: whole body vibration device|Other:

routine physical therapy treatment
Device: Ring gantry kV-CBCT combined with

linear accelerator (Halcyon)|Radiation: Quad
shot radiation
Device: Minimally invasive glaucoma surgery

(MIGS)
Device: Reia Vaginal Pessary
Drug: Sacubitril-Valsartan|Drug: Standard of

care
Device: Total hip arthoplasty (THA)
Device: JuggerKnot Mini Soft Anchor
Device: Flexitouch Plus with Cellular

Connectivity (FT-CC)
Device: Emergency Ventilator Splitter
Device: 3D NAM|Device: Traditional NAM
Device: Cardiac resynchronization therapy ON|

Device: Cardiac resynchronization therapy OFF
Device: iTBS Device/Motor Threshold Coil|

Device: iTBS Device/Treatment Coil
Device: Breath Biopsy face masks with
removable filters and fitted PVA strip|
Diagnostic Test: Nasopharyngeal swab|
Diagnostic Test: oropharyngeal swabs
Device: Anterior Vertebral Body Tethering
Device: Tbit system
Device: PITA
Device: Wearable Medical Device (Empatica

E4)|Diagnostic Test: COVID-19 PCR Swab|
Diagnostic Test: Pulse Oximeter
Behavioral: PAI score to motivate physical

activity|Behavioral: Step Counter to motivate
physical activity
Device: Nano-X Patient Rotation System|

Radiation: Conventional CBCT scan|Other:
Psychometrically validated questionnaires
Other: FEops HEARTguideTM
Device: Bilirubin estimates from Smartphone

Application|Diagnostic Test: Bilirubin
concentration measured in standard blood
samples|Device: Bilirubin estimates from
standard transcutaneous device|Other: Visual
assessment of jaundice
Procedure: Device: Persona Total Knee|

Procedure: Device: NexGen Total Knee|
Procedure: Device: Vanguard Total Knee
Device: Exoskeleton footwear
Device: TetraGraph
Drug: Ameluz|Device: Portable Apple Smart

Phone Protoporphyrin IX Spectrometer
Camera|Device: Photodynamic Therapy Light
Device: Medtronic Synchromed II pump

Drug: INO-4500|Device: CELLECTRA??2000|
Drug: Placebo
Biological: SBI-101
Device: DreaMS
Device: Reveal LINQ??Insertable Cardiac

Monitor with investigational ALLEVIATE-HF
RAMware download|Other: Medication
intervention
Other: Remote Automated Monitoring System
Device: Tetragraph
Device: High Flow Nasal Cannula|Other:

Standard respiratory support
Device: Whoop strap 3.0
Device: Active biphasic pulse stimulation---

Home Settings|Device: Active biphasic pulse
stimulation---VIN Biphasic|Device: Active
biphasic pulse stimulation---Stimulator Off
Device: StimRelieve Halo System

Device: TTFields
Device: Using robot system of endotracheal

intubation and airway cleaning
Device: DiaNose
Device: Medtronic Summit Rechargable (RC)

+S|Procedure: ipsilateral thalamic (VIM+VO)
DBS|Procedure: standard ET DBS|Procedure:
ipsilateral VO
Drug: vadadustat|Drug: placebo
Device: CloudCath Monitoring System
Combination Product: Furoscix Infusor
Device: Med-Jet|Other: Traditional Syringe
Device: Temporary Continuous Glucose

Monitoring System
Device: CardioMEMSTM HF sensor -

pulmonary artery pressure measurement
Other: 13C-MRS procedure/Acetate infusion|
Device: Continuous glucose monitoring
Device: Core Warming|Other: Standard of Care
Other: Virtual Reality
Device: Cytosponge|Device: Transnasal

Endoscopy (TNE)|Device:
Esophagogastroduodenoscopy
Device: SPRINT Peripheral Nerve Stimulation

(PNS) System
Other: Specialized heart function clinic
Device: LifeSignals Biosensor 1AX*|Other:

Standard of Care
Diagnostic Test: Electrocardiogram diagnosis
Device: Tandom t:slim X2 with HCL or PLGS
Combination Product: Aromastick

Device: iSens
Biological: CAR-20/19-T cells
Device: NovoTTF-200A|Drug: Pembrolizumab
Device: Actiwatch 2 (Philips Respironics,

Murrysville, USA)
Device: CivaDerm
Device: Endodrill Model X|Device: Fine-needle

aspiration/biopsy
Device: EaseVRx headset|Device: Active control

VR sham program
Device: LLLT Combination Red/Gold/IR

Therapy
Device: Placebo comparator: VR googles and
the non reality experience|Device: Active
Comparator: VR googles and the real VR
program to enter act with and experience
Device: A&D UA-651 Blood Pressure Monitor|

Device: ADC 740-N Manual
Sphygmomanometer
Device: FEAST|Device: FEAST RP|Device: FEAST

RC
Device: Omnipod Horizon??Automated
Glucose Control System
Device: Capillary Refill Assessment
Device: NMES and exercise supplemented

with high BFR|Device: NMES and exercise
supplemented with low BFR
Device: Active NIR-PBM|Device: Sham NIR-

PBM
Behavioral: Arm Boot Camp
Device: TetraGraph
Device: The ZELTIQ System
Device: Virtual Reality Distraction
Device: Evalyn Brush
Device: Tattoo machine

Device: mp-BUS data collection
Device: Optune짰
Device: Remote Ischemic Conditioning (RIC)

Treatment
Device: Catheter
Device: a/LCI-OCT imaging probe|Procedure:

esophageal biopsy
Device: bright light therapy
Device: Active TENS|Device: Sham TENS
Device: Non invasive ventilation via helmet
Device: KinetiGait
Biological: Ipilimumab|Biological: Nivolumab|

Device: NovoTTF-100A Device|Other: Quality-
of-Life Assessment|Other: Questionnaire
Administration|Radiation: Radiation Therapy|
Drug: Temozolomide
Device: InterStim Micro
Device: IRIS 1.0
Device: novel dynamic compression

intramedullary nail
Device: Intrauterine system|Other: Alternative

contraception to intrauterine system
Device: UroLift|Device: Rezum
Behavioral: Site selection
Device: rTMS|Device: Sham rTMS|Procedure:

MRI scan
Behavioral: Device-based feedback, self-

monitoring, and eduction: CORE|Behavioral:
Sedentary Screen Time lockout: LOCKOUT|
Behavioral: Context-based prompts: TEXT|
Behavioral: Earn sedentary screen time
through moderate-vigorous physical activity:
EARN
Device: 2.0g G-PUR짰|Other: Placebo
Device: Coala Heart Monitor

Drug: Propofol + morphine|Drug: Isoflurane +
morphine
Device: Hydrophilic polymer and potassium

ferrate powder
Device: Real cTBS to the vmPFC|Device: Sham

cTBS to the vmPFC|Device: Real iTBS to the
dlPFC|Device: Sham iTBS to the dlPFC
Device: nasal spray|Other: no treatment
Device: Baerveldt 350 implant|Device: Ahmed

ClearPath 350 implant
Device: High-flow nasal cannula oxygenation|

Device: Regular nasal cannula
Other: Standard of Care Physical Therapy|

Other: Blood flow restriction
Device: Swept-Source OCT Angiography|

Device: Spectral-Domain OCT Angiography|
Device: Fundus Imagning|Device: Axial Length
Measurement Device
Device: Nipple-Sparing Mastectomy
Device: lymphtaping using Easytape짰|

Procedure: compression treatment|Device:
sham taping
Other: Ultrasound use
Device: Dermal Handpiece
Device: MagicTouch PTA Sirolimus drug

coated balloon|Device: POBA balloon
Device: MagicTouch PTA sirolimus drug

coated balloon (DCB)|Device: POBA standard
balloon
Device: Robotic-assisted early mobilization|

Other: Early mobilization
Device: Moderato IPG's CNT pacing signals|

Device: CD Leycom Pressure/Volume
Combination Catheters
Device: Pulsed Field Ablation (PFA) Therapy
Device: Respiratory filter in-line placed with

the standard mask|Other: Standard mask
Device: Robotic Endovascular Procedure
Device: Transnasal Humidified Rapid-

Insufflation Ventilatory Echange
Drug: ACEI/ARB|Drug: ARNI
Device: Neuronavigation-guided single-

element focused ultrasound transducer|Drug:
Definity|Other: Magnetic Resonance Imaging
(MRI) with or without gadolinium contrast
agents|Other: Positron Emission Tomography
(PET)|Other: Amyvid
Device: Remote ischaemic conditioning|Other:
conventional therapy
Device: Carotid artery stenting|Drug:

Antiplatelet Agents
Drug: Vitamin D3 or Placebo|Device: Doctella
telehealth monitoring
Combination Product: High flow nasal

cannula|Combination Product: CONTROL
Device: Whole body vibration
Device: Low-level laser
Drug: Cerliponase Alfa|Device: Administration

Kit
Device: Remote ischemic conditioning.|

Procedure: Endovascular treatment.|Device:
Sham remote ischemic conditioning
Device: Peripheral electrical stimulation|Device:

Single pulse TMS
Drug: dolutegravir oral tablet 50mg|Drug:

emtricitabine/tenofovir alafenamide oral tablet
200mg/25mg|Drug: tenofovir disoproxil
fumarate oral tablet 300mg|Drug: lamivudine
oral tablet 300mg
Other: Headache Journal|Drug: Sphenopalatine

Block|Device: Tx360
Other: Exercise Time|Behavioral: Supervised
Group Exercise
Device: Covera Vascular Covered Stent
Other: Support for breastfeeding and the

feeding of infants' with breast milk
Behavioral: Active training|Behavioral:

Conventional training
Device: Usual Practice|Device: Improvised

dressing|Device: Advanced dressing
Combination Product: CAir

Diagnostic Test: Myocardial Perfusion Imaging
Study|Drug: AMMONIA N-13 37.5 mCi in 1 mL
INTRAVENOUS INJECTION [Ammonia N 13]
Behavioral: Cedrus RB-844 response pad;

Adtech Behnke-Fried micro-electrodes;
Neurolynx electrophysiology system; Blackrock
Cerestim stimulator
Device: Nevisense 3.0|Device: Dermlite Cam|

Procedure: Skin biopsy
Procedure: crestal sinus approach technique|

Procedure: Lateral sinus approach
Other: Electronic Cigarette
Procedure: LAAC combined with

radiofrequency ablation group
Diagnostic Test: Exploratory physiopathology

study, including non-invasive functional
explorations carried out in patients with
chronic pathology.
Drug: Liposomal bupivacaine|Drug:

Bupivacaine|Other: Control group
Other: Observation of Virtual Actions|Other:
Relaxation|Other: Acceptability questionnaire|
Other: Observation of Virtual Actions (step 4)|
Other: Performing Virtual Actions|Other:
Haptic stimulation|Other: Without haptic
stimulation
Device: Flexible orthotic|Device: Standard

orthotic
Other: Ultrasound guided hydrodissection of

superior cluneal nerve
Diagnostic Test: measuring neuromuscular

block
Behavioral: Positive Emotion Induction|

Behavioral: Neutral Emotion Induction
Behavioral: Auditory Brian Training

Games/Activities
Drug: Tramadol|Other: IV PCA
Other: Internet-Delivered Brief Intervention

Procedure: amniotomy|Device: Foley Catheter|
Drug: Misoprostol
Other: AFib detection with wearable smart

watch
Diagnostic Test: Stool test for microbial

analysis
Behavioral: Physical Activity Intervention
Other: Navio Mobile App
Behavioral: Smartphone + Text Messaging

with Health Coach
Drug: Tavo|Drug: Nivolumab|Device: OncoSec

Medical Electroporation Therapy System
Other: Best Practice|Procedure: HPV Self-

Collection|Other: Informational Intervention|
Other: Medical Chart Review|Behavioral:
Patient Navigation Program|Other: Survey
Administration
Device: Gait training performed on a treadmill|
Device: Gait training performed in a
Movement Amplification Environment
Other: Virtual Care at Home
Drug: Perflutren lipid microsphere|Drug: Sulfur

hexafluoride lipid microspheres
Drug: NP-120 (Ifenprodil)

Drug: Pegylated Interferon-慣2b|Other:
Standard of Care
Biological: Blood collected specifically for this

study
Diagnostic Test: Stool-based SDC2 and SFRP2

DNA methylation test|Diagnostic Test: FIT
Drug: Cenicriviroc (CVC)|Drug: Placebo
Behavioral: Motivational MRI and Behavioral

Intervention|Behavioral: Control MRI and
Behavioral Intervention
Other: Augmented Reality (AR)|Other:

Standard In Person Training Simulation
Drug: Tofacitinib 10 mg|Drug: Placebo
Drug: Nitric Oxide|Drug: Placebo

Device: interoperable Artificial Pancreas
System (iAPS)|Other: Sensor-Augmented Pump
(SAP)/Predictive Low Glucose Suspend (PLGS)
Device: Intervention group (Robotic

rehabilitation)|Other: Control group
(Conventional physiotherapy)
Device: ACUVUE짰 OASYS 1-DAY

Device: intermittent theta burst stimulation
using a MagPro X100|Device: sham
intermittent theta burst stimulation using a
MagPro X100
Device: Magnetic Resonance Imaging (MRI)|

Device: Ultrasound Imaging
Device: Cooling Vest|Device: Control Group

without cooling vest
Device: McGRATH laryngoscopy|Device:

Macintosh laryngoscopy
Device: transcranial Altering Current

Stimulation|Device: Sham tACS
Device: Reverse Total Shoulder Arthroplasty|

Device: Hemiarthroplasty
Device: Sham tape|Device: Dynamic tape

Device: Portex|Device: Mallinckrodt
Device: Test Contact Lens|Device: Control

Contact Lens
Device: VESTA respirator|Device: Conventional

N95 respirator
Device: Physiological pacing|Device: Right

ventricular pacing
Device: RadiaAce gel|Device: Biafine
Device: LifeCath-CT PICC easy??(Vygon)|

Device: PowerPICC-SOLO짰 (C.R. Bard)
Device: Near-infrared spectroscopy (NIRS)|

Device: Angiography
Device: Lens A|Device: Lens B

Device: active tVNS|Device: Sham tVNS
Device: sham stimulation|Device: nVNS
Device: Biliary drainage with PC-SEMS|Device:

Biliary drainage with U-SEMS
Device: comfilcon A|Device: Samfilcon A
Device: 5mm retraction of clip deployment

apparatus.|Device: No retraction of clip
deployment apparatus.
Device: Helmet Continuous Positive Airway

Pressure (CPAP)|Device: High Flow Nasal
Oxygen (HFNO)
Device: Total hip arthroplasty

Device: Sleep Healthy Using the Internet
(SHUTi) Intervention Group|Device: Online
Patient Education (PE) Control Group
Device: Colloid priming solution for ECC

circuit|Device: Standard priming solution for
ECC circuit
Device: Lithium disilicate onlays (IPS

emaxCAD/Ivoclar)|Device: Chairside zirconia
crowns (3M)
Device: HTC Vive with Karuna Virtual Reality

Program|Device: HTC Vive with Lumen
Program
Device: neuroConn DC-Stimulator MR|Device:

Soterix MxN HD-tES
Device: sirolimus-coated balloon catheter|

Device: uncoated balloon catheter
Device: iovera쨘|Device: iovera쨘 sham
Device: Experimental feedback|Device: Control

feedback
Device: thin pvc gastric tube|Device: thick

silicone gastric tube
Device: Nasal Delivery of High-Flow Air and

Oxygen Therapy|Device: Nasal Delivery of
Oxygen Therapy
Device: active rTMS|Device: sham rTMS
Device: 2-Octyl Cyanoacrylate and Mesh|

Device: 2-Octyl Cyanoacrylate
Device: HygiPrep (HyGIeaCare System)
Device: nasal spray
Device: Prometra II Programmable Pump -

Flowonix Medical
Device: OMNI Surgical System
Device: Dilapan-S
Device: EarSats Pulse Oximeter Probe
Device: Photobiomodulation
Device: Neuromuscular electrical stimulation

(NMES)
Device: Dilapan S
Device: microwave ablation
Device: Allergan Vollure
Device: Various commercially available face

coverings
Device: BVA-100
Device: Fitness tracker based activity training

for Arm A and B. Booklet "physical training,
exercise and cancer" and an introduction
about physical activity during cancer therapy
for Arm A, B, C
Device: Holmium laser
Device: continuous positive airway pressure
Device: Epidural electrical stimulation (EES) of

the cervical spinal cord
Device: NextDose (nextdose.org)
Device: Apple Watch
Device: Artificial Pancreas (AP)
Device: direct laryngoskopy
Device: cerebral oximetry ( INVOS 5100 )
Device: Fitness tracker based activity training

for Arm A and B. Booklet "physical training,
exercise and cancer" and an introduction
about physical activity during cancer therapy
for Arm A, B, C
Device: Virtual Reality
Device: EYE-SYNC
Device: transcranial Direct Current Stimulation

(tDCS)
Device: Anodal transcranial direct current

stimulation (tDCS) - Soterix Medical Inc, 1x1
tDCS (conventional)
Device: t:slim X2 pump with Control-IQ

technology
Device: Combined Non-invasive brain

stimulation and functional electrical hand
stimulation
Device: Monitoring of the autonomic nervous

system
Device: Alcon Vivity or Vivity Toric IOL
Device: Brainwave Entrainment

Device: KELEA Excellerated Water
Device: High-Flow Oxygen Therapy
Device: Remote Photoplethysmography (rPPG)

vital sign acquisition
Device: Near Infrared Laser Stimulation
Device: Globe Positioning System
Device: Ellipsys Vascular Access System
Device: CT of the chest
Device: Nasogastric tube placement
Device: Endosonography guided transmural

drainage
Device: ERCP and insertion ofBio-degradable

bile duct stent
Device: educational video
Device: Medtronic Interstim II Model 3058

Neurostimulator
Device: Withings ScanWatch
Device: Total joint arthroplasty of the

glenohumeral joint
Device: Gengigel Forte짤
Device: Virtual reality
Device: BIS
Device: non-invasive transcranial electrical

stimulation
Device: Geniculate Artery Embolization
Device: DBS of the LHA
Device: miniprobe Alveoflex
Device: Dilapan-S
Device: double lumen tube

Device: Transcranial Magnetic Stimulation
Device: Holter electrocardiogram
Device: Oncomfort, commercially available

Virtual Reality headset
Device: PHOENIX Wound Matrix
Device: Virtual Reality Headset Distraction
Device: optical coherence tomography
Device: External negative pressure dressing

system (Yuwell 7E-A portable suction unit)
Device: Fetal embolization of vein of Galen

malformation using Target XL and XXL
Detachable Coils
Device: Ischemic Preconditioning
Device: Vielight RX Plus
Device: Biliary cannulation
Device: PET/CT, H-MRS and MRI
Device: Repetitive Transcranial Magnetic

Stimulation (rTMS)
Device: Prostatic Artery Embolization

(HydroPearl짰 compressible microspheres)
Device: Three dimensional sensor system

designed for fall detection (Fearless)
Device: 2D or 3D Melanoma Surveillance

Photography
Device: Esthesiometer measurement
Device: Percutaneous Coronary Intervention

Device: V/Q Vest
Device: Luminis ultrapulse fractional ablative

carbon dioxide laser
Device: High pressure non invasive ventilation

in acute hypercapnic respiratory failure
Device: INGEVITY+ Lead
Device: Vessel loop (FDA product code FZZ)
Device: BodyGuardian Heart
Device: Mechanomyography (MMG)
Device: Peritron perineometer
Procedure: Rotator cuff repair surgery
Device: Neuro-Feedback EFP

Device: CUSABT
Device: Activation of Advisory
Device: novel mobile phone application for

blood pressure monitoring.
Device: repetitive Transcranial Magnetic

Stimulation (rTMS)
Device: Novel support surface
Device: Drug-coating balloon
Device: computed tomography pulmonary

angiography
Device: IMPEDE-FX Embolization Plug
Device: GnRH Agonist
Device: convex skin barrier
Device: Clinical Electrical Stimulator

Device: Restylane Refyne
Device: Multiphase scan CT, non-invasive

vascular ultrasound elastography by
ultrasound (NIVE)
Device: reSET-O app
Device: Epidural Prefrontal Cortical Stimulation

(EpCS)
Device: Unna Boot
Device: Scatter corrected s-DCT
Device: HFVI
Device: Thermax Blood Warmer
Device: brainHQ by Posit Science
Device: Second-generation colon capsule

endoscopy system
Drug: Atorvastatin|Drug: Placebo
Device: Magnetic Resonance Imaging

Device: Transcranial Direct Current Stimulation
Other: cervical mobilization|Other: home-

based exercise
Combination Product: 20% TCM and PBM|

Other: 20% TCM and PBM placebo
Diagnostic Test: Testing procedure for Binding

antibodies|Diagnostic Test: Neutralizing
antibodies
Other: Inspiratory Muscle Training
Drug: Oral Anti-diabetes Drugs alone|Drug:

Basal bolus insulin|Drug: Supplemental insulin|
Device: (Optional) FreeStyle Libre Pro Flash
Glucose Monitoring System
Behavioral: PAP Treatment|Behavioral: Sleep
Education I|Behavioral: Sleep Education II
Device: moxibustion combined with

characteristic lifestyle intervention of
traditional chinese medicine|Device:
Moxibustion combined with lifestyle
intervention.|Device: lifestyle intervention
Device: Personalized Feedback|Device:
Decision Support System|Device: Sensor-
Augmented Pump therapy
Device: Amadeo-assisted training-1|Device:

Amadeo-assisted training-2|Device: Amadeo-
assisted training-3
Device: HYDRAL Oral Rinse|Device: BIOTENE짰

Oral Rinse|Device: Placebo Oral Rinse
Procedure: Percutaneous Tibial Nerve

Stimulation (PTNS)|Procedure: Sham
Percutaneous Tibial Nerve Stimulation (PTNS)|
Procedure: Standard Cystoscopy
Other: Kinesiotaping
Other: control group|Other: mobilization

group
Procedure: Biospecimen Collection|Other:

Diagnostic Laboratory Biomarker Analysis|
Other: Electronic Health Record Review|Other:
Questionnaire Administration
Behavioral: Healthy Habits|Behavioral: Sleep

Habits
Device: Stroke Riskometer Application|Other:
Informational Leaflets
Device: transcranial direct current stimulation

and traditional physical therapy program|
Other: designed physical therapy program
Device: Acupuncture+Usual care|Behavioral:

Usual care
Device: ViTrack|Procedure: Radial artery

catheterization
Device: USCTR|Procedure: mOCTR
Device: e-ink screen|Behavioral: Treatment as

usual
Device: PICSI|Other: Second ejaculate

Device: Papillary Muscle Sling|Procedure:
CABG surgery
Device: Dexcom G6 CGM|Diagnostic Test: POC

BG
Device: Active IR sock|Other: Placebo socks
Device: Exablate BBBD|Drug: Carboplatin
Device: Forearm cooling|Other: Mist-fan

cooling
Device: Application of the FreeStyle Libre
Flash Glucose CGM.|Diagnostic Test: InBody
270 multifrequency bioimpedance
Device: Grass S8800 stimulator with SIU8TB

stimulus isolation unit; UDel stimulator|Other:
Fast treadmill walking
Device: Home blood pressure apparatus|Other:

Clinic blood pressure
Device: CamAPS|Drug: Standard insulin

therapy
Device: Positive airway pressure|Other:

Conservative care (control arm)
Device: E cigarettes|Other: Nicotine

Replacement Therapy
Device: high-definition transcranial direct

current stimulation|Behavioral: modified
constraint-induced language therapy
Device: RelieVRx headset|Drug: multi-modality

pain management
Drug: Durvalumab|Drug: Tremelimumab|

Device: TDS-IM v1.0 System|Biological:
Neoantigen DNA Vaccine|Procedure: Research
blood draw
Device: acupuncture and IVF|Device: sham

acupuncture and IVF|Other: IVF only
Device: HD-tCES|Device: Sham HD-tCES|Other:

Lower limb rehabilitation
Device: Ozone|Device: CGF|Other: Traditional
treatment
Device: Coronary Calcium Scoring|Procedure:

Standard Care
Device: Active HD-tDCS|Device: Sham|Other:

Word List Learning Intervention (WordLLI)
Device: Activapatch intellidose 2.5 using active

Iontophoresis|Device: Activapatch intellidose
2.5 using inactive Iontophoresis|Drug:
Dexamethasone
Diagnostic Test: Doppler Ultrasound|Device:

Vantage 256 with C5-2v transducer
Procedure: Standard Cryoballoon Pulmonary
Vein Isolation (PVI)|Device: Cryoballoon PVI +
Posterior Wall Isolation
Drug: LMWH/Rivaroxaban|Device: IPC
Other: Gait Training|Device: Transcutaneous

Spinal Stimulation
Drug: Ranibizumab Injection|Device: Laser

photocoagulation
Procedure: Phacoemulsification|Device:
Selective Laser Trabeculoplasty
Procedure: Structural allograft|Device:

Tritanium C
Procedure: Standard of Care Surgical
Procedure|Device: VersaWrap Treatment
Behavioral: CBT-I (Cognitive Behavioral

Therapy for Insomnia) with rTMS|Device:
Repetitive Transcranial Magnetic Stimulation
Drug: Definity|Device: Acoustic Angiography
Procedure: photobiomodulation and

photodynamic therapy
Device: Tissue Glu|Device: Drain|Other:

Questionnaires
Behavioral: Adapting MultiPLe Behavior

Interventions That eFfectively Improve
(AMPLIFI) Cancer Survivor Health|Other: Diet-
Exercise|Other: Exercise-Diet|Other: Wait-list
Control- Combined Diet and Exercise
Drug: NSAIDS|Device: Battlefield Acupuncture|

Device: GV26 with manual tonification
Drug: Spironolactone|Drug: Placebo
Biological: ASP3772|Biological: PCV13
Drug: Colchicine Tablets|Drug: Placebo
Genetic: Receive an adult-onset result|Genetic:

Receive a pediatric-onset result|Genetic:
Control - No Result
Drug: Allopurinol|Other: Dietary Intervention
Behavioral: WALC-R|Other: Information leaflet
Other: Nicotine content

Device: Decipher|Device: Prolaris|Device:
Oncotype Dx Genomic Prostate Score (GPS)|
Other: Standard of care (askMUSIC score)
Device: FDG PET/CT|Device: FLT PET/CT|Device:

PET/MR|Drug: [F-18] flurothymidine
Other: Hygiene Instructions|Procedure: Sealant

application|Radiation: Low-level Laser
Other: Water-only Fasting
Device: DualStim Therapy|Biological: Umbilical

cord-derived Wharton's Jelly|Other: Saline
Device: SQUID|Procedure: Burr-hole|Other:

Medical Management
Device: medium cut-off (MCO) dialysis

membrane|Dietary Supplement: Dietary fiber
mixture (Plantago Psyllium 69% and Inulin
30%)|Dietary Supplement: Sodium propionate
Device: medium cut-off (MCO) dialysis

membrane|Dietary Supplement: Dietary fiber
mixture (Plantago Psyllium and Inulin)|Dietary
Supplement: Sodium propionate
Device: Vest|Behavioral: Resistance Exercise
Training|Behavioral: weight loss program
Device: Epidural infusion pump|Drug:

Ropivacaine|Drug: Fentanyl
Other: Targeted gown and gloves use
Behavioral: Education|Other: Standard post

intubation sedation practices
Device: Electroconvulsive Therapy (ECT)|

Device: Transcranial Magnetic Stimulation
(TMS)|Drug: Ketamine|Drug: Esketamine
Dietary Supplement: Eubacterium hallii|Other:

Placebo
Drug: Nivolumab|Drug: Ipilimumab|Device:

bland embolization
Drug: AbobotulinumtoxinA|Drug: Placebos|

Device: Custom Thoracolumbosacral Orthosis
Other: High Intensity LASER Therapy (HILT)|

Other: Ibuprofen Gel Phonophoresis (IGP)|
Other: Transcranial Direct Current Stimulation
(tDCS)|Other: Conventional
Device: Epicutaneous Physiotherapy
cryoimmunotherapy|
(CPT)
Drug: Topical imiquimod|Drug:
Pembrolizumab|Other: Dermatologic Quality
of Life Index|Other: Functional Assessment of
Cancer Therapy|Drug: Intra-lesional GM-CSF|
Device: Cry-AC|Procedure: Cutaneous tumor
biopsy|Procedure: Peripheral blood draw for
research
Behavioral: morning Yoga-based breathing
support|Behavioral: pre_lunch Yoga-based
breathing support|Behavioral: pre_dinner
Yoga-based breathing support
Biological: ALLO-ASC-SHEET
Procedure: Augmented preoperative planning
Device: CURATE.AI|Drug: Capecitabine|Drug:

XELOX|Drug: XELIRI
Diagnostic Test: Three-dimensional Endoanal
Ultrasound|Diagnostic Test: Transperineal
Ultrasound(multiplanar)|Diagnostic Test: The
MolecuLight i:X: Bacterial autofluorescence
camera|Device: Silhouette짰 3D camera:
Three-dimensional
Procedure: wound
transversus measuring
abdominis camera
block|
Procedure: Erector spinae block|Drug:
Bupivacaine 0.25% Injectable Solution|Device:
Siemens Acuson x300 3-5MHz Ultrasound
Drug: Buspirone Hydrochloride|Drug:
Buspirone placebo|Device: Noninvasive
Ventilation (NIV)|Device: Sham Non-invasive
ventilation (NIV)|Other: Functional Electrical
Stimulation Row Training (FESRT)
Other: Manuel Therapy
Behavioral: Circuit training (combination of

strength and endurance exercises)
Other: Clinical imaging is performed during
the 24 and 60 month follow-up visits
Other: Whole Body Vibration (WBV)|Other:

Electrical Stimulation
Other: Development of a screening algorithm

designed to determine a "dysmobility" profile
in patients with chronic illness.
Drug: Topotecan|Drug: Melphalan
Behavioral: Multidisciplinary care with a

personalized care
Drug: Prednisone/ Prednisolone|Biological:

Mepolizumab|Drug: Salbutamol
Behavioral: Technology-assisted Index
Other: No intervention
Behavioral: Family Nurture Intervention (FNI)
Other: High frequency and intensive

prevention program
Behavioral: Cooking Ventilation Intervention
Drug: Interferon beta-1a|Other: Placebo|Drug:

Remdesivir
Other: Short-form survey instrument|Other:

Behavioral: cardiovascular rehabilitation
Demographic data|Other: Hospital Anxiety and
program
Depression Scale|Other: Nijmegen
questionnaire|Other: The Self-evaluation of
breathing questionnaire|Other: six-minute
exercise test|Other: Indirect calorimetry|Other:
Oxygen saturation monitoring|Other: Heart
rate variability analysis|Other: Continuous
measurement of arterial blood pressure|
Diagnostic Test: Lung function test|Other:
Respiratory muscle function|Other: Manual
assessment
Drug: Vitamin of D|Drug:
respiratory motion|Other:
Placebo
Breath-hold test|Other: Physical Activity
monitoring|Other: Asthma Control
Questionnaire
Drug: Buprenorphine|Drug: Naltrexone|Drug:
Oral Placebo|Drug: IM Placebo|Device: Theta
burst stimulation (TBS) of the ventromedial
prefrontal cortex.
Biological: BM-Allo.MSC|Biological: Placebo
Behavioral: mHealth Intervention Group|

Behavioral: Educational Brochure
Biological: Allocetra-OTS
Other: Training|Other: Control

Other: Computer-Assisted Intervention|Device:
Dermatoscope|Other: Educational Intervention|
Dietary Supplement: Best Standard of Care +
Other:
Other: Questionnaire Administration|Other:
Transcranial direct current stimulation
CARDIO|Dietary Supplement: Best Standard of
Text Message
(tDCS)|Other: Ankle motor training|Behavioral:
Care
High intensity
Drug: interval
Ginkgo Leaf speed
Extract andbased treadmill
Armillariella
Drug: Duvelisib|Drug: Placebo
training (HIISTT)
Mellea Powder Oral Solution|Drug: Simulation
of Ginkgo Leaf Extract and Armillariella Mellea
Powder Oral Solution
Effectiveness of the LiquiBand FIX8 OHMF device|Safety
of the LiquiBand FIX8 OHMF device|Effectiveness of the
LiquiBandFIX8 OHMF device for topical wound closure|
Assessment of acute post-operative pain using the 피험자
임상시험 평가항목
Visual Analogue Scale: the minimal clinically important 대상 성별
difference
Change in and
foot patient
pain from acceptable
screening symptom state.|Long
visit to week 4 visit
term
as reported on the Pittsburgh Foot Survey.|Change of
performance of the study device|Comparison in All
cost-effectiveness of patients treated
foot pain from screening visit to week 4 visit aswith the
LiquiBandon
reported FIX8
theOHMF device Foot
Manchester compared with Index.|
and Ankle costs for
those treated using standard surgical technique.|
Change in foot pain from screening visit to week 4 visit
Comparison
as reported on of costs of patients'
the Mayo Clinical clinical
Scoringevents
System treated
Mean bias and limits
with the LiquiBand FIX8inOHMFof agreement between
device comparedmeasured
with All
Questionnaire.|Change foot pain from screening visit
oxygen
costs
to weekforconsumption
4those treated
visit as (VO2)
reportedusingand
on carbon
standard
the dioxide
surgical
American
elimination (VCO2)
technique.|Clinician
Orthopaedic Foot and in mechanically
satisfaction ventilated
Ankle Society (AOFAS) Ankle- children
assessed
Hindfoot using the Q-NRG+
Scale.|Device indirect calorimetry
durability|Participant device
compliance
and
with the V(max) Encore indirect
device|Participants' reported calorimetry
satisfactiondevice.|
and/or All
Calculated
difficulties total
with testing
the device.time, including calibration,
Sleep
requiredState Scoring
to complete From nPSGstate
a steady and Portable EEG
indirect calorimetry
Device|Stage Shift Index (SSI) as
measurement using the Q-NRG+ device and the Measured by Standard
V(max)
nPSG
Encore.and EEG Device on Night 2|SSI as Measured by
All
Standard nPSG and EEG Device During the Period at
Home|Number of Microsleeps and State Transitions
During the Maintenance of Wakefulness Tests (MWTs)
The
Totalprimary
Symptoms outcome
Scoreof the study is to determine if
(TSS) All
positional therapy, using the LEFT device, is effective in
improving nighttime GERD-related symptoms as
measured by GERD symptoms checklist (questionnaire,
involves no specific units of measure).|The secondary
All
outcome of the study is to determine if positional
therapy improves quality of sleep and health-related
Setup
qualitycueing
of life device|System
as measured by Usability
EpworthScale|Usability|
Sleepiness, Scale
Acceptance|Frequency using the device|Walking
and Sleep quality, SF-36 and Berlin questionnaires. speed
No
[meters/second]|Cadence
units of measure. [steps/minute]|Walking All
distance [in meters]|Step length right/left [in meters]|
Initial step latency [in seconds]|Number of FOG
Primary Outcome - Line Breaks|Primary Outcome - Line
Dislodgment|Primary Outcome - Line Infections|Change
from baseline in parental stress at 3 months|Change
from
Repairbaseline in parental stress
success|cumulative at 6 of
incidence months|Change
complications
from baseline in parental stress at 9 months|Change
(CIC)|Cumulative incidence of SADEs|Improved sensory All
from baseline in parental stress atformation
recovery|Questionnaire|Neuroma 12 months|Change
from baseline in child activity level at 3 months|Change
from baseline in child activity level at 6 months|Change
Depression|Anxiety|Future
from baseline in child activity Orientation|Rumination|
level at 9 months|Change All
Quality
from of Life-inSubjective
baseline Experience|Irritability
child activity level at 12 months|
Change from baseline in sleep at 3 months|Change
from baseline in sleep at 6 months|Change from
baseline in sleep at 9 months|Change from baseline in
Elapsed All
sleep at time to succeed endotracheal
12 months|Change from baseline intubation forat 3
in school
each training period|Elapsed time to
months|Change from baseline in school at 6 months| successful
insertion
Change from of supraglottic
baseline in airway
schooldevice and ventilation
at 9 months|Change
of
fromthebaseline
manikininfor each at
school training period|Elapsedfrom
12 months|Change time to
identification of vocal cords via fiberoptic
baseline in extracurricular activities at 3 months|Change bronchoscope All
for
Test
from each
effecttraining
baselineof A/Z period|Elapsed
modification of
in extracurricular time to introduction
supraglottic
activities airway of
at 6 months|
fiberoptic
device
Changeon bronchoscope
ratebaseline
from in into
of successful the tracheaactivities
oxygenation
extracurricular for eachat 9
and
training
ventilationperiod|Success
months|Change before rate
beginning
from of
baselinea in endotracheal
fullextracurricularintubation
clinical trial|Rate of
for each
successful training
exchangeperiod|Number
from of
supraglottic trials
to
activities at 12 months|Change from baseline in family endotracheal All
ventilation using A/Z modified
travel at 3 months|Change fromSGA|Rate
baseline of in successful
family
exchange from endotracheal to supraglottic
travel at 6 months|Change from baseline in family ventilation
using
travel A/Z
at 9 modified
Community Need forSGA
months|Change a Device-based
from baseline Opioid Overdose
in family
Intervention|Community
travel at 12 months Preferences for a Device-based All
Opioid Overdose Intervention
Composite of Stroke, Systemic Embolism, and Device-

related Thrombosis|Incidence of Major Bleeding Events| All
Incidence of Minor Bleeding Events
Lumbar
Range ofdynamometry|Photogrammetric
Motion|Timed up and go (TUG)goniometry
performance| All
Knee pain as measured on a 10-point pain scale|Knee
swelling|Lower extremity functionality as measured
using the Lower Extremity Functionality Scale (LEFS)|
Ambulation using the 6 Minute Walk Test (6MWT)|Days All
to ambulate without assistive devices and/or assistance|
The
Dayslevel of pain
to return to and change
activities of in pain
daily between each
living|Opioid usage|
time
Knee point
Injurywill
andbe assessed using
Osteoarthritis the Wong-Baker
Outcome Score (KOOS)|
FACES
Oxford scale
Knee with
Scoreuse of thermomechanical device
(OKS) All
delivering stimuli, without delivering stimuli, and
without use of the thermomechanical device.|Number
of participants with at least one adverse event
Ventricular Pressure Volume Loop Analysis|Survival and
All
device explant rate
Symptoms severity according to an ETD Visual
Analogue Scale|Symptoms severity according to a
Pain/pressure Visual Analogue Scale|McGill Pain
All
Questionnaire - Short Form|Worst Pain Using the
Modified Brief Pain Inventory - Short Form (m-BPI-sf)|
Mean Change in Overall ETDQ-7 Score
Positive predictive values of device detected atrial
All
arrhythmias
Blinded Dermatology Assessment of Facial Skin Health|

Changes in Self-Report Skin, Hair & Nail Health and All
Satisfaction
Efficacy - Urogenital
Safety from DistressEvents|Technical
Major Adverse Inventory (UDI-6)|Efficacy
Feasibility -
Bladder diaries|Survey evaluations of incontinence
to implant the Mitral Touch Device|Safety from Serious
Pelvic Organ Prolapse Distress Inventory All
Adverse Events from Implantation of the (POPDI-6)|
Mitral Touch
Patient
Device Reported perception of general
Time to major adverse cardiac event (primary safetyhealth Short
Form-20 (SF-20)|Self-reported adherence|Correlations
outcome)|Cost effectiveness|Quality of Life - Short Form
between self-reported
(SF36)|Quality of Life - adherence and Acceptance
Florida Patient device reported
adherence in the leva of group|Incidence of Treatment- All
Survey (FPAS)|Quality Life - Florida Shock Anxiety
Emergent Adverse Events (Safety and tolerability)|
Scale (FSAS)|Quality of Life - Brief Illness Perception
Feedback
Questionnaireon perception
(BIPQ) of treatment - likelihood of
recommending to a friend|Feedback on perception of
treatment - interest in surgical treatment|Survey Female
evaluations of incontinence Colorectal-Anal Distress
Inventory-8 (CRADI-8)|Survey evaluations of
incontinence Pelvic Floor Distress Inventory (PFDI-20)|
Survey
Muscle evaluations
Surgical mass of incontinence
time per technical Pelvic Organ
phase measured in minutes| All
Prolapse/Urinary Incontinence Sexual Questionnaire
Rate of Surgical Complications|Surgical costs per device
(PISQ-IR)|Survey
used|Patient Outcomes:evaluations of incontinence
Post-operative Patient
Pain|Patient
Global Impression of Severity (PGI-S)|Survey
Outcomes: Change in Pain|Patient Outcomes: Change in evaluations
of incontinence
International HipPatient
OutcomeGlobal
ToolImpression
(IHOT-12) of Scores| All
Improvement (PGI-I)|Survey evaluations of
Patient Outcomes: Change in Non-Arthritic Hip Scores| incontinence
Pelvic
PatientFloor Impact Change
Outcomes: Questionnaire
in Western(PFIQ)
Ontario and
rate
McMaster Universities Hip Osteoarthritis Index tears|
of vaginal tears|rate of low-grade perineal
rate of high-grade
(WOMAC-HIP) perineal tears|Maternal adverse
Scores Female
effects|Fetal adverse effects|Maternal comfort with the
BabySlide|User abilitiy
Sensitivity and specificity of the system will be
evaluated by comparing the imaging result with
Female
pathology findings of the imaged tissue|Number of
patients with reported adverse events
Mortality at Day 60|Dialysis Dependency|Ventilation at
Day 28|Mortality at Day 28|Urinary output
All
change|P02/FiO2 change|Safety Assessments|SCD
Integrity
Viral load measured in tracheal aspirate 72 hours after
initiation of core warming|PaO2/FiO2 ratio 72 hours
All
after initiation of core warming|Duration of mechanical
ventilation
Residual CIN2+ diagnosis of recurrent and or untreated
cervical intraepithelial neoplasia grade 2 or with cervical
cancer diagnosis Diagnosis of recurrent and or
Female
untreated cervical intraepithelial neoplasia grade 2 or
with cervical cancer diagnosis|Patient's pain assessed
using the Wong-Baker FACES scale
Regular device use at three months|Acceptability of the
Hailie Smartinhaler as determined by the Adolescent
All
Medical Devices Assessment Toolkit (AMDAT)|Asthma
Control|Device use at one month
Target area hair count (TAHC)|Hair phase|Vellus hairs|

Male
Terminal hairs
Speech perception with narrowband noise|Speech

All
perception with broadband noise|Acceptance of noise
Number of participates with AF episodes identified

Pain
usingScores With Movement|PROMIS
continuous Pain Intensity
ECG monitoring compared to routine All
Survey|PROMIS
practice. Pain Interference Survey|Total Milligram
Morphine Equivalents (MME)|ObsQoR-11 Survey|
Recovery variables from med record: time to discharge|
Recovery variables from med record: ICU admission|
Female
Recovery variables from med record: readmission|
Recovery variables from med record: readmission due
to pain issues|Recovery variables from med record: time
to first opioid request|BPI8 survey|BPI25 survey|Device
Total body weight
Tolerability loss
survey|Satisfaction survey All
Stroke volume|Heart rate|Ejection fraction|Cardiac

output|End-systolic pressure|End-systolic volume|End-
All
diastolic pressure|End-diastolic volume|Right ventricular
dP/dt|Stroke work
Clinical Success|Monitoring of Adverse Events to

All
confirm safety of the meniscal repair device
Engagement with study protocol|Effectiveness of

All
notifications
Primary Efficacy: Acute Procedural Success|Primary
Safety: Freedom from Peri-procedural major adverse
events (PPMAE)|Rate of device related complications
requiring intervention|Rates of MAEs over time|Patency
All
rate|Occlusion freedom|Clinical outcome 1 - ankle
brachial index (ABI)|Clinical outcome 2 - walking
impairment questionnaire (WIQ)|Clinical outcome 3 -
Rutherford clinical categories (RCC)
Quality-of-life (Atrial Fibrillation Effect on QualiTy-of-

life)|Proportion of participants with acute care use at 6
months|Proportion of participants with acute care use
at 12 months|Proportion of participants with outpatient
care use at 6 months|Proportion of participants with
outpatient care use at 12 months|Proportion of
participants with rhythm-related diagnostic testing at 6 All
months|Proportion of participants with rhythm-related
diagnostic testing at 12
Change in proportion ofmonths|Proportion
dispensed doses fromof patients
the first
taking
two weeksanticoagulants|Quality-of-life (Atrial
(baseline) to last two weeks Fibrillation
of study (device
Effect on QualiTy-of-life) Domains|Proportion
use)|Adherence to hydroxychloroquine using the of
participants with clinicalSelf-Reported
Medication Adherence treatment forInventory
atrial fibrillation
(MASRI)
or flutter
score|Adherence to hydroxychloroquine using serum
drug levels|Adherence to hydroxychloroquine using
electronic pill counts|Adherence to hydroxychloroquine
using manual pill counts|Disease activity as measured All
by Systemic Lupus Activity Questionnaire (SLAQ) score|
Disease activity as measured by the Systemic Lupus
Rate of successful
Erythematosus catheterisation
Disease of the
Activity Index bladder| score
(SLEDAI-2K)
Number
collectedof passes arequired
through remote prior to successfully
teleresearch exam|Disease
catheterising the bladder|Rate of successful
activity as measured by the Systemic Lupus Female
catheterisation using flexible
Erythematosus Disease cystoscopy
Activity into the score
Index (SLEDAI-2K)
bladder|Complication
recorded in the CARRA rate
Registry
Glucose biomarker data from the continuous glucose
monitoring device, which will be analyzed as a function
of different homeostasis responses from the 3 different All
cohorts of individuals (i.e., i) low to moderate risk; ii)
high risk, iii)ofvery
Correlation high risk). oxygen dynamics
subcutaneous
measured by the Wireless Lumee Oxygen Platform and
a TcPO2 device in the arm|Correlation of subcutaneous All
oxygen dynamics measured by the Wireless Lumee
Oxygen Platform and a TcPO2 device in the foot
Number of subjects with treatment-related adverse
events|Number of subjects to experience significant All
improvement from implantation of the device
Safety Endpoint as determined by the frequency and
severity of all unanticipated adverse device-related
events (UADE)|Primary effectiveness Endpoint - Device All
Number
retentionof pain medications
rate|Secondary taken postoperatively|
effectiveness Endpoint -
Timing of pain medications
Improvement in BCDVA taken postoperatively|
Postoperative pain levels|Number of pain medications
taken after discharge|Intraoperative narcotic use|
Analgesia
Change in requirements
nerve conductionin thestudy
post distal
anesthesia care unit|
latency|Change All
Volume
in nerve of CO2 consumed
conduction study Fduring surgery|Length of
wave latency|Change in
stay|Time
nerve to first flatus|Time
conduction to first bowel
study conduction movement|
velocity|Change in
Time to solid diet|Postoperative complications|Duration
nerve conduction study conduction amplitude|Change
of Surgery|Incision
in hand length
grip strength|Change in Rasch-built Overall All
Disability Scale (R-ODS) for CIDP|Change in tumor
necrosis factor (TNF)-慣|Change in hepatocyte growth
Hospital Length of Stay|Hospital
factor (HGF)|Change in macrophage length-of-stay
inflammatoryindex|
Time to (MIP)-1棺|Change
protein first ambulation|Time to first bowel
in interleukin movement|
(IL)-1棺 All
Rate of venous thromboembolism|Total hospitalization
costs
Total area hair count|Hair shaft diameters|Number of

hair follicles|Yellow dots|White dots|Perifollicular halo| Female
Vellus hairs|Terminal hairs|Hair phase
Safety in the 1 year following implantation|Device

Placement|Left-Right shunt through AFR device|NYHA All
status|Change in Quality of life
The proportion of treated subjects who are free from

the following incidences:|Secondary endpoints, which
will only be tested for superiority of Adherus over All
DuraSeal Exact after the primary objective of the study
has been met:
Change in Modified Lund Kennedy Score|Change in
Sinonasal-Outcomes Test-22 (SNOT-22) Score|Change
All
EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) Score|
Change in sinus culture results
Safety assessment - no device related reoperation|

Efficacy assessment - achieving facet fusion 12 months All
post procedure
Safety - Incidence of Adverse Events|Feasibility -

Incidence of patient being able to complete
All
intervention of EsoCheck|Sensitivity and Specificity of
EsoCheck|Sensitivity and Specificity of Brush Cytology
Comparison of an in- hospital diurnal pressure pattern
of intraocular pressure to the pattern derived from self-
tonometry using icare HOME in an outpatient setting.| All
variance of diurnal intraocular pressure|Influence of
daily activities|Change of treatment
To demonstrate the success rate of iATP in the fast VT
(FVT) zone is greater than 60%|To demonstrate the
success rate of iATP in the FVT zone is greater than All
70%|To characterize arrhythmia-related syncope events|
To characterize unnecessary and inappropriate shocks
Degree
Impact of biofeedback
Participant
of agreement|Bland
Acceptance therapy and
of the Altman
AbbVie
on analysis
Duodopa
change ofpain
in knee
agreement|Degree
Specialist (ADS)
measured ofAnalogue
Nurse
on Visual agreement
SupportScale
andwith threshold values|
Communication
(VAS).|Impact of All
Minimal SpO2 value|Mean
Access|Participant pulse
Satisfaction rate
With ADS Nurse
biofeedback therapy on knee function measured by Support
and Communication
Western Ontario andAccess|Participant Satisfaction
McMaster Universities Arthritis
Scoring
Index 8 to 10 on a VASofwith
(WOMAC).|Impact the ADS Nurse
biofeedback therapySupport
on
and Communication Access|Caregiver Satisfaction
muscle strength measured by EMG biofeedback device.| With All
ADS Nurse
Impact Support and on
of kinesitherapy Communication Access| on
knee pain measured
Caregiver
Visual Acceptance
Analogue Scale of ADS Nurse of
(VAS).|Impact Support and
kinesitherpay on
Communication Access|Investigator Satisfaction
knee function measured by Western Ontario and With
Nurse Support|Participant
McMaster Satisfaction
Universities Arthritis With Video
Index (WOMAC).|Impact All
Functionality
of of the
kinesiotherapy onDevice|Change of Caregiver
quadriceps muscle strengthBurden
measured by EMG biofeedback device.|Impact of
electrical stimulation of the quadriceps muscle on knee
pain measured on Visual Analogue Scale (VAS).|Impact
of electrical stimulation on knee function measured by
Western Ontario and McMaster Universities Arthritis
Index (WOMAC).|Impact of electrical stimulation on
quadriceps muscle strength measured by EMG
biofeedback device.
HPV DNA (HPV16, HPV18, other high-risk HPV (HPV31,
-33, -35, -39, -45, -51, -52, -56, -58, -59, -66, -67, and -
68)) measured using the HPV-risk assay (Self-Screen
BV).|Methylation ratio of a host cell gene marker panel
Female
(PreCursor-U+) measured using quantitative
methylation specific PCR (qMSP).|Human DNA (GAPDH)|
Internal control DNA (IC DNA)|Human DNA (Beta-
globin)|Human DNA reference gene (ACTB)
Usability tests of the Elmo system using Euristic

usability principles|Evaluation
Cardiac Performance of the effectiveness
System electronic of the
data for Cardiac All
ELMO system using
Output|Cardiac physiological
Performance Systemparameters
electronic data for
Pulmonary Artery Pressure|Cardiac Performance System
electronic data for Pulmonary Artery Wedge Pressure|
Pulmonary Artery Catheter electronic data for Cardiac All
Output|Pulmonary Artery Catheter electronic data for
Pulmonary Artery Pressure|Pulmonary Artery Catheter
electronic
Changes indata for Pulmonary
probing Artery Wedge
depth (PD)|Crestal bone Pressure|
level (CBL)|
Echocardiography
Bleeding electronic
on probing data forcrevicular
(BoP)|Gingival Ejection fluid
Fraction All
(GCF)|Visual analogue scale (VAS)
Recruitment Rate|Completion of Bariatric Surgery|Loss

to Follow-Up Rate|Completion of Patient Reported Female
Outcome Questionnaires|Complete Response Rate
Postural stability|Time up and go test All

Feasibility as measured by the successful completion of
Quad shot radiation using CBCT instead of routine CT
simulation
To assess the in 80% of of
ability attempted
the studysimulated
device topatients|
be retained
Average time (days) required from initial
during Valsalva compared to the ability of the subject'sconsult to All
completion
current pessary of radiation therapyduring
to be retained for patient
Valsalvatravel
(byand
visits to the department|Percentage
measuring the distance from each pessary's leadingof patients from
whom
edge torepeat CT simulation
theofhymen)|To assess was
theeliminated
ability of the study
Proportion patients with serious device-related
device All
adversetoeventbe retained
in studythroughout
eye regular activity (by
vaginal examination)|To assess the shape of the study
pessary during expulsion if it is not able to be retained
(by vaginal examination)|To assess the orientation of
Freedom
the study frompessaryall-cause death, deterioration
stem following regular activity in renal
(by Female
function (reaching end-stage renal
vaginal examination)|To assess the discomfort disease (ESRD), renal
death or 50% decline in eGFR), hyperkalemia
experienced with removal of the subject's current or
symptomatic
pessary compared hypotension|Change
to the discomfort in experienced
NT-proBNP from with
enrolment to 8 weeks|Change in Burden
removal of the study pessary (by visual analog scale)|Toof
All
hemocompatibility
assess the discomfort (hemocompatibility
experienced withscore)|Number
insertion of the
of RV failure
subject's events|Time
current to first unplanned
pessary compared to the discomfort
hospitalisation|Number
experienced with insertion of unplanned
of the study hospitalizations|
pessary (by
Change in blood-pressure lowering medications|Change
VAS)|To globally assess the comfort associated with use
in
of eGFR values
the study pessary (by verbal description)
Implant survival based on removal or intended removal
of the device and determined using the Kaplan-Meier
method|Pain and functional performance based on the
Harris Hip Score|Subject quality-of-life determined by
Device Safety
the EQ-5D Assessed
(EuroQoI) Through the
score|X-rays Incidence
evaluated forand All
Frequency of Revisions,
radiolucencies, Complications,
osteolysis, hypertrophy, and Adverse
subsidence,
Events|Device performance
heterotopic ossification, and Clinical
etc|Safety basedBenefits
on eventual
Assessed by a Pain Assessment. and
complications occurred including dislocations and
Temporomandibular
revisions/removals Joint Function of the Pain All
Assessment Survey Case Report Form.|Device
performance and Clinical Benefits Assessed by a TMJ
Function Pain Assessment
Compliance|Change in ArmSurvey Case Report
Girth|Quality of LifeForm|
Device performance
Assessment and Clinical
via LYMQOL Benefits
ARM|Quality Assessed by a
of Life
Headache Female
Assessment via SF-36|Symptoms Assessment viaForm
Pain Assessment Survey Case Report LSIDS-
A
Completion of 1-minute test|Completion of 24-hour

All
test
Volume responsebyand
Fit as measured PackerofClinical
number Composite
adjustments to theScore|
Effect All
deviceon left ventricular function in both arms|
Difference in quality of life as measured by the
Minnesota Living with Heart Failure questionnaire score
and EuroQol 5D index score in both arms|Difference in
All
6 minute walk test distance in both arms|Difference in
predictive value for volume response|Difference in
predictive value for long-term patient outcome in both
The primary objective of this work is to acquire acoustic
arms|Difference in long-term patient outcome in both
signals from two groups of COPD patients, that can
arms
subsequently be used to carry out COPD signal
All
processing research.|To explore the usability aspects of
a small wearable device in the context of COPD
patients
Change in HAM-D Score from Baseline to Week 1|

Change in CDRS-R Score from Baseline to Week 1|
Change in HAM-D Score from Baseline to Week 4| All
Safety Defined by Change in C-SSRS Evaluations|
Completion Rate|Withdrawal Rate|Durability of
Treatment Effect with HAM-D Scores|Durability of
Treatment Effect with CDRS-R Scores|Presence of Non-
Suicidal Self Injurious Behavior Through SITBI
Positive control for technical validation|Evaluation of
All
test performance
Rate of SAEs and device- &/or procedure-related AEs|

Percentage of subjects with maintenance of the major
Cobb angle less than or equal to 40 degrees at 60
months post-surgery|Adverse Events|Reoperation|
Number of participants with new curves that develop
above or below the tethered portion of the spine.|
Number of participants with secondary curves that
progress to the point of clinical significance.|Number of
participants with device integrity failures including cord
breakage and screw migration.|Mean (SD) and
All
distributions of sagittal balance (mm) from pre-op
through last visit|Mean (SD) and distributions of lumbar
lordosis (degrees) from pre-op through last visit.|Mean
score of Scoliosis Research Society 22r Patient
Questionnaire|Number of participants with
compromised lung function|Measurement (degrees
rotation) of trunk shape by scoliometer device. Mean
(SD) [min, max] will be reported.|Trunk flexibility as
Feasibility
determinedasby assessed
distanceby(cm)
percent ventricular
of flexion capture
and lateral bend
through Holter monitoring|Safety
using fingertip to floor method. as assessed by
number of arrhythmia episodes via device interrogation|
Cranial
Safety asCTassessed
Intracranial Hemorrhage
by the number offindings and the or
hospitalizations
binary Tbit??System
ER visits (positive/negative)|Tbit??System
for arrhythmia or heart failure|Tolerability as
sensitivityby
assessed and specificity|Negative
change in Kansas City predictive value of
Cardiomyopathy All
the Tbit??System|Positive predictive value of
Questionnaire (KCCQ) score|Tolerability as assessedthe Tbit??
by
System|Overall accuracy of the Tbit??System|Safety
change in distance during 6-minute walk test|Safety as and
adverse event
assessed profile of tachytherapies delivered by
by number
ICDs|Tolerability as assessed by change in Global Well-
All
Being score on a Visual Analog Scale|Tolerability as
assessed by change in Subjective Dyspnea score on a
Visual Analog Scale|Tolerability as assessed by change
in Frailty Index|Tolerability
COVID-19 as assessed Observations
Infection|Symptoms|Clinical by change in All
Sleep Quality|Presence of dyssynchrony on
Physical Activity Level|DailyinStep
echocardiography|Change Count|BMI|Glycosylated
N-terminal pro b-type
Hemoglobin (HbA1c)|Total
natriuretic peptide cholesterol|Low
(NT pro-BNP) Density
values|Change in
Lipoprotein
troponin (LDL)
values cholesterol|High
(ng/mL)|Change in Density
sodium
Number of Cone Beam Computed Tomography (CBCT) Lipoprotein
values All
(HDL)
images cholesterol|Triglycerides|Blood
(mEq/L)|Change
acquired in serum
with creatinine
horizontal pressure
values
patient (systolic
(mg/dL)|
rotation that
and
are diastolic)|Mood
Change
deemedin serum
to beblood urea nitrogen
of comparable (BUN)
image values
quality to
clinical CBCT or deemed acceptable for radiotherapy
image guidance as scored by a panel of experts.| All
Change in Short Form State/Trait Anxiety inventory
(STAI) and Fast Motion Sickness (FMS) questionnaire
scores before and after rotation as assessed by the
Wilcoxon signed rank test.
overall device success conform the VARC-2 document|
incidence of more than trivial PVL|conduction
All
abnormalities and need for new permanent pacemaker
Smartphone
implantation application sensitivity|Repeatability|
Correlation between bilirubin estimates by smartphone
pictures and by total serum bilirubin|Correlation
between bilirubin estimates by smartphone pictures All
and by standard transcutaneous readings.|Correlation
between bilirubin estimates by smartphone pictures
and visual assessment of jaundice
Evaluate the accuracy of implant alignment for ROSA
total knee robotic instrumentation compared to
conventional instrumentation|Measure operative
workflow efficiency by recording following time points
during surgery|Evaluate the change of the Oxford Knee
Score between baseline and each post-operative follow
up|Evaluate Health related quality of life at baseline and
All
each post-operative follow up|Evaluate Pain intensity at
baseline and each post-operative follow up|Evaluate
knee functionality at baseline and each post-operative
follow up|Evaluate awareness of patients affected knee
joint at baseline and each post operative follow up|
Evaluate patient satisfaction at baseline (first postop
visit) and each post operative follow up
biological ankle torque in Newton meters/kilogram|

Muscle Oxygenation|Energy cost|Rate of perceived
All
exertion|Claudication Onset and Peak Walking Times
Change in Protoporphyrin IX levels in the skin at
(seconds)
baseline and at serial time points after Ameluz
Consistency of values
application (the between visual
intervention)|Effect of observation and
Skin temperature
numeric
on change value obtained from IX
in protoporphyrin TetraGraph|Incidence
levels at baseline andof All
residual
at serial neuromuscular
time points afterblockade
Ameluz application (the
intervention)|Effect of Age on change in protoporphyrin
IX levels at baseline and at serial time points after
All
Ameluz application (the intervention)|Effect of
Fitzpatrick skin type (skin pigmentation) on change in
protoporphyrin IX levels at baseline and at serial time
points after Ameluz application (the intervention)|Effect
Number of patientsIXTreated|Serious
of Protoporphyrin Adverseof
levels in Development Events
Adverse All
Effects of Pain or Discomfort after receiving
photodynamic therapy (the intervention)
Number of Participants with Adverse Events (AEs)|
Number of Participants with Injection Site Reactions|
Number of Participants with Adverse Events of Special
Interest (AESIs)|Change from Baseline in Lassa Virus
All
(LASV) Antigen Specific Binding Antibodies|Change
from Baseline in Lassa virus (LASV) Neutralization
Assays|Change from Baseline in Interferon-Gamma
Response Magnitude
Safety and tolerability as measured by incidence of IP-

All
related serious adverse events
Determination of the quality of measurements of

Test Reliability of digital biomarkers measured by Intra
clinical signs provided by MultiSense짰 strip in
Class Correlation|Test Reliability of digital biomarkers
comparison to measurements made with conventional
measured by Coefficient of variation|Determination of
medical devices in the hospital setting, in terms of All
user acceptance of each digital biomarker with regards
accuracy.|Determination of the quality of measurements
to acceptance based on a questionnaire using a likert
of clinical signs provided by MultiSense짰 strip in
scale
comparison to measurements made with conventional
medical
Safety ofdevices in themanagement
the patient hospital setting, in terms
pathway (i.e. of
connectivity.|Determination of the quality
proportion of medication interventions withof associated All
measurements of clinical signs provided
medication intervention related serious adverse by MultiSense
events)
짰 strip in comparison to measurements made with
conventional medical devices in the hospital setting, in
terms of generation of artefactual data.|Determination
All
of the quality of measurements of clinical signs
provided by MultiSense짰 strip in comparison to
measurements made with conventional medical devices
in the hospital
Consistency of setting, in terms TetraGraph
values between of stability of
anddata
transmission.|Usability All
IntelliVue|Incidence of of a dataneuromuscular
residual acquisition patch by
blockade
health care providers (HCPs) in different hospital
settings assessed via questionnaires.|User
Dypnea|Comfort|Dose experience
of Opioid|Delirium|Intensive of
Care
surgical patients with the continuous use of asupport
data
Unit (ICU) stay|Mortality|Usage of respiratory All
acquisition patch during remote postoperative
devices
monitoring assessed via patient's final questionnaires.|
Assess patients'
Inflammatory tolerability
Bowel Diseasetoflares|Change
prolonged use of an
in Sleep
adhesive patch during remote postoperative
(hours per night)|Change in Heart Rate Variability All
monitoring.
(HRV)|Change in Resting Heart Rate (RHR)
Volume of tissue activated from stimulation with ET

DBS|Baseline DBS settings versus active biphasic pulse
All
DBS settings|The Fahn-Tolosa-Marin Tremor Rating
Scale|Tremor motor physiology|Gait impairment
Headache Days|Adverse Events|Migraine Days|Headache

All
Impact Test (HIT) Score|Pain Medication
Safely conducted therapy rate (SCTR)|Number of
participants with treatment related adverse events as
assessed by CTCAE V 5.0.|Progression-free survival|The
correlation between the Optune device usage and the All
health-related quality of life of elderly patients and
families undergoing this therapy in combination with
radiotherapy/chemo-radiotherapy.
success rate of endotracheal intubation|success rate of

airway cleaning|complications of endotracheal All
intubation and airway cleaning robot system
collecting and analyzing of DiaNose sensors signals
from potential VOC markers in the breath samples of
All
all subjects to build and validate a predictive
algorithmic model for diagnosing COVID 19.
Efficacy Assessment - Tremor All

Number of participants who are classified 8 (dead), 7
(hospitalized, on invasive mechanical ventilation or
ECMO), or 6 (hospitalized, on non-invasive ventilation
or high flow oxygen devices) on the NIAID ordinal All
scale|Number of participants with a total score of 0 on
the
TimeModified Sequential
of peritonitis Organ
detection (vsFailure Assessment of
lab measures)|Time
(MSOFA)
Differencescale
peritonitis detection (vs clinical measures)|Sensitivity
in total HF-attributable direct medical costs|
and specificity
Hospital of thebetween
admissions CloudCaththeSystem
Furoscixdetection of
Infusor arm All
peritonitis|Ability
and of study(treatment
propensity-matched participants
as to use the
usual) arm|HF-
CloudCath System as intended
related hospital admissions between the Furoscix
Infusor arm and propensity-matched (treatment as
usual) arm|HF-related emergency department visits All
between the Furoscix Infusor arm and propensity-
matched (treatment as usual) arm|HF-related clinic visits
Number
between oftheparticipants with treatment-related
Furoscix Infusor arm and propensity- adverse
events
matched as (treatment
assessed byasCTCASE v5.0|Efficacy as measured
usual) arm|Health-related quality
by the target physician global assessment|Tolerability as
of life
measured by the visual analog pain scores|Quality of All
Life metric as assessed by the dermatology life quality
assessment|Pruritus as measured by visual analog
pruritus scale
Primary efficacy endpoint: composite of unplanned HF-

related rehospitalisations
Blood glucose and all-cause
profile|participant survey death|Primary All
safety endpoint: device-related complications|Co-
primary safety endpoint: sensor failure|Major secondary
endpoint: changes in disease-related quality of life|
Changes in generic health-related quality of life|HF-
All
related mortality|Cardiovascular Mortality|All-cause
Mortality|Unplanned HF-related hospitalizations|
Unplanned cardiovascular-related hospitalizations|
Unplanned all-cause hospitalizations|Unplanned
hospitalizations, other|Non-serious Adverse Events|
Serious Adverse Events|Symptoms of heart failure
Change in percent 13C enrichment of bicarbonate
measured via carbon-13 magnetic resonance All
spectroscopy (13C-MRS)
PaO2/FiO2 ratio|Viral Load Measurement|Duration of

All
mechanical ventilation|Mortality
Proprioception will assessed by Cervical Range of

Motion device.|Balance will assessed by Dynamic
All
Posturography.|Pain threshold will assessed by
algometer device.|cervical lordosis Cobb angle
7 days post-EGD Impact of Events Score (IES) -

Cytosponge|7 days post-EGD Impact of Events Score
(IES) - TNE|7 days post-EGD Impact of Events Score
(IES) - EGD|Visual Analog Scale (VAS) Score -
Cytosponge|Visual Analog Scale (VAS) Score - TNE|
Visual Analog Scale (VAS) Score - EGD|7 days post-EGD All
Willingness to repeat - Cytosponge|7 days post-EGD
Willingness to repeat - TNE|7 days post-EGD
Willingness to repeat - EGD|7 days post-EGD Ranking
of preferred screening modality|Number of participants
reporting
Reductionpreferred screening
in average modality
pain intensity|Study-Related
Adverse Device Effects|Average pain intensity|Mean
pain relief|Long-term durability of average pain
intensity|Pain medication usage|Pain Catastrophizing All
Scale (PCS)|Patient Global Impression of Change (PGIC)|
Pain interference|Function (i.e. physical recovery)|Six
Change in Left
Minute Walk Ventricular
Test (6MWT) Ejection Fraction (LVEF)|
Mortality rate|Heart failure hospitalization frequency|
All
Rate of adherence to guideline directed medical
therapy
Monitored versus Non-Monitored in-patient admission|
Emergency Department Visits|Length of stay|patient
All
satisfaction|the incidence of mechanical ventilation and
ECMO|serious adverse events
Positive diagnostic correlation|Diagnostic accuracy 1|
All
Diagnostic accuracy 2
CGM Measured Time <70 mg/dL|Hypoglycemia|Glucose

Control|Hyperglycemia|HbA1c|Hypoglycemia All
Unawareness
The primary endpoints for this study are patients' self-

reported evaluations of the quality of pain
All
management provided during their hospital stay.|
Subjects' evaluation of the aromastick
Determine the safety (dose level) of CAR-20/19-T cell
Orthotics and Prosthetics
administration in relapsedUsers Survey
refractory (OPUS) Quality
B-ALL.|Determine All
of Life Index|Modified Box and Blocks
the feasibility to manufacture CAR-20/19-T cells locally
from pediatric and young adult apheresis products
using the CliniMACS Prodigy Cell processing device.|
Determine the anti-tumor responses as measured by All
response rates.|Describe the duration of response for
responding patients.|Determine persistence of CAR-
Number of Participants with
20/19-T cells.|Determine the Dose
effectsLimiting Toxicity|
of CAR-20/19-T
Overall
infusionResponse Rate|12-month
on non-neoplastic CD19 Overall
& CD20Survival Rate|
B cells in All
6-month progression-free
vivo.|Evaluate survival (PFS)
MRD using molecular rate|Quality of
technologies.
Life Assessment
Length of functional rehabilitation|Quality of recovery|
The quantization of fatigue|The quantization of pain|
The quantization of vomiting.|The quantization of
All
nausea.|The quantization of Activity Counts|Length of
sleep time|The quantization of morbidity|The
quantization of mortality
skin toxicity events|dose delivered to target All
Proportion of patients with pre-specified adverse

events|Amount of visible biopsy material over or under All
5 mm at endoscopy examination
pain: Numerical Pain Rating Scale|opioid consumption|

All
patient compliance|program retention
Fat Reduction|General Health Improvement All

Complications of Interbody Implants|Radiographic
Pain
FusionScores|Total opioid consumption|Time
Success|Percentage of subjects meetingweighted
minimal
average pain
clinically score|Perception
important of videoassystem
difference (MCID) usability|
compared to All
Post discharge analgesia.
baseline for back/leg pain measured by visual analog
scale (VAS).|Percentage of subjects meeting minimal
clinically important difference (MCID) as compared to
baseline for disability measured by the Oswestry All
disability index.|Percentage of subjects meeting minimal
clinically important difference (MCID) as compared to
baseline measured by overall physical and mental
health Pressure
Blood from PROMIS-10.|Complications
Triplet attributable to All
the use of any additional NuVasive instruments,
Seizure
implants,Drive Markers on EEG|Seizure characteristics on
or technologies
EEG|Seizure characteristics by motor observation|Time
for Reorientation in Seconds|Amnestic Side Effects|
All
Change in Hamilton Depression Rating Score (HDRS)|
Change in Inventory for Depressive Symptoms - Self
Report (IDS-SR) Score
(DKA) (events per person months)|Glycated hemoglobin
(A1C)|Time in range 70-180 mg/dL|Percent of time in
range 70-180 mg/dL|Percent of time in range 70-140
mg/dL|Percent of time > 180 mg/dL|Percent of time ??
250 mg/dL|Percent of time ??300 mg/dL|Percent of
time
Change< 70in mg/dL|Percent
Lower ExtremityofMuscle
time <Strength-
54 mg/dL|Mean
Extension|
glucose|Standard deviation|Coefficient of
Change in Lower Extremity Muscle Strength- Flexion|variation| All
Percentage
Change in Lowerof time in hybrid
Extremity closed-loop
Muscle as proportion
Strength- Hip
of overall device
Posterolateral usage time|Glucose
Stabilizer|Change management
in Mobility- Timed Stair
indicator
Blood (GMI)
lactate
Climb Test|Change based on overallForward
Level|Vasoactive|28
in Mobility- mean glucose|Total
day hospital mortality
Step-Down All
daily insulin (TDI) (units)|Total daily insulin
Test|Change in Mobility- 30-Second Chair Stand Test| (TDI)
(units/kg)|Total
Change in Mobility- daily 6-Minute
basal insulin
Walk(units)|Total
Test|Change daily
in
basal insulin
Physical (units/kg)|Total
Activity- daily bolusininsulin
Steps walked|Change (units)|
Physical All
Total daily
Activity- bolusexpenditure|Change
Energy insulin (units/kg)|Body Mass Indexof
in Symptoms
(BMI)
PFPS- (kg/m2)
Knee pain limiting actiivty (AKPS)|Change in
Symptoms of PFPS- Pain at rest and post-activity (VAS)|
Change
Change inin Active group
Symptoms of ARENA scores
PFPS- Knee compared
Injury and to All
Sham group ARENA scores
Disability (IKDC)|Change in Quality of Life- Overall: The
Short Form Health Survey Version 2.0 (SF-12v2) Health
Survey
Hand counts captured using an activity monitor|

ArmCAM (Arm Capacity and Movement Test)|Stroke
All
Impact Scale - hand and strength scales|Hand count
measured during the intervention sessions|REACH Scale
Consistency of values between flexor hallucis brevis and

adductor pollicis muscles|Incidence of residual All
neuromuscular blockade
Body Satisfaction Scale (BSS) All
Child's pain score during the IV procedure|Child's total

distress score during the IV procedure|Child's Fear|
Parental anxiety|Parent/ Caregiver Satisfaction|Nurse
All
Satisfaction|Child Satisfaction|Frequency of adverse
events related
Evaluating the to the study
relative intervention|Child's
sensitivity and specificity distress
of HPV
during the IVtesting
methylation procedure
from collected samples|Evaluating
the relative sensitivity and specificity of host gene
Female
methylation testing from collected samples|Comparing
the absolute sensitivity and specificity of HPV versus
host gene
Total methylation
area hair testing
count|Hamilton-Norwood score|Hair
shaft diameter|Change in follicular units|Presence of
Male
yellow dots|Presence of white dots|Perifollicular halo|
Hair phase|Vellus hairs|Terminal hairs
Change in minutes spent in moderate-vigorous physical
activity, measured by accelerometry|Change in minutes
spent in moderate-vigorous physical activity, measured All
by questionnaire|Change in minutes spent in inactive
(sedentary) behavior, measured by accelerometry.
Speed-of-sound
Overall imaging shows malignancy
Survival (OS)|Progression of(PFS)|1-
Free Survival lesion Female
and 2-year survival rates|Overall Radiological response
Time to complete
(ORR)|Next wound closure.|Percentage
progression-free of target
survival (PFS2)|Progression-
wounds achieving
free survival closure|Percentage
at 6 (PFS6) and 12 months wound area
(PFS12)|Severity
reduction from of
and frequency TV-0 per week
adverse measured with changes
events|Pathological digital All
planimetry and physical examination|Change
in resected GBM tumors following study treatments| in DFU
maximum
Quality of depth in mm
Life EORTC assessed by the Principal of
Questionnaire|Dependence
Investigator andon
overall survival documented
TTFields dose by at
computer planimetry|
the tumor|The
Change in
NANO scale score of each domain on the CWIQ (Cardiff
All
Wound Impact Questionnaire)|Change in pain regarding
to the ulcer assessed using PEG (Pain, Enjoyment and
General Activity) Scale|The percentage of time
offloaded|Change
Selectra 3D-relatedinSADE-free
skin sensitivity on the foot|
rate|Successful
Percentage ofratetime wearing the boot|Change in Foot All
implantation
Infection|Change in Wound Drainage|Change in
oxygenation
percentage ofatimaged
the woundsitessite
correctly categorized as
squamous or Barrett's mucosa|percentage of imaged
All
sites with adequate tissue contact to acquire a high
quality image
Rate of declined particilation in the study|Attrition rate|
Change in brief fatigue inventory|Change in Pittsburgh
Sleep Quality Index|Change in Hospital Anxiety and All
Depression Scale|Change in McGill Quality of Life
Questionnaire - Hong Kong
Assess whether the TENS units is effective over
standard pain control measures for intra-procedure
pain management during office cystoscopic Intra-
detrusor Onabotulinumtoxin A in women with OAB.| Female
Evaluate the effect of TENS units on participant
satisfaction following cystoscopic intra-detrusor
onabotulinumtoxin A injection in women with OAB.
Need for Endotracheal Intubation|Improvement in
Oxygen Saturation|Ventilator-free Days|Intensive Care
All
Unit Length of Stay|Overall Mortality|Need for Proning|
Intensive Care Unit Mortality|Patient Tolerability
Prosthetic Limb Users Survey of Mobility (PLUS-M)|

Patient-Reported Outcomes Measurement Information All
System (PROMIS)-29|Provider
Progression-free survival (PFS)survey
(Phase II)|Overall survival
(OS) (Phase III)|PFS for the entire cohort (Phase II/III)|OS
proportion|Comparative frequency of specific adverse
events of interest|Frequency summaries for all adverse All
event types|Patient reported symptom burden|
Neurocognitive function (NCF)|Patient-reported toxicity
outcomes
Overactive Bladder Cohort|Fecal Incontinence Cohort|
All
Non-Obstructive Urinary Retention Cohort
Clinical utility of IRIS 3D model with CT scans during

Intra-Operative navigation|Clinical utility of IRIS 3D
All
model with CT scans during preoperative surgical
planning
Pain assessment|functional assessment|Change in

Functional Assessment|Fusion, as measured by All
radiograph and CT scan
Continuation rate after one year from insertion|

Female
Expulsion rate
Catheter Independent Male
Speech recognition with deactivation All

Effect of a rTMS session on the performance for a
memory task, as measured by accuracy (in percentage
of correct responses)|An effect of a rTMS session on
the performance for a memory task, as measured by All
reaction time (in ms)|An effect of a rTMS session on
fMRI brain representation for a memory task, as
measured by BOLD signal
Changes in Sedentary Screen Time|Changes in
moderate to vigorous physical activity|Changes in time
spent sitting|Changes in time spent standing|Changes
All
in time spent stepping|Changes in time spent in leisure
activities|Changes in time spent in work activities|
Changes in time spent in housework activities
The bioavailability of fumonisin is estimated based on

the concentration of urinary biomarkers FB1 and FB2|
Incidence of (serious) adverse device effects|Urinary All
biomarkers FB1 and FB2 (separately and sum of FB1
and FB2)
Reducing admission rates|Reduction in use of
medications|Increased quality of life|Improved clinical
management|Show the value of using Coala Heart All
Monitor in rural care - patients|Show the value of using
Coala Heart Monitor in rural care - providers
Occurrence of a delirium in intensive care|Mortality in
intensive care|Mortality at day 28|Hospital cost per All
patient
Time (in seconds) to bleeding cessation with
hydrophilic
Neuroimaging polymer and potassium
outcomes: changes inferrate; timereactivity
drug cue (in
seconds) to bleeding
as specified cessation
by changes in BOLDwith direct pressure
signal|Changes in with All
sterile
Delayed gauze|Number of participants
Discounting Cognitive with at
Behavioral least one
Task|
adverse event
Questionnaire on Smoking Urges administered daily
both pre/post TMS to measure craving|Hypothetical
Purchase Task to measure tobacco product value and
All
sensitivity|Biochemical assessment of tobacco use via
quantitative urine screens to detect cotenine level|Self-
report assessment of tobacco use through Timeline
Total Nasal Symptom
Follow-Back Score (TNSS)|Nasal assessment
(TLFB) Interview|Biochemical airflow|Nasalof
secretion|Total
recent tobacco ocular
use viasymptom score (TOSS)|Total
breath Carbon Monoxide (CO) All
asthma
sample symptom score (TASS)
Change in intraocular pressure (IOP)|Complication rate|

Change in Best corrected visual acuity (BCVA)|Change
in number of individual eyedrop medications that the
patient is on (prescribed and actually taking)|Change in
Slit lamp exam (SLE) findings|Change in Dilated fundus
exam (DFE)|Change in Humphrey visual field (HVF)|
Change in Ocular coherence tomography (OCT)|Change
in Pachymetry|Change in Motility exam (9 gaze photos)| All
Change in Motility exam (stereo test)|Change in Motility
exam (Worth 4-dot)|Change in Motility exam (Hess
Screen Test)|Change in Self-report Dysesthesia Scale
questionnaire|Quality of life, as measured by glaucoma
utility index|Quality of life, as measured by glaucoma
symptom scale|Quality of life, as measured by
glaucoma related quality of life 15 questionnaire
The incidence of hypoxia|The incidence of subclinical

respiratory depression|The incidence of severe hypoxia|
Other adverse events include other adverse events
recorded by tools proposed by the World Society of All
Intravenous Anesthesia International Sedation Task
Force and HFNC supportive oxygen therapy-related
efficacy
adverse of blood flow restriction therapy on patients
events.
with Achilles injury by measure pre and post blood flow
All
restriction therapy measured by muscle strength|
Measure of pain using Visual Analog Scale (VAS)
Correlation of Imaging All

Primary Effectiveness: No conversions to open NSM|
Female
Primary Safety: Incidence of adverse events
Change in leg circumference between day 1 and day 8

(in cm)|Change in leg circumference between day 0 and
day 8 (in cm)|Change in leg circumference between day All
0 and after 6 weeks and 12 weeks (in cm)|Change in
range of motion of knee (in degree)
IUD expulsion|IUD insertion complication|Additional

Female
procedures|Receiving IUD
Volume change in the submental region|Incidence,

severity, and relatedness of adverse events|
Improvement in overall lift: H2 and Stand Up Vectra|
Improvement in Assessments: Global Aesthetic
Improvement Score|Subjects Assessment of Pain: All
Numerical Pain Rating Scale|Improvement in Non-
invasive Measurements: Aquaflux|Improvement in Non-
invasive Measurements:
Primary patency OCT|Improvement
at 6 months|Device in Non-
and procedure
invasivedeath|All-cause
related Measurements death|Major
: BTC2000 target limb
amputation|Target vessel thrombosis|Procedural
success|Clinically-driven Target Lesion Revascularisation|
Clinically-driven
Primary patency Target Vessel Revascularization|
at 6 months|30-day device and All
Amputation Free Survival|Primary patency|Restenosis|
procedure related death|All-cause death|Major target
Freedom
limb from major adverse
amputation|Target vesselevents|Change in
thrombosis|Procedural
Rutherford classification|Device Success|Technical
success|Freedom from clinically-driven Target Lesion
Success
Revascularisation|Freedom from clinically-driven Target All
Vessel Revascularization|Amputation Free Survival|
Feasibility of early mobilization|Mobilization
Primary patency|Major adverse events|Change level|
in
Mobilization duration|Frequency of mobilization|Pain
Rutherford classification|Device Success|Technical
level|Anxiety|Patient
Success satisfaction with mobilization|
All
Inflammatory response|Health care provider
assessment|Muscle wasting|Oxygen consumption during
mobilization|Oesophageal pressure|Safety events
Effects of the Moderato CNT pacing signals on cardiac
function|Effects of CNT pacing signals on blood All
pressure
Number of Participants with of Primary Adverse Events
(PAEs)|Rate of Freedom from Documented
(Symptomatic and Asymptomatic) Atrial Arrhythmia
(Atrial Fibrillation [AF], Atrial Tachycardia [AT], or Atrial
Flutter [AFL] Greater than Equal to (>=)30 Seconds
Within 91-365 days post Index Procedure|Number of
Participants who Achieved Acute Procedural Success| All
Rate of Freedom from Documented Symptomatic Re-
Occurrence Atrial Arrhythmia (Atrial Fibrillation [AF],
Atrial Tachycardia [AT], or Atrial Flutter [AFL]) >=30
Seconds Within 91-365 days post Index Procedure|
Change from Baseline in Atrial Fibrillation Effect on
Quality of Life (AFEQT) Total Score
Aerosol particle concentrations during CPET|Aerosol

particle concentrations within 1 hour after CPET is
completed|minute ventilation during CPET|oxygen All
uptake during
Procedural CPET|carbon
Technical dioxide output
Success.|Incidence during
of Inta- CPET|
and
Heart rate during
Peri-procedural CPET|Borg dyspnea
Events.|Robotically score during
Navigate Device CPET
to
the Target Aneurysm|Robotically Navigate Device into
the Target Aneurysm|Robotically Deploy Therapeutic All
Device into the Target
Group differences Aneurysm|Overall
in oxygen desaturationProcedure
index|Relative
Time|Fluoroscopy Time|Patient Radiation Exposure|
incidence of desaturations <90% or defined by a 5%
Contrast
fall from Fluid Volume|Adverse
baseline Events < 94%.|
if baseline saturation
Incidence of oxygen desaturation|Duration and severity All
of desaturations <90%|Relative number of surgical
Proportion
interruptions of due
patients with VA, ICD and ATP
to desaturation|Relative eventsand
number
over 6 months
severity of airway of interventions
ACEI/ARB anddue 6 months of ARNI
to desaturation
treatment|Numbers of NSVT, SVT, PVC, ICD shock and
All
ATP experienced by patients|LVEF (%)|NT-proBNP
(pg/mL) level|Number of hospitalizations for arrhythmia
Clinical
Total efficacyofoutcome: proportion of patients
or HF Number Individuals
related hospitalizations with Successful Opening of
achieving a favorable modified Rankin
the BBB|Total number of Safety Events Related scale score
to (mRS
0-2)|Clinical efficacy outcome: Proportion of
Opening of BBB|Percent Change in Amyloid PET Signal patients All
achieving a favorable
Intensity|Change modified Rankin
in Mini-Mental scale score (mRS
State Examination
0-2)
(MMSE)at 90 days (dichotomized) according to sex|Clinical
Score
Change outcome:
efficacy in Unified Ordinal
Parkinson's disease
logistic Ratingfor
regression Scale -
Session III|Changes
functional improvementon Depression|Changes
on the Modified Rankin on Scale
All
Cognitive function|Changes on quality of life|Levodopa
(mRS) score (shift analysis)|Clinical efficacy outcome:
Equivalent
Median Dose|frequency
National Institutes of adverse eventsScale
Health Stroke
(NIHSS) score|Clinical efficacy outcome: Median
Modified Rankin Scale (mRS) score|Clinical efficacy
In vivo cyclic All
outcome: Ratecurvature andconfirmed
of clinically mean curvature of pacing
recurrent
and defibrillation
ipsilateral stroke or leads in the
retinal extravenous regionefficacy
ischemia|Radiological will
be determined during specified arm movements.|In
outcome: Proportion of patients with complete or near- vivo
cyclic curvature
complete and mean curvature of
recanalization|Radiological pacing
efficacy and
outcome:
defibrillation
Proportion ofleads in the
patients withintracardiac region(with
ICA thrombosis will beor All
determined
without stent)|Clinical efficacy outcome: Median vivo
during two or more cardiac cycles.|In
cyclic curvature
Montreal and Assessment
Cognitive mean curvature(MoCA)of pacing and
score|Clinical
defibrillation leadsRate
efficacy outcome: in theof connector region
any recurrent will or
stroke beretinal
determined during
ischemia|Clinical specified
efficacy arm movements.
outcome: Proportion of
patients achieving a favorable modified Rankin scale
(mRS) score
Patients requiring admission to the hospital or
All
experiencing death
arterial partial pressures of oxygen|pH measurement All
Change in Function mobility|Change in Static and

dynamic balance|Change in static balance|Change in
foot pressure|Change in Cadence of gait|Change in
All
support phase of gait|Change in swing phase of gait|
Change in Risk of falls|Change in Functionality
assessment
% of patients with reduced severity of lymphedema and

fibrosis|Symptom burden score|Neck range of motion All
degree|Quality of life score
Safety surveillance of cerliponase alfa|Hypersensitivity|
Severe SAE impact on patient's motor and language All
Cerebral
functionsinfarction volume.|The proportion of enrolled
subjects that completed all the designed RIC
procedures.|The severity of global disability at 90 days,
as assessed by modified Rankin scale (mRS).|Change in All
NIHSS.|Symptomatic Intracerebral Hemorrhage.|Safety -
Maximum
Assessment
Changes inconcentration
of adverse
Amount (Cmax)
events
of Motor of serious
and dolutegravir,
adversein
Inhibition|Changes
emtricitabine,
events. lamivudine, tenofovir disoproxil
motor evoked potentials (MEPs)|Changes in cortico- fumarate,
tenofovir alafenamide, and metabolites|Time
muscular coherence in ET and/or PD participants| to All
maximum
Changes inconcentration (Tmax)motor
kinematics|Clinical of dolutegravir,
score change|
emtricitabine, lamivudine,
MRI/rs-fMRI connectivity tenofovir disoproxil fumarate,
tenofovir alafenamide, and metabolites|Minimum
concentration (Cmin) of dolutegravir, emtricitabine,
All
lamivudine, tenofovir disoproxil fumarate, tenofovir
alafenamide, and metabolites|Area under the
concentration-time curve (AUC) of dolutegravir,
emtricitabine,
Reduction lamivudine,
in frequency of tenofovir
headachedisoproxil
days: pre-fumarate,
tenofovir alafenamide,
treatment|Reduction in and metabolites|Half-life
frequency (t쩍) of
of headache days:
dolutegravir, emtricitabine,headache
post-treatment|Maximum lamivudine, tenofovir
severity: pre-
disoproxil fumarate, and
treatment|Maximum tenofovir
headache alafenamide
severity: post-treatment| All
Headache duration: pre-treatment|Headache duration:
post-treatment|Use of rescue medication: pre-
treatment|Use of rescue medication: post-treatment
Change from Baseline high Blood Pressure (mmHg) at
12 Weeks|Change from Baseline Waist Circumference
(centimetres) at 12 Weeks|Change from Baseline LDL-
cholesterol (mmol/L) at 12 Weeks|Change from Baseline
HbA1c (Glycated Hemoglobin %) at 12 Weeks|Change
from Baseline Fasting Plasma Glucose (mmol/L) at 12
Weeks|Change in prevalence of cardiovascular All
(percentage) risk factors clustering|Change from
Baseline body mass index (BMI, kg/m^2) at 12 Weeks|
Change from Baseline Physical Activity (IPAQ
Questionnaire) at 12 Weeks and 16 weeks|Change from
Baseline Physical Activity (AX3 Device) at 12 Weeks and
16 weeks
Safety through 30 days|Target Lesion Primary Patency

(TLPP)|Access Circuit Primary Patency (ACPP)|Rate of
Device and Procedure Related Adverse Events involving
the access circuit.|Total Number of Arteriovenous (AV)
Access Circuit Reinterventions|Total Number of Target All
Lesion Reinterventions|Index of Patency Function (IPF)|
Index of Patency Function for Target Lesion|Post-
Intervention Secondary Patency|Acute Technical Success
for Stent Graft Placement|Acute Procedural Success
Measurement of bilirubin with a Transcutaneous

bilirubinometer in the study and control groups|
Female
hospitalization due to jaundice in the study and control
groups
Change in motor behavioral scores|Change in

somatosensory acuity|Change in Fugl-Meyer
Assessment for Upper Extremity (FMA-UE)|Change in
streamlined Wolf Motor Function Test (WMFT)|Change All
in Erasmus-MC
Change version
in wound of area
surface the Nottingham Sensory
from baseline (if wound
Assessment (EmNSA)|Change in Modified Ashworth
is not closed in 12 weeks)|Wound closure time from
Scale (MAS)|Change
initial assessment (if in pain management
wound is closed in 12 weeks)|
Persistent wound pain: Faces Pain Scale - Revised (FPS-
R)|Procedural (dressing change) wound pain: Faces Pain
Scale - Revised (FPS-R)|Amount of pain medication
All
taken: number of morphine equivalents plus non-opioid
pain medications taken for any reason|Time wound is
dependent|Patient overall quality of life: ASCQ-Me
questionnaire|Patient wound-specific
Health-related quality-of-life quality of life:
(HrQoL)|Symptom burden|
Wound-QoL questionnaire|Materials costs|Time spent All
Spirometry|Accelerometry|Functional exercise capacity
performing dressing changes|Wound complication rates
Establish the N-13 measured MBF (ml/g/min) value
All
range
Incident AF [At Risk Group]|Progression of AF [AF

Group]|Recurrence of AF after treatment with direct
All
current cardioversion (DCCV) or AF ablation [AF Group]|
Symptom Burden [AF Group]
Detection of SpO2-oscillations caused by cyclic

All
recruitment and derecruitment of atelectasis.
Vertical acceleration in m/s짼 during the sit to stand

phase of the Timed-Up and Go test.|Maximum
Persistent Neuronal Activity (Firing Rates)|Persistent
voluntary isokinetic strength (Nm) of the quadriceps
Neuronal Activity (Power)|Decision Making (Firing
muscles in slow speed (60째/s) concentric contraction.|
Rates)|Decision Making (Power)|Decision Making
Demographics information|Weight (Kg).|Height (cm).| All
(Timing)|Disruption of learning and memory via
Waist circumference (cm).|Hip circumference (cm).|
electrical stimulation (firing rates)|Disruption of learning
Brachial circumference (cm).|Calf circumference (cm).|
and memory via electrical stimulation (memory)
Percent
Body of agreement
Mass between incomposition.|Self-
Index (Kg/m짼).|Body person
recommendation and telemedicine
Reported Number of Falls during the recommendation|
previous year|
Estimate therisk.|Balance
Sarcopenia performance of the telemedicine
confidence in performingsystem
and in-person
various dermatologist
activities|Maximum in diagnosing
voluntary skinstrength
isometric cancer.| All
Impact on patient centered outcomes
of the quadriceps muscles at 45째 (Nm).|Maximum based on analysis
of patient isokinetic
voluntary responses|Percentage
strength of the of accuracy
quadricepsusing
muscles
Nevisense
at 60째/s
Long in diagnosis
term(Nm).|Maximum
Implant voluntarybone
stability|Vertical isokinetic strength
height gain|
of the quadriceps
Post-surgical musclessatisfaction
pain|Patient at 240째/s regarding
(Nm).|Maximum
the All
voluntary isokinetic
function|Plaque
Nicotine Exposure: strength
Index|Modified of the quadriceps
Bleeding Index
Blood Nicotine|Nicotine muscles
Exposure:
at 30째/s (eccentric contraction) (Nm).|Maximum
Saliva pH|Subjective Effects: Withdrawal|Subjective
voluntary isokinetic strength
Effects: Craving|Subjective of theReward|
Effects: hamstring muscles
at 60째/s (Nm).|Maximum voluntary isokinetic strength
Cardiovascular Effects: Heart Rate|Cardiovascular Effects: All
of the hamstring muscles at 240째/s
Skin Blood Flow|Vaping Topography: Puff Number| (Nm).|Maximum
injected
voluntary contrast
isokinetic
Vaping Topography: mediaPuffasDuration|Vaping
strength well
of as
thefluoroscopy
hamstring time
muscles
Topography:
were
at recorded|the
30째/s
Inter-Puff Interval time
(eccentric from femoral
contraction) vein puncture to
(Nm).|Statokinesigram
transseptal
surface areapuncture to closure were
(mm짼).|Stabilogram recorded|residual
length (mm).|Maximal All
shunt and DRT after transcatheter closure of left atrial
deflection (forward, backward left and right).|Velocity
appendage(mm/s).|Romberg
variations detected|new pericardial effusion,
ratio according to sway
pericardial tamponade
area|Romberg were detected
ratio according to center of pressure
path length.|Plantar pressure ratio sway area.|Plantar
All
pressure ratio length|Walking velocity (cm/s).|Cadence
(steps/min).|Step length (left and right foot) (cm)|Stride
length (cm).|: Single support time left and right foot (%
of walking cycle)|Double support time (% of walking
MME|Assessment
cycle).|Swing time of
(%functional
of walkingrecovery
cycle).|Swing phase (% Female
of walking cycle).|Stance phase (% of walking cycle).|
Functional capacity Timed-Up and Go|Functional
capacity TDM6|Vertical acceleration (m/s짼) during the
sit to stand phase of the Timed-Up and Go test (TUG).|
Time (s) to complete the Timed-Up and Go test.|
Anteroposterior acceleration (m/s2) during stand to
walk phase of the Timed-Up and Go test|Vertical
angular speed (m/s) during the TUG test.|Medio-lateral
angular velocity (m/s) during the TUG test.|Time (s) of
6-minute test|Time for 10-meter test|6-minute walk
test|Recovery time|Normal or deficient posture balance
in sitting and standing|Berg Balance Scale|Timed Up
and Go test|Duration for the test of the 10 chair lifts| All
MRC scale|Functional Independence Measure|
Acceptability|Acceptance|Fatigue|Undesirable effects|
Confidence in the future
Change in perceived psychosocial well-being - parents|
Change in perceived psychosocial well-being - children|
Change in gross motor function|Change in lower All
extremity kinematics and posture stability|Change in
balance
Bone Mineral Density (g/cm2)|Hip structural analysis|
Physical Activity Level|Lipid panel|Homeostatic Model
All
Assessment for Insulin Resistance|Hemoglobin A1c|
Vitamin D
Oswestry Disability Questionnaire|Short Form-36
Questionnaire|Visual analogue scale|Ultrasound
evaluation of SCN (Grey scale)|Ultrasound evaluation of All
SCN (Elastography )|Electrophysiological test (Sensory
nerve study)
TOF-PTC value All
bone mass/bone density maesurement|blood sample

(Vit. D/Calcium)|haemophilia related clinical data|level of
physical activity|orthopaedic joint status|pain condition| Male
subjective quality of life and subjective physical
performance
Self-reported emotion ratings|Means of self-reported

emotion ratings|Skin conductance level|Mood ratings|
All
Debriefing of instructions|Task difficulty|Task
compliance|Experience with task images
Change in Hearing Aid Satisfaction After Auditory
Training|Change in Hearing Aid Usage After Auditory
All
Training|Change in Percent Words Correct on Speech
Perception Measures after Auditory Training
postoperative pain|Analgesic consumption All
Change in Heavy Episodic Drinking|Change in Modal

alcohol consumption|Change in Negative Emotional
All
State -- Depression|Change in Alcohol-related
problems|Change in Suicidal ideation
time to delivery|Cesarean delivery rate|Time to vaginal
delivery|Maternal length of stay|Indication for cesarean
delivery|Chorioamnionitis|3rd/4th degree perineal Female
laceration|Blood transfusion|Endometritis|Wound
separation-infection|Neonatal death
AFib detection with heart rate data measured by Smart

All
Watch
To identify trends in data collected from mHealth

technologies.|To identify predictors of worsening
asthma using mHealth technologies.|Using new All
definitions of worsening and improving asthma, assess
response to biologic therapy
Difference in microbial composition of gut microbiome
in study and control groups|Change in microbial
All
composition of gut microbiome after successful VT
therapy
Change of Gate Speed from Baseline vs. 6 months|

International Physical Activity Questionnaire|Medical All
Outcome Survey - Short Form 36
Change in Body Weight|Change in Physical Activity-
Patterns of self-reported clinical
Active Minutes/Day|Change Pain|Patterns of Pain
in Physical
Catastrophizing|Patterns of Positive Questionnaire
Activity-Steps/Day|Food Frequency Mood|Patterns(FFQ)
of
All
Negative Mood|Patient
measuring Adherence
change in eating as assessed
habits|Healthy by Index
Eating
completion
(HEI) of questionnaire
measuring on theeating
change in healthy app score|Rate of
Participants who are Adherent to Self-Monitoring|
Change in Dietary Self-Efficacy Scale (Diet-SE)|Change
All
in Self-Efficacy for Exercise Scale|Experiences of
Discrimination Scale (EoD)|Patient Health Questionnaire
(PHQ) for Adults,
Pathological PHQ-9|Ideal
Complete body image|Treatment
Response|Objective Response
Self-Regulation Questionnaire (TSRQ) for Diet and of
Rate|Relapse Free Survival|Overall Survival|Incidence
Exercise|NIH Patient Reported Outcome Measurement All
Treatment-Emergent Adverse Events [Safety and
Information System
Tolerability]|Risk
Effectiveness (PROMIS)
of Surgical
of human Measure
Delay
papillomavirus for
(HPV)Emotional
Support
intervention|Equitableness of HPV intervention|Safety of
HPV intervention|Fidelity of HPV intervention|
Female
Sustainability of HPV intervention|Cost-effectiveness of
HPV intervention|Satisfaction with HPV self-testing and
PN|Satisfaction with provider education sessions
Daily Stepping|Lane Width Optimization Test|Lower
Extremity Motor Score|Walking Index for Spinal Cord
Injury II (WISCI II)|Functional Gait Assessment (FGA)|10
Meter Walk Test (10MWT)|Activities Specific Balance
Confidence (ABC) Scale|Balance Evaluations Systems
Test (BESTest)|Berg Balance Scale (BBS)|The World
Health Organization Quality of Life Scale (WHOQOL-
BREF)|International Consultation on Incontinence All
Questionnaire-Urinary Incontinence Short Form (ICIQ-UI
SF)|Biomechanical Assessment - Step Width|
Biomechanical Assessment - Step Length|Biomechanical
Assessment - Minimum lateral margin of stability|
Biomechanical Assessment - peak lateral center of mass
speed|Biomechanical Assessment - lateral center of
mass excursion
14 Day Patient Satisfaction Questionnaire|Emergency

All
Department Visits|14 Day EQ-5D-5L Scores
Predicting kidney mass diagnosis using 3D CEUS
generated metrics|Comparing diagnostic accuracy of F-
R infusion imaging technique to low MI bolus imaging All
technique|Predicting kidney mass stage using 3D CEUS-
generated metrics
Patient clinical status (on the WHO 7-point ordinal

scale) at day 15 in IP versus SOC control group
patients:|Status on an ordinal scale assessed daily while
hospitalized and on days 15 and 28 in IP versus control
group patients|NEWS assessed days 3, 5, 8 ,11 daily
while hospitalized and on days 15 and 29 in IP versus
control group patients|Rate of mechanical ventilation in
IP versus control group patients|Duration of mechanical
ventilation (if applicable) in IP versus control group
patients|Duration of supplemental oxygen in IP versus
All
control group patients|Time to return to room pressure
(SpO2 > 94%) on room air|Duration in ICU (if
applicable) in IP versus control group patients|Rate of
Mortality in IP versus control group patients|Duration of
hospitalization in IP versus control group patients|Time
to discharge in IP versus control group patients|Effect
on the rate of change of partial pressure of oxygen
(PaO2) and PaO2/FiO2 ratio taken at baseline and
measured once daily up to 2 weeks of treatment in IP
versus control group patients
Change in Clinical status of subject on a 7-point ordinal
scale|PCR test|Supplemental Oxygen|Mechanical
Ventilation|Incidence of Treatment-Emergent Adverse
All
Events|C-reactive protein (CRP)|Interleukin 6 (IL-6)|D-
dimer|Interferon gamma|Ferritin|TNF alpha|Interleukin 1-
S
棺ensitivity, specificity, positive predictive value and
Isolate
negative macrophages
predictive value of bi-target stool DNA testing All
(the methylation status of SDC2 and SFRP2) with
comparison to colonoscopy, both with respect to
cancer and advanced precancerous neoplasm.|To All
compare the performance of the bi-target stool DNA
Subject쨈s
testing to aResponder
commerciallystatus (score FIT
available on assay,
the 7-point
both with
ordinal
respect scale on Day
to cancer and15)|Evaluation of change in clinical
advanced precancerous
condition
neoplasm.based on the 7-point ordinal scale|Evaluation All
of change in clinical condition based on the 7-point
ordinal scale and Responder Status|Hospital resource
utilization comparison
Daily activity|Functional and structural brain measures|
All
Cognitive functioning|Affective processing
Death or respiratory failure ate Day 28|National
Institute of Allergy
Anesthetists and Infectious
non-technical Diseases
skill (ANTS) (NIAID)
Assessment|
ordinal scale Anchored
Behaviorally of diseaseRating
severity at Day(BARS)
System 14|Status of
alive and not on mechanical ventilation or ECMO in at All
Assessment|Time to first compression (measured
Day 14 and 28 NIAID
seconds)|Positive ordinal scale
and Negative of disease
Affect Scheduleseverity
at Day 14|Status of requiring supplemental oxygen at
Day 28|Status of being alive and not hospitalized at
Day 14 and 28|National Institute of Allergy and All
Infectious Diseases (NIAID) ordinal scale of disease
severity at Day 14 NIAID ordinal scale of disease
severity at Day 28|Number of patients with cure|
Exercise
Number Capacity|Cardiac
of patients at theOutput|Pulmonary artery
ICU or on ventilatory All
pressure
support at Day 28|Number of days free from
mechanical ventilation at 28 days|Number of days in
hospital|Number of days in ICU
CGM Time in Range 70-180 mg/dL|Non-inferiority for
CGM time <54 mg/dL|CGM Mean Glucose|CGM Time >
180|CGM Time > 250|CGM Time < 70|CGM Time < 54
(Superiority)|Coefficient of Variation|CGM Time in Range
70-140 mg/dL|Standard Deviation|CGM Time < 60|LBGI|
CGM Hypoglycemia Events|CGM Time > 300|HBGI|
HbA1c at 13 weeks|Number of Participants With HbA1c
<7.0% at 13 weeks|Number of Participants With HbA1c
<7.5% at 13 weeks|HbA1c improvement from baseline
to 13 weeks >0.5%|HbA1c improvement from baseline
to 13 weeks >1%|HbA1c relative improvement from
All
baseline to 13 weeks >10%|Number of Participants
With HbA1c Improvement From Baseline to 3 months
>1.0% or HbA1c <7.0% after 3 months|Diabetes
Distress Scale at 13 weeks - total score and 4 subscales:
Emotional burden, Physician-related distress, Regimen-
related distress, Interpersonal distress|Glucose
Monitoring Satisfaction Survey|Hypoglycemia
Confidence Scale|Diabetes Technology Attitudes Survey|
INSPIRE survey scores - following study system period
only|SUS survey scores - following study system period|
Total Daily Insulin|Basal: bolus insulin ratio|Weight|BMI
Functionality|Muscle strength|Quadriceps muscle

thickness|Echogenicity of the rectus femoris muscle|
Spasticity|Mobility|Disability and dependence|Quality of
life indicator|Heart rate|Peripheral arterial oxygen All
saturation|Systolic blood pressure|Diastolic blood
pressure|Muscle pain|Lower
Overall Comfort|Overall limboffatigue|Time
Quality of
Vision|Monocular
hospital stay
Distance Visual Performance (Low Luminance/High
Contrast)|Monocular Distance Visual Performance (High All
Luminance/Low Contrast)|Average daily wear time (in
hour)
Change in Montgomery-Asberg Depression Rating
Scale (MADRS)|Presence and changes in severity of side
effects|Change in Beck Depressive Inventory (BDI)|
Change in 21-item Beck's Anxiety Inventory (BAI)|
Change in Fatigue Severity Scale (FSS)|Change in
Pittsburgh Sleep Quality Index (PSQI)|Change in Expand
Disability Status Scale (EDSS)|Change in Cortical silent
All
period (CSP) duration|Change in short-interval
intracortical inhibition (SICI)|Change in intracortical
facilitation (ICF)|Changes in long-interval intracortical
inhibition (LICI)|Change in slow-wave/fast-wave
(theta/beta) ratio from resting-state
electroencephalograph (EEG) recording|Serum
biomarker
MRI PDFF correlation/agreement to UDFF All
Self-rated thermal comfort.|Mean core temperature.|

Mean skin temperature|Surgeons' cognitive
performance, measured with the C3B battery.|Surgeon'
perceived ergonomic workload measured with Borg
CR10 scale of exertion and the rating-of-fatigue (ROF) All
scale.|Surgeon' perceived fatigue measured as 0
representing not fatigued at all, 5 moderately fatigued,
and 10 total fatigue & exhaustion|Time the surgeon
wore the Cooling Vest|Operating Room Temperature
Number of participants with first-attempt success|Mean

All
arterial pressure|Heart rate|Time required|Complications
Essential Tremor Severity Change All
Change in Constant score (CS)|Change in Oxford

Shoulder Score (OSS)|Change in Western Ontario
Osteoarthritis of the Shoulder Index (WOOS)|Change in All
EQ5D questionnaire|Change in Numeric Ranking Scale|
Complications|Change in humeral tuberosities
Change from baseline in shoulder force after pitching|
Change of pitching velocity during pitching|Change of
All
pitching spin rate during pitching|Change of delayed
onset muscle soreness after pitching
The adequacy of nasotracheal tube tip location in
neutral, extended and flexed neck position|The
adequacy of nasotracheal tube cuff location in All
extended and flexed neck position|The adequacy of
nasotracheal tube length
Overall lens fit acceptance|Lens Centration|Post-blink

All
movement|Push-up tightness
Incidence of laboratory-confirmed COVID-19|Ability of

the filtering element to inactivate the SARS-Cov-2|
Usability and comfort of the respirator|Adherence to All
the use of the Respirator|Stress|Burnout|Self-reported
quality of life|Musculoskeletal discomfort|Work ability
Clinical combined endpoint: survival; and improvement

> 1 point in NYHA class or > 25% increase in the
distance covered in the 6-minute walking test.|Change
in left ventricular ejection fraction.|Correction of
echocardiographic asynchrony: septal flash expressed in
mm.|Distance covered in the 6-minute walking test.|
All
Change in NYHA functional class.|Change in degree of
mitral regurgitation.|Change in NTproBNP.|
Hospitalization due to heart failure.|QRS duration|Score
on quality of life/symptoms Questionnaire (KCCQ-12
Kansas City Cardiomyopathy Questionnaire )|Correction
of global longitudinal strain
Skin assessment (RD grade)|Pain (VAS)|Patient's

Female
assessment of the skin condition (DLQI questioner)
Distance from catheter tip to cavo-atrial junction (CAJ)|

All
Length of the outgoing catheter|Haemostasis time
Proportion of stent strut coverage|Uncovered stent

struts|Persistent stent malapposition|Maximal neointimal All
growth
Subjective at-home ratings of Lens handling for

All
insertion
Brain activity during functional magnetic resonance
imaging (fMRI)|Cardiac autonomic function during
functional magnetic resonance imaging (fMRI)|Change
All
in serum cortisol levels|Change in serum levels of pro-
inflammatory cytokines|Change in depressive symptoms
assessed by the Beck Depression Inventory
CAPS|insula|HVLT-R % retention|Change in IL6
Concentration in Blood with Stress|hippocampal All
activation|PPG amplitude
Re-intervention rate|Evaluation of patency, migration

All
and adverse events rate
Lens Handling at Insertion All
Number of breast biopsy patients whose clip migrated

greater than 10mm from the biopsy site.|Percentage of
breast biopsy patients whose clip migrated greater than
10mm from the biopsy site.|Average distance of clip Female
migration for the arm that received 5mm retraction.|
Average distance of clip migration for the arm that did
not receive clip retraction.
Ventilator-Free Days (VFD)|ICU and Hospital Length of

Stay|Intubation|Renal Replacement migration
Implant survival at 3 years|Implant Therapy (RRT)|
measured All
Mortality
with Computer Tomography Microanalysis in a
subcohort of patients motion Analysis (CTMA) in a sub-
cohort of patients|Implant survival at 10 years|EQ-5D|
All
Plain radiographs in a sub-cohort of patients|Adverse
events using the national patient register|Adverse
events using the regional VEGA database|Oxford Hip
Score|Forgotten Joint Score
Change in Insomnia Severity Index (ISI) scores from
Baseline to Post-Intervention (approximately 10 weeks
after Baseline)|Change in Childhood Cancer Survivor
Study-Neurocognitive questionnaire (CCSS-NCQ) scores
from Baseline to Post-Intervention (approximately 10
weeks after Baseline)|Change in The NIH Toolbox
Cognitive Battery (NIHTB-CB) scores from Baseline to
Post-Intervention (approximately 10 weeks after
Baseline)|Change in daily sleep behaviors evaluated by
a Sleep Diary from Baseline to Post-Intervention
All
(approximately 10 weeks after Baseline)|Change in
Patient Health Questionnaire (PHQ-9) scores from
Baseline to Post-Intervention (approximately 6 months
after Baseline)|Change in Generalized Anxiety Disorder-
7 (GAD-7) scores from Baseline to Post-Intervention
(approximately 6 months after Baseline)|Change in
Patient-Reported Outcomes Measurement Information
System (PROMIS) Global Health questionnaire (HRQoL)
scores from Baseline to Post-Intervention
(approximately 6 months after Baseline)
Incidence of post-operative AKI|NAG excretion|eGFR|

Incidence of AKI|Hemolysis|CNS injury markers| All
Myocardial injury markers
Functional long-term properties clinical performance of

restorations (onlays and crowns) [Change from
baseline]|Esthetic properties of restorations (onlays and
crowns) [Change from baseline]|Biologic properties of All
restorations (onlays and crowns) [Change from
baseline]|Short-term post-operative sensitivity [Change
from baseline]|Gingival index|Plaque index
Physical Functioning measured by PROMIS 6 (Patient
Reported Outcome Measurement Information System)|
Patient-Reported Pain Intensity|Disability measured by
the Oswestry Low Back Disability Questionnaire|Mental All
Functioning measured by PHQ-9 (Patient Health
Questionnaire)|Mental Functioning measured by GAD-7
(Generalized Anxiety Disorder)|Adverse Events
The Auditory Hallucination Rating Scale (AHRS) All
unplanned major amputation of the target limb|

endovascular or surgical target lesion re-vascularization
for critical limb ischemia|composite of unplanned
All
(major or minor) index-limb amputations or any target
lesion re-vascularization within 365 days after
enrolment
Total opioid consumption in oral morphine equivalent
dose from TKA (Day 1) to Day 42 (6 weeks post-TKA)|
The area under the curve (AUC) of the Numeric Rating
Scale (NRS) "worst pain" intensity scores from TKA (Day
1) to Day 42 (6 weeks post-TKA)|Numeric Rating Scale
All
(NRS) pain intensity scores "right now" at Day 15, 30,
42, and Day 90|Numeric Rating Scale (NRS) pain
intensity scores "average pain" at Day 4 to Day 42|Total
opioid consumption
Opioid in oral
use|2. Functional morphinepatterns
connectivity equivalents from
in the
TKA-Day 15, TKA-Day 30, TKA-Day 42, and TKA-Day 90 All
brain|Opioid Craving|Negative affect
introduction time|rate of changing tube All
Effectiveness of partial replacement of concentrated

oxygen by high flow ambient air for Long Term Oxygen
Therapy|Dyspnea relief achieved with of partial All
replacement of concentrated oxygen by high flow
ambient air for Long Term Oxygen Therapy
Evaluation of effect of rTMS for primary dysmenorrhea Female
Time for Incision Closure|Cost of Closure|Wound

Appearance|Dehiscence|Wound drainage|Superficial
All
Infection|Deep wound infection|Number of wounds that
require post operative intervention
Assess change in bowel movements PRE and POST

HygiRelief procedure|Assess colon effluent samples All
(HygiSample) collected during the HygiRelief procedure
Nasal Congestion Symptom Score (NCSS)|Nasal airflow|

Total nasal symptom score (TNSS)|Total ocular
All
symptom score (TOSS)|Total asthma symptom score
(TASS)|Nasal secretion
Comparison of spasticity control with Synchromed II

versus Prometra II|Comparison of patient report of All
spasm frequency with Synchromed II versus Prometra II
Adverse events (intraoperative and perioperative)|Best

Corrected Visual Acuity (BCVA)|Mean intraocular
All
pressure (IOP)|Mean number of ocular hypotensive
medications
Rate of cervical dilation using DILAPAN-S|Gauze vs. No

Female
gauze|Patient satisfaction
In-Ear vs finger SpO2 All
ERG function All

Change in strength test (Dynamometer) from baseline
to 12-weeks post EMS in EMS vs. controls|Change in 6-
minute walk test distance from baseline to 12-weeks
post EMS in EMS vs. controls|Change in right ventricle
All
diastolic function from baseline to 12-weeks post EMS
in EMS vs. controls|Change in peak oxygen
consumption, measured score
Time to delivery|APGAR by spiroergometry from
at 1and 5 min|number of
baseline to 12
participants weeks
with post infection|NICU
maternal EMS in EMS vs.admission|
controls
All
Need for neonatal antibiotics|Need for resipiratory
support|mode of delivery
Complete tumor ablation rate|First complete tumor

All
ablation rate|Complete ablation rate of lesions
Quantitiative Global Scaring Grading System (QGSGS)

score|Adverse Events|Global Aesthetic Improvement
Scale (GAIS)|24 Month Global Aesthetic Improvement
Scale (GAIS) Results|24 Month Quantitiative Global All
Scaring Grading System (QGSGS) Results|Result of
Placebo Group based on the Quantitiative Global
Scaring Grading System (QGSGS)
Respiratory particle production All
Control - Insulin doses, insulin sensitivity factor 6-12
months|Glycemic Control - Insulin doses, insulin
sensitivity factor 12-18 months|Glycemic Control -
Total blood volume (absolute and relative to ideal body
Insulin doses, insulin sensitivity factor 18-24 months|
weight)|Red blood cell volume (absolute and relative to
Glycemic Control - Differences in CGM readings over
ideal body weight)|Plasma volume (absolute and
prior month, Time 70-180 mg/dL|Glycemic Control - All
relative to ideal body weight)|Transudation rate of the
Differences in CGM readings over prior month, Time
131I albumin tracer|Incidence of new onset renal injury
<70 mg/dL|Glycemic Control - Differences in CGM
(failure) and requirement for renal replacement therapy
readings
Evaluationover prior
of the month,
impact of Time >180 tracker
an Activity mg/dL|Glycemic
based
Control - Differences in CGM readings
Fitness programme on the Qualitiy of Life after over prior All
month, TimeTherapy
oncological >250 mg/dL|Glycemic Control -
Differences in CGM readings over prior month, Number
IPSS
of total score|surgery
hypoglycemia time, totalControl
events|Glycemic energy,- resected
Differences
prostate volume, immediate complication|IPSS-
in CGM readings over prior month, Total daily insulin Male
subscore, IPSS-QoL,
injected|Triple Label OABSS total score|Qmax,
Tracer, Difference in overallpost
insulin
voided residual
sensitivity (SI) aturine volume
24 months|Triple Label Tracer,
Difference in overall insulin sensitivity (SI) at 12 months|
Change of AF burden|change of left atrium volume|
Triple Label Tracer, Change in insulin sensitivity (SI) at
change of Quality of Life|Number of participants All
24 months|Triple Label Tracer, Change in insulin
hospitalized for cardiovascular or all causes
sensitivity (SI) at 12 months|Triple Label Tracer,
Evoked motor responses in arm muscles asses with
Difference in overall Hepatic SI at 24 months|Triple
surface electromyography (EMG)|Change in
Label Tracer, Difference in overall Hepatic SI at 12
comfort/discomfort levels during electrical stimulation All
months|Triple Label Tracer, Change in overall Hepatic SI
of the cervical
Percentage spinalWithin
of Time cord|Selectivity of muscleof Time
Range|Percentage
at 24 months|Triple Label Tracer, Change in overall
recruitment|Shoulder,
Measure|Time elbow
to months|Triple
Stable and wrist joint
Dose|Number angles
of participants
Hepatic SI at 12 Label Tracer, Difference
who experience at least one of the following
in Peripheral SI at 24 months|Triple Label Tracer, safety
events:|Percentage
Difference in Peripheral of prescribed doses within 0.625
SI at 12 months|Triple Label mg All
of the NextDose proposed dose.|Mean
Tracer, Change in Peripheral SI at 24 months|Tripledifference
between the prescribed
Label Tracer, dose and the
Change in Peripheral SI atNextDose
12 months|
proposed
Triple dose.
LabelofTracer, Difference in Endogenous glucose
Difference Standard Deviation of NN Intervals upon
uptake at 24 months|Triple Label Tracer, Difference in All
Discharge Compared to Admission
Endogenous glucose uptake at 12 months|Triple Label
Tracer, Change in Endogenous glucose uptake at 24
months|Triple Label Tracer, Change in Endogenous
glucose uptake at 12 months|Triple Label Tracer, All
Difference in Glucose uptake at 24 months|Triple Label
Tracer, Difference in Glucose uptake at 12 months|
laryngeal
Triple Label mask placement|complications
Tracer, Change in Glucose uptake of laryngeal
at 24
mask insertion|hemodynamic response|insertion
months|Triple Label Tracer, Change in Glucose uptake time|
All
respiratory dynamics|hemodynamic
at 12 months|Triple responce|oxygen
Label Tracer, Difference in Meal
saturation
glucose uptake at 24 months|Triple Label Tracer,
Difference
cerebral in Meal glucose saturation
saturation|oxygen uptake at 12 months|Triple
( SPO2 )|arterial
Label Tracer, Change in Meal glucose
partial pressure of carbon dioxide ( PaCO2 )|End uptake at 24Tidal
All
months|Triple Label Tracer, Change in Meal
CO2 ( ETCO2 )|Positive End Expiratory Pressure ( PEEP )| glucose
uptake atof12
Fraction months|Division
inspired oxygen of diabetes management
responsibilities, child, difference in score at 24 months
(adjusted
Evaluationfor of baseline)|Division of diabetes
the impact of an activity tracker based
management Female
fitness programme on the fatigue syndrome in score
responsibilities, child, difference
at 12 months (adjusted for baseline)|Division of
diabetes management responsibilities, parent,
difference in score at 24 months (adjusted for baseline)|
Division of diabetes management responsibilities,
parent, difference in score at 12 months (adjusted for
baseline)|Family conflict, child, difference in score at 24
months (adjusted for baseline)|Family conflict, child,
difference in score at 12 months (adjusted for baseline)|
Family conflict, parent, difference in score at 24 months
Semi-structured interview with 15 patients on their
experiences of VR for rehabilitation from COVID-19.|Use
of VR|Semi-structured interviews with physiotherapists
on their experiences of VR for rehabilitation from
COVID-19.|Change in baseline performance test
(guidelines KNGF) - Patient specific complaints.|Change
in baseline performance test (guidelines KNGF) - 6
All
minute walk test|Change in baseline performance test
(guidelines KNGF) - one-repetition maximum test|
Change in baseline performance test (guidelines KNGF)
- 30 sec sit to stand|Change in baseline performance
test (guidelines KNGF) - Borgscale for fatigue|Change in
activities of daily life.|Change in HADS.|Change in CFQ.|
Change in SF12.|Change in positive health.
Eye Tracking and ADHD measure correlation|Eye

Tracking
Changes ADHD
in rootDiagnostic
mean squareROC|MANCOVA
of successive Eye
NN-interval All
Tracking in ADHD
Cognitive dual-task
differences Treatment Population
(RMSSD)interference (%) in Timed-up &
during mobilisation|Changes in go
test|Physical dual-task
root mean square interference
of successive (%) in Timed-up
NN-interval &
differences
go test|Timed-up
(RMSSD) & go test (sec):
during sleep|Changes in single
standard task|Timed-up
deviation of
All
& gointervals
N-N test (sec): cognitive
(SDNN) dual-task|Timed-up
during mobilisation|Changes & go intest
(sec): physical
standard dual-task|Stroop
deviation test|Trail
of N-N intervals (SDNN) making test|
during
Digit span test
sleep|Percentage of successive RR intervals
isometric quadriceps torque|quadriceps rate of torque that differ
by more than 50 ms (pNN50)
development|Corticospinal during mobilisation|
excitability - active motor
All
Percentage of successive
threshold|Corticospinal RR intervals
excitability that of
- slope differ
the by
Incidence
more than rates
50 of
ms severe
(pNN50)
stimulus response curve hypoglycemia
during (SH)
sleep|Changes and in low
diabetic ketoacidosis (DKA)|Safety of the
frequency (LF) power during mobilisation|Changes in automatic
population
low frequency of CGM readings
(LF) power into sleep|Changes
during the bolus calculatorhigh
of the Control-IQ system|Glycemic Outcomes as a high
frequency (HF) power during mobilisation|Changes All
measure
frequencyof(HF)
efficacy
power of during
the Control-IQ system|Patient-
sleep|Changes in ratio of
reported satisfaction with and trust in the
LF-to-HF power during mobilisation|Changes in ratio of Control-IQ
system,
LF-to-HFusability of the sleep|Changes
power during system, and sleep in Squality
(area of the
Box and
ellipse blockrepresents
which test|Motortotal
evoked
HRV)potential|Hand force
during mobilisation| All
Changes in S (area of the ellipse which represents total
HRV) during sleep|Changes in SD1 (Poincar챕 plot
standard deviation perpendicular the line of identity)
during mobilisation|Changes in SD1 (Poincar챕 plot Male
Percentage of patients
standard deviation reporting "not
perpendicular at all"
the line of or "just a
identity)
little"
duringwhen asked, "With
sleep|Changes or without
in SD2 glasses,
(Poincar챕 plot how much
standard
do you notice glare or haloes around lights
deviation along the line of identity) during mobilisation| in dim light
situations?"|Percentage
Changes in SD2 (Poincar챕 of postoperative
plot standardpatients
deviation who
All
report
along the "rarely" when
line of askedduring
identity) "How sleep|Changes
often do you need in
glasses
SD1/SD2 to see
ratio the
duringcomputer?"|Percentage of
Numerical
postoperative ratingsmobilisation|Changes
painpatients (NRS)|Qualitative
who report datain
thatarterial
they do
SD1/SD2
from
not
ratio during
semi-structured sleep|Changes in systolic
interviews|Electroencephalography pressure
data|
require
(SAP) reading
during glasses for various in
mobilization|Changes activities
diastolic arterial
Pittsburgh sleep quality index (PSQI)|Multidimensional All
pressure (DAP) during
Fatigue Inventory mobilization|Changes
(MFI)|EuroQol - 5 dimensions in mean
(EQ-
arterial pressure
5D)|Brief (MAP) during
Pain Inventory (BPI) mobilization|Changes in
pulse pressure (PP) during mobilization|Changes in
heart rate (HR) during mobilisation|Changes in cardiac
output (CO) during mobilization|Changes in stroke
volume (SV) during mobilization|Changes in systemic
Inhalation of KELEA Excellerated Water in Covid-19
All
Infected Individuals
Change of Horovitz index All
Accuracy of rPPG
[Depression (MDD)] heart
Beckrate|Accuracy of rPPG oxygen
Depression Inventory (BDI-II)|
saturation|Accuracy of rPPG respiratory rate|
[Anxiety] Beck Anxiety Inventory (BAI)|[Dementia] Quick
Reproducibility
Dementia RatingofScale
rPPG (QDRS)|[Concussion/Traumatic
heart rate readings| All
Reproducibility
Brain of Brief
Injury (TBI)] rPPGPainoxygen saturation
Inventory readings|
(BPI)|[All] Global
Reproducibility of rPPG respiratory
Rating of Change (GRC)|[MDD & TBI] Patient rate readings
Depression Questionnaire (PDQ-9)|[MDD] Hamilton
Depression Rating Scale (HAM-D)|[Anxiety] Hamilton Female
Anxiety Rating Scale (HAM-A)|[Dementia] Repeatable
Battery Assessment of Neuropsychological Status
(RBANS)
Procedureversions A-D|[Dementia]
time|Ablation Montrealtime|
time|Fluoroscopy Cognitive
Assessment (MoCA)
Fluoroscopy dose area versions 7.1-7.3|[MDD]
product|Left Beck dwell
atrial catheter All
Depression Inventory
time|Percent (BDI-II)|[TBI]
of pulmonary Brief Pain Inventory
veins isolated
(BPI)
Number of patients maintaining Secondary Patency at
12 months|Cumulative number of subjects with
All
occlusion|Cumulative percentage of subjects with
occlusion
Clinical evaluation All
Respiratory status All
Number of patient achieving Clinical Success|Re-

Interventions|Number of patients achieving Long term All
success|Number of patients developing Adverse events
Resolution of bile leak|Incidence of cholangitis in

patients who had ERCP for bile duct stones and are All
awaiting gall bladder removal.
anxiety All
Evoked bladder contractions of at least 20 centimeters

All
of water (cmH2O)
Rate of participants with a combination of
hospitalization and unplanned use of hospital
emergency department or emergency medical service|
Rate of participants hospitalized|Rate of participants
All
with unplanned use of hospital emergency department
or emergency medical service|Rate of participants
experiencing death of any cause|Rate of participants
Constant-Murley
experiencing deathScore (CMS)|Oxford Shoulder Score
of Covid-19 All
(OSS)|Short Form Health 36 (SF-36)
Wound reduction|Compliance|Number of painkillers
consumed|VAS pain|VAS swelling|Bleeding|Socket
wound healing score|Mucosal scarring index| All
Dimensional changes in the buccal soft tissue profile|
Dimensional changes of the alveolar process
Anxiety rating|Pain rating Female
BIS50|BIS95 All
Processing speed change from baseline assessment|

All
EVO performance
Safety as Assessedchange from
by Grade 3-4baseline
Adverseassessment
events|
Change in Knee Injury and Osteoarthritis Outcome
Score (KOOS)|Change in Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)|IL-
Safety - Complication Rates|Resting metabolic rate All
6 Concentration|Prostaglandin E2 Concentration|Matrix
(RMR)|Energy intake|Impact of weight
Metalloprotinase 1 Concentration|Vascularon quality of life:
Endothelial
IWQOL-Lite|Binge Eating Scale (BES)|YaleProtein
Growth Factor Concentration|C-Reactive Food
Addiction Scale|Power of Food
Concentration|Erythrocyte Scale|Eating
Sedimentation inventory|
Rate
Body shape perception|Food craving inventory|Food All
preferences|Delayed reward discounting|Appetitive
sensations|Quality of life measure: SF-36|Depression
Number of COVID-19
score|Changes Participants
in metabolic hormoneWith Notable
profiles|Body
Differences in the pCLE
mass index|Change images
in DXA bodyincomposition
comparison with the
pCLE images of non-COVID-19 Participants|Number of
Participants With the Correspondence of pCLE Images All
to High Resolution Computer Tomography and
Morphologic Data as a Measure of Specificity and
Sensitivity of the Method
Rate of overall vaginal delivery|Rate of vaginal delivery
within 24 hours|Rate of vaginal delivery within 36
hours|Time to reach active stage of labor defined as ??
Female
cm|Change in Bishop score|Rate of spontaneous vaginal
delivery|Rate of operative vaginal delivery|Rate of
caesarean
correct sections
position of DLT with proper lung deflation
All
without use of FOB
Retention in the study|Retention in psychosocial
treatment|Functional connectivity measured with fMRI|
Flanker task|Kirby Delay Discounting Questionnaire|
Number of days of stimulant use in the past week|Urine
drug screen positive for stimulant|Brief substance
craving scale|Brief Addiction Monitor|Quality of Life
All
Enjoyment and Satisfaction Questionnaire-Short Form|
Patient Health Questionnaire--8 item scale|Generalized
Anxiety Disorder 7-item scale|Assessment of Recovery
Capital|Positive and Negative Affect Scale|Pittsburgh
Sleep Quality Index|Difficulties in Emotion Regulation
Scale--Short Form|UPPS-P Impulsive Behavior Scale
Low Frequency/High Frequency (LF/HF) ratio at the
onset of the first night seizure|Low Frequency/High
Frequency (LF/HF) ratio at the onset of the first daytime
All
seizure|Low Frequency during daytime and night
seizure|High Frequency (HF) during daytime and night
seizure|Correlation between several parameters
Change in pain experience as assessed using visual
Female
analog scale
Wound Microbiome|Wound pH All
Anxiety Score|Pain Score|Sedation Requirements|Global

All
Impression of Change|Patient Experience Satisfaction
Standard Deviation All
incidence of wound dehiscence|post operative pain|

length of hospital stay|the need for re-admission|further
Female
need for additional antibiotics|peri-incision blistering|
patient mobility|surgical site infection
Prenatal safety of fetal embolization for patients with
vein of Galen malformations|Efficacy of fetal
Female
embolization for patients with vein of Galen
malformations
Muscle damage|Blood lactate concentration|Evaluation
of muscle structure using ultrasound using Siemens
equipment|Muscle strength in isokinetic|Muscle pain|
Pain threshold|Resistance through Bioimpedance
analysis (BIA)|Reactance through Bioimpedance analysis
(BIA)|Phase angle through Bioimpedance analysis (BIA)| Male
Tone muscular through Myotonometry used the
MyotonPRO equipment|Stiffness through
Myotonometry used the MyotonPRO equipment|
Elasticity through Myotonometry used the MyotonPRO
equipment|Perception of recovery
Time to recovery|Time to elimination of COVID-19
related symptoms|Mean number of days with mild
COVID-19 related symptoms|Mean number of days with
mild overall respiratory symptoms|Time to symptom All
reduction|Time to elimination of symptoms|Average
number of days with mild respiratory symptoms|Oxygen
saturation|Hospitalization rate|Mortality
Post-ERCP pancreatitis rate All
The data of multimodal image recognition system|

All
Molecular subsets in in diffuse gliomas|Overall survival
fMRI Classifier Fit|Effect of Individualized Stimulation

Frequency on Working Memory|Working Memory
All
Performance in MRI Sessions|Working Memory
Performance in Behavior Sessions
Mean Change in IPSS at 6 Months|Mean Change in
Quality of Life Scores at 6 Months|Mean Change in
Male
Curine Flow|Mean Change in Prostate Volume|Percent
of Prostate Infarcted|Incidence of Adverse Events
Falls detection rate All
Diagnostic accuracy of Melanoma Surveillance

Photography (MSP)|Cost-effectiveness of MSP|
Diagnostic accuracy for melanoma|Diagnostic accuracy All
for keratinocyte lesions|Health-Related Quality of life|
Patient anxiety
Rebound esthesiometer operating threshold|Rebound
All
esthesiometer operating parameters
Acute Success All

Change in Arterial Oxygenation Levels|Number of
participants requiring advanced therapy|Number of
All
participants avoiding proning ventilation|Number of
participants delaying proning ventilation
Histological change in nerve density|Histological change

in nerve morphology|Symptomatic Improvement All
Assessment
High pressure non invasive ventilation in acute

All
hypercapnic respiratory failure
Primary Safety: Lead-related Complication-Free Rate|

Primary Effectiveness: Pacing Capture Threshold
Responder Rate|Secondary Effectiveness: Sensed All
Amplitude in mV|Secondary Effectiveness: Pacing
Impedance in Ohms
Patient satisfaction with suture removal|Pain with suture

removal|Time to close the surgical wound|Time to All
remove suture|Wound complications|QuickDASH
Comparison of blinded, manual measurements of the
ECGs to the patch monitor tracings as measured by the
All
Bland-Altman Plot|Frequency of major arrhythmia
occurrence|Trajectories of QT prolongation
PROMIS Questionnaire|Oswestry Disability Index (ODI) All
Greater proportion of reduced ICIQ-SF score in

magnetic stimulation arm group after 8 weeks of
treatment|Greater proportion of increased perineometry
Female
value in magnetic stimulation arm group|Greater
proportion of better patient global improvement in
magnetic stimulation arm group
Constant-Murley Score (CM)|EuroQol-5D-3L (European
Quality of Life)|Simple Shoulder Test (SST)|Visual All
Clinical
Analogue measures- PSTD
Pain Scale symptoms|Sleep quality- REM
(VAS)
latency and sleep latency|Self-report questionnaires-
PCL (PTSD checklist )|self-report questionnaires- Beck
Depression Inventory (BDI-II)|Self-report questionnaires-
Male
State-trait Anxiety Inventory (STAI)|Self-report
questionnaires- Toronto Alexithymia Scale (TAS)|Self-
report questionnaires- Dissociative Experience Scale
(DES)|Self-report questionnaires- Locus of Control (LOC)
Effectiveness of bone removal to access lesion per
All
surgeon assessment: Multifactorial 5-point Likert scale
Change of AUC of driving pressure|Change in ventilator

free days|28-day mortality, 90-day mortality and one-
year mortality|Change in ARDS incidence|Reintubation All
rate due to respiratory failure|Reduction of mechanical
power
Confirmation of Blood pressure values measured

All
simultaneously with the novel mobile phone application
Change in Psychological Distress, Depression|Change in

Psychological Distress, Depression and Anxiety|
Recruitment Rate|Completion of Intervention| All
Completion of Follow-up|Anxiety|Existential Distress|
Death Anxiety|Participant Quality of Life: WHOQOL-Bref
PTAUC|Pressure sores - NPUAP (National Pressure Ulcer
Advisory Panel) grade|Patient's comfort|Discomfort or All
pain|Suggestions
prognostic importance
Rate of major of computed
adverse cardiac tomography
event|Rate of all-cause
pulmonary artery obstruction index (CT-PAOI)|
death or cardiac death|Rate of periprocedural MI,
prognostic importance of White All
Spontaneous MI, or target vesselblood
MI|Rate cellof clinically-
count(WBC)
driven TLR or.|prognostic
TVR|Rate ofimportance
thrombosisof
polymorphonuclear cell count|prognostic importance of
lymphocyte cell count|prognostic importance of a D-
dimer level|prognostic importance of Troponin level| All
prognostic importance of C-reactive protein|prognostic
Incidence
importanceofofrelated
arterialmajor
blood adverse eventsthe
gases while (MAEs)|
patients
Efficacy
are breathing room air.|prognostic importance ofserious
- Technical Success|Incidence of related
adverse events
hemoglobin (SAEs)|Efficacyimportance
level|prognostic - Type II endoleaks|
of platelet cell All
Efficacy - Type I and
count|prognostic type III endoleaks|Efficacy
importance of red cell - AAA
distribution
Bone
sac marrow adiposity by magnetic resonance
diameter/volume|Efficacy - Open repair|Efficacy imaging
-
width
(MRI)|Magnetic
Reinterventions resonance spectroscopy (MRS)|Total
body bone mineral density Z-score by Dual-energy X-
ray absorptiometry (DXA)|Spine BMD Z-score by DXA| All
Spine apparent density Z-score by DXA|Volumetric
bone mineral density (vBMD)|Bone strength by
quantitative computed
peristomy skin tomography
complication rate|(2) pQCT
life quality stomy
care questionnaire|(3) stomy appliance satisfaction All
questionnaire
Peak Acceleration|Time to Peak Acceleration|End

All
Acceleration|Fatigue Ratio
Retention
Improvement in treatment on MAT
in transverse neck for 6 months after
rhytides|Adverse
All
enrolling
Events|GAISin the study|Opioid and other substance
abuse as assessed through biological specimen|Opioid
and
AAA other
strainsubstance abuse as strain
measurement|AAA assessed through
measurement
participant
determinedself-report|Cravings
by NIVE|AAA strain to use drugs as
measurement All
assessed by the reSET-O
determined by multiphase CT app|Overall mental health
symptoms related to depression and anxiety as
assessed by the K-10|Mental health symptoms specific
to depression as assessed by the PHQ-9|Mental health All
symptoms related to PTSD as assessed by the PCL-C|
Health status as assessed by the EuroQol|Coping
strategies as assessed by the CSS|Social Connectedness
as assessed
Change by Amplitude|Change
in LPP the SCS|HIV Risk asinassessed by the
HRSD Scores All
SERBAS|Satisfaction of using reSET-O as a form of
treatment as measured
Baseline swelling by a qualitative
using Figure-8 interview|
Measurement|Mean
Effectiveness
swelling usingofFigure-8
the reSET app content as measured
Measurement|Mean by
pain scores
the IAFF analogue scale at initial encounter|Mean pain
on visual All
scores on visual analogue scale at 6 week follow up
visit
Reader confidence in s-DCT images (arbitrary units)|
Sensitivity of s-DCT images (percentage of positive All
scans)
Change in Numerical Pain Scores (NPS)|Percentage of
patients minimal pain (NPS < 3) during recovery|
Number of opioid analgesics administered in the
All
Spanish
operating Rey Auditory
room Verbal
(OR) and Learning Test|Escala
post-anesthesia care unit
Wechsler de Inteligencia
(PACU).|Incidence Para Adultos-IV
of postoperative nausea(WAIS-IV;
and vomiting
Wechsler,
(PONV) in 2008) Retenci처n de d챠gitos|Escala Wechsler
the PACU
Temperature,
de Inteligenciaaccuracy|Temperature,
Para Adultos-IV (WAIS-IV) differences|Historic
Claves All
comparator
subtest|Color Trails 1 and 2 (D'Elia, Satz, Lyons-
Uchiyama, & White, 1996)|FAS (Lezak, 1995; Pont처n et
al., 1996; O'Bryant et al., 2017; Benton, Hamsher, &
Sivan, 2000)|Animal Naming (Lezak, 1995; O'Bryant et All
al., 2017|Spanish SF-36 (Ware, 1992; Alonso, 1995;
Ware, 2000)|Spanish Satisfaction with Life Questionnaire
The diagnostic
(Diener, Emmons, yield tests &
Larsen, in Griffin,
detecting a bleeding
1985; Diener &site
and comparison
Gonzalez, of rates|The
2011; V찼squez, sensitivity
Duque, for lesion
& Herv찼s, 2013)| All
localization|The specificity for lesion localization|The
Spanish Beck Depression Inventory-Second Edition
accuracy for lesion
(Beck, Steer, & Brown,localization
1996)|Spanish Beck Anxiety
change
Inventoryin (Beck
Aortic&pulse
Steer,wave
1993)velocity (PWV)|change in
Augmentation index (AIx)|change in Central systolic
All
blood pressure (CSP)|change in Peripheral blood
pressure (PBP)|change in central pulse pressure (PP)
Anatomic and functional MRI characteristics in
transplant kidneys with stable renal function|Anatomic
All
and functional MRI characteristics of transplant kidneys
with transplant complications
MCCB??MATRICS??(Measurement and Treatment
Research to Improve Cognition in Schizophrenia)
All
Consensus Cognitive Battery|Positive and Negative
Symptoms Scale (PANSS)
Static Posturography Assesment (NeuroCom짰 Balance
Master짰 Systems)|Dynamic Gait Index|Clinical Test of
Sensory Integration on Balance|Functional Reach Test| All
Tandem Stance Balance Test|Unified Parkinson's Disease
Rating Scale
Changes in the levels of S specific antibodies in
Fine wrinkles|Coarse
severely wrinkles|Abnormal
ill patients compared pigmentation| in
to mild cases.|Changes
Global evaluation|Visual
the levels Analog Scale
of N specific antibodies (VAS) for
in severely ill pain|
patients All
Scale of Satisfaction
compared to mild cases.|S specific binding antibodies
of SARS-CoV-2|N specific binding antibodies of SARS-
CoV-2|Neutralizing antibodies directed against S
All
protein of SARS-CoV-2|The severity category of critically
ill|Length of ICU|Length of hospital stays|Alive status at
28-days|Alive status atmuscle
Change in inspiratory 90-day|Correlation between the
strength|Pneumonia|Major
levels of cardiovascular
adverse S neutralizing events
antibodies and disease
(MACE)|Vital signsseverity|
of
Correlation between the levels of N neutralizing All
participants during training|Satisfactory assessment|
antibodies
Length of stayand disease severity
severe (<40 mg/dl) events|% BG within target 70-180
and without hypoglycemia|Number of episodes of
hyperglycemia (BG > 280 mg/dl) after the first day of
treatment|Number of patients using oral antidiabetic
drugs (OADs) on admission|Number of patients using
oral antidiabetic drugs (OADs) during hospitalization|
Average oral antidiabetic drugs (OADs) dose used in
the hospital|Number of patients with dose increase|
Number of patients with dose decrease|Number of
patients on OADs requiring insulin rescue therapy|
Number of episodes of treatment failure for basal bolus
insulin versus OADs|Glycemic variability for basal bolus
insulin versus OADs in patients receiving CGM
monitoring|Time above range (>180 mg/dl) for basal
bolus insulin versus OADs in patients receiving CGM All
monitoring|Time in range (70-180 mg/dl) for basal
bolus insulin versus OADs in patients receiving CGM
monitoring|Time below range (BG <70 mg/dl) for basal
bolus insulin versus OADs in patients receiving CGM
monitoring|Composite of hospital complications for
basal bolus insulin versus OADs|In-hospital mortality for
basal bolus insulin versus OADs|Differences in total
hospital costs for basal bolus insulin versus OADs|
Length of hospital stay for basal bolus insulin versus
OADs|Costs for diabetes specific therapies oral agents
vs. injection administration|Number of hospital re-
admissions within 30 days of hospital discharge for
basal bolus insulin versus OADs|Number of emergency
room visits within 30 days of hospital discharge for
Changes
Psychomotorin waistline|Changes in weight|Changes
Vigilance Test (PVT)|Epworth in
Sleepiness
body
Scale mass index|Changes in body
(ESS)|Multi-dimensional fat Symptom
Fatigue percentage|
Changes in basal metabolic value|Changes in hip All
Inventory-Short Form (MFSI-SF)|Reactive hyperemia
circumference|Changes
index|24-hours Ambulatory in waist-to-hip
Blood Pressurecircumference
ratio|Changes in fasting blood-glucose|Changes in
fasting insulin|Changes in insulin resistance index
insulin resistance index insulin resistance index|Changes All
in total cholesterol|Changes in triglyceride|Changes in
Glycemic
low density Outcomes|percent
lipoprotein|Changestimeininhigh-density
clinical
hypoglycemia|percent
lipoprotein|Changes intime below recommended
uric acid|Changes in blood
threshold|percent time in target range|percent
pressure|Changes in Constitution in Chinese Medicine time
All
above range|percent time
Questionnaire|Changes above
in the 250 mg/dL|average
IWQOL - Lite scale score|
gycemia|Low Blood Glucose
Changes in the Kessler 10 score Index|High Blood Glucose
Index
Fugl-Meyer Assessment, FMA|Modified Ashworth scale
of muscle spasticity, MAS|Grip and pinch power|Medical
All
Research Council scale, MRC|Wolf Motor Function Test,
WMFT|Nine-hole pegboard test, NPT|User experience
Change in dry mouth symptom by Visual Analog Scale
at 14 days|Change in dry mouth symptoms by
xerostomia questionnaire at 14 days|Change in quality
All
of life by Oral Health Impact Profile at 14 days|Change
in oral functions by Revised Oral Assessment Guide at
14 days
The firstDiscomfort|Safety
Patient assessment of electromyographic
of PTNS: adverse activity|The
events All
second assessment of electromyographic activity|The
third assessment of electromyographic activity|The last
assessment of electromyographic activity|The first
assessment of maximum isometric voluntary
Spirometry All
contraction to measure second
torque|The the change from baseline
assessment in
of maximum
forced vital capacity (FVC) and forced expiratory
isometric voluntary contraction torque|The third volume
(FEV) over aof
assessment 12-month
maximum time period voluntary
isometric in 3-month
Static Posturography
increments.|Change
contraction torque|The Assesment
in Exhaled (NeuroCom짰
Nitric Oxide
last assessment fromBalance
of maximum
Master짰
baseline Systems)|Dynamic
isometricover a 12-month
voluntary Gaitperiod
time
contraction Index|Modified
torque in 3-month All
Parkinson Activity Scale
increments.|Change in Airway Reactivity using airway
oscillometry (Tremoflo) from baseline over a 12-month
time period in 3-month increments.|Change in level of
e-cigarette aerosol inhalation measured with a All
Topography device from baseline over a 12-month time
period in 3-month increments.|Change in Salivary
Convalescent
Cotinine from plasma
baseline(CCP)
over units infused time
a 12-month in coronavirus
period in
disease-2019 (COVID-19) patients|All-cause
3-month increments.|Changes in product use evaluated mortality|
Insomnia Severity Index (ISI)|Wrist All
Donor
over a antibody
12-monthlevels|Incidence
time period in 3 ofactigraphy|PROMIS
adverse
month events|CCP
increments
Physical
recipient Function
outcomes (short form)|PROMIS Mobility|NIH
with an evaluation of the changes in dependence over
Toolbox Motor Tests|PROMIS Applied Cognitive
a 12 month period evaluated in 3-month increments
Abilities|PROMIS Applied Cognitive Abilities - General
using the Hooked on Nicotine Checklist (HONC).
Concerns|NIH Tool Box Cognition Tests|Activities of All
Daily Living (ADLs)|Instrumental ADLs (IADL) scale|Sleep
Diary|Knee injury and osteoarthritis outcome score
(KOOS)|Hip disability and osteoarthritis outcome score
(HOOS)|StepWatch
Stroke Risk Awareness|Body Mass Index (kg/m^2)|Blood
All
Pressure (mmHg)|Stroke Risk Probability
sway index of sensory integration test|risk of fall index Female
Change in Menstrual Frequency (cycles/month)|Change

in Menstrual Period|Change in Estradiol (E2)|Change in
Luteinizing Hormone (LH)|Change in Serum Follicle
Stimulating Hormone (FSH)|Change in Free
Testosterone (T)|Change in LH/FSH Ratio|Change in
Antral Follicle Count (AFC) in the Ovary and Ovarian
Volume|Change in Body mass index (BMI)|Change in
Female
Waist Hip Ratio (WHR)|Change in acne severity
evaluated by Pillsbury acne grading system|Change in
quality of life evaluated by the 36-Item Short Form
Health Survey (SF-36)|Adverse events|Incidence of
abnormal complete blood count|Incidence of abnormal
Measure the effect of USCTR vs mOCTR on the
erythrocyte sedimentation rate|Incidence of abnormal
longitudinal change in QuickDASH.|Measure the effect
renal function|Incidence of abnormal liver function
of USCTR vs mOCTR on the longitudinal change in
BCTQ-S.|Measure the effect of USCTR vs mOCTR on the
longitudinal change in hand pinch and grip strength.|
Comparison
Measure the of Diastolic
impact Blood vs
of USCTR Pressure|Comparison
mOCTR on participant of
All
Systolic Blood
perception Pressure|Skin
of change Irritation
in overall physical condition|
Change in military work status as assessed using single-
item self-report assessment|Surgical time to perform
procedure (minutes)|Change in self-reported
All
satisfaction as assessed using a satisfaction rating scale|
Change in self-reported pain as assessed using the 11-
item Pain Numeric Rating Scale (NRS) participant pain
emergency
levels over 1department satisfaction:
month following the CTR likert scale|Quality
procedure.|
of emergency department stay: likert scale|Preference
Change in pain medication usage as assessed using All
for virtual white
single-item board assessment|Incision length in cm|
self-report
Change in self-reported pain as assessed using the 11-
item
OngoingPain pregnancy
Numeric Rating Scale (NRS)|Change
rate|Cleavage in self-
rate|Blastulation rate|
reported pain as assessed using the 4-item CTS Palmar All
Blastocyst quality rate|Pregnancy rate|Implantation rate
Pain Scale over 1 month following CTR procedure
Change in left ventricular function as assessed by LVEF|
Change in left ventricular volume|Mortality Rate|
Number of Major Adverse Cardiac Events (MACE)|
Percentage of participants at each FMR severity grade|
All
Change in MLHF Questionnaire Score|Change in
Functional Status as assessed by 6MWT|All Cause
Readmission Rate|Heart Failure Readmission Rate|
Incidence of Mitral Leaflet Tenting
coefficient of variability (%CV)|Mean amplitude of
glucose excursions (MAGE)|Rate of asymptomatic and
nocturnal CGM-detected hypoglycemia (<70 mg/dl)|
Rate of asymptomatic and nocturnal CGM-detected
hypoglycemia (< 54 mg/dl)|Rate of asymptomatic and
nocturnal CGM-detected hypoglycemia (equal to 40
mg/dl)|% time in hypoglycemia (< 70 mg/dl)|% time in
hypoglycemia (< 54 mg/dL)|% time in target range (70-
180 mg/dl)|% time in hyperglycemia (>180 mg/dL)|%
time in hyperglycemia (>250 mg/dl)|10-90% glucose
percentiles|Mean hourly interstitial glucose|%MARD for
glucose <70 mg/dL|%MARD for glucose <54 mg/dL|
%MARD for glucose 70-180 mg/dL|%MARD for glucose
>250 mg/dL|% MARD during non-dialysis hours|%
MARD during dialysis hours|Proportion of CGM values All
within 짹20% or 짹20 mg/dL (%20/20) of reference
glucose values <70 mg/dL|Proportion of CGM values
within %15/15 of reference glucose values <70 mg/dL|
Proportion of CGM values within %30/30 of reference
within %15/15 of reference glucose values <100 mg/dL|
glucose values >100 mg/dL|Proportion of CGM values
within %15/15 of reference glucose values >100 mg/dL|
Change in oxygenation of feet and lower legs All
Occurrence of Adverse Events|Contrast intensity on MR

All
imaging
Change in Rectal Temperature|Change in Mean Skin

Temperature|Change in Heart Rate|Change in Rating of
Perceived Exertion (RPE)|Change in Thermal Sensation Male
(TS)|Change in Perception of Fatigue|Change in
Perception of Thirst|Environmental Symptoms|POMS
Primary outcome is time in range (TIR)|-Frequency of
hypoglycemia (<70mg/dL, <54mg/dL) to measure Time
Bellow Range|-Time in hyperglycemia > 180, 250 mg/dL
to measure Time Above Range|-Adherence to CGM use All
and sensor
Change utilization
in gait for diabetes care
propulsion|Change management
in TMS motor
using
evoked potential (MEP) amplitude|Change inand
CGM|- Rate of emergency room visits
hospitalization|-Glucose
intracortical Variability in H-max/M-max
facilitation (ICF)|Change
ratio for the soleus|Change in energy cost (EC) of All
walking|Change in ankle peak plantarflexor moment
during
Office
The gait|Change
systolic
proportion blood inpressure
of time ankle
spentpower
theduring
(BP)|Office
in gait|Change
diastolic
target glucoseBP|
in over ground
Proportion with walking
BP below endurance
target (office
range from 5.6 to 10.0 mmol/L based on sensor BP <130/80
mmHg)|Number of BPthe
glucose levels during lowering medications|Treatment
time from hospital admission All
satisfaction|Concentration
for of plasma creatinine|Urine
elective surgery until discharge.|Proportion of time
protein/creatinine ratio
spent with sensor glucose values above target (> 10.0
mmol/L)|Proportion
Neurocognitive of time
function spent
Trails withTrails
A and sensor
B| glucose
<3.0 mmol/L|Average of sensor glucose level|Time
Neurocognitive function PASAT|Neurocognitive function All
spent with
Stroop sensor glucose
color-word below target (5.6 mmol/L)|
interference|Neurocognitive function
Proportion of time spent
DIGIT|Neurocognitive with sensor
function glucose levels in
WASI|Neurocognitive
significant hyperglycaemia (glucose
function WMS|Neurocognitive function PVT| levels > 20
mmol/L)|Standard
Neurocognitive deviation
function and coefficient of
HVLT-R|Sleepiness variation
ESS| All
of sensor glucose
Sleepiness levels|Total
PSQI|Quality of life daily insulin requirements|
SF-36v2|Quality of life
Daily time spent on diabetes management
FOSQ|Quality of life SGRQ|Hours of nightly positive
airway pressure (PAP) use|Patient preferance for type of
Proportion of participants
PAP (PAP arm)|Fatigue who achieve 50% reduction
severity|Sleep-dependent All
in CPD at 3 weeks.
memory|Blood CO2 or bicarbonate level
Change in Western Aphasia Battery Aphasia Quotient

All
(WAB-AQ)
Safety of the combination
acute postoperative of durvalumab
pain|opioid &
consumption|Post-
tremelimumab
anesthesia carewith
unit or without
length neoantigen DNA
of stay|Hospital vaccine
length of
when given to patients with renal cell carcinoma
stay|Time to initial ambulation|KOOS Jr. score|Veterans as
measured by the Survey
RAND 12 Health percentage
(VR-12)of patients
physical with adverse
component All
events of gradeof3surgical
score|Number or higher|Response rate in patients
complications|Clinic and
with
emergency department visits|Inpatient readmissionsand
renal cell carcinoma treated with durvalumab for
tremelimumab
uncontrolled pain with or without neoantigen DNA vaccine
by RECIST 1.1 as measured by percentage of patients
All
with radiographic complete response or partial
response|Rate of progression-free survival (PFS) in
patients with renal cell carcinoma treated with
durvalumab and tremelimumab with or without
Change from baseline in the
CPR|OPR|LBR|Biochemical Fugl-Meyer Assessment
indexes|Questionnaire
neoantigen DNA vaccine|Rate of overall survival score
(OS) in Female
lower extremity scale (FMA-LE) after intervention|
patients with renal cell carcinoma treated with
Change from baseline in the Berg Balance Scale (BBS)
durvalumab and tremelimumab with or without
after intervention|Change from baseline in the Timed
neoantigen DNA vaccine
Up and Go Test (TUG) after intervention|Change from
All
baseline in the Gait Evaluation after intervention|
Change from baseline in the Modified Ashworth Scale
(MAS) after intervention|Change from baseline motor
evoked potential (MEP) after intervention|Incidence of
treatment-emergent adverse events
Change in post-operative pain assessed: visual analog
(VAS) scale|Granulation tissue health|Oral hygiene
All
degree|Inflamation severity|Change in the quality of
postoperative life after the procedures performed
Major Adverse Cardiovascular Events|Length of Stay All
accuracy of semantically unrelated - trained word-lists|

Change in auditory recall accuracy based the sum of
words recalled in Trials 1-5 of semantically related -
untrained word-lists|Change in auditory delayed recall
accuracy of semantically related - untrained word-lists|
Change in auditory recall accuracy based on the sum of
words recalled in Trials 1-5 of semantically unrelated -
untrained word-lists|Change in auditory delayed recall
accuracy of semantically unrelated - untrained word-
lists|Change in Rey Auditory-Verbal Learning Test
(RAVLT) score|Change in Mini Mental State Examination
(MMSE)|Change in Mnemonic Similarity Task (MST)
score|Change in word repetition score|Change in non-
word repetition score|Change in sentence repetition
score|Change in oral naming Boston Naming Test All
score|Change in oral naming Philadelphia Naming Test
score|Change in written naming as assessed by Boston
Naming Test|Change in written naming as assessed by
Philadelphia Naming Test|Change in oral naming of
action as assessed by Hopkins Assessment of Naming
Actions (HANA)|Change in syntactic comprehension as
assessed by Subject-relative, Object-relative, Active,
Passive (S.O.A.P.) Syntactic Battery|Change in verbal
fluency task score|Change in spelling as assessed by the
Johns Hopkins Dysgraphia battery|Change in digit span
forward score|Change in digit span backward score|
Change in spatial span forward score|Change in spatial
span backward score|Change in semantic content of
connected speech|Change in attention and
Static Physician Global Assessment baseline|Static
Physician Global Assessment Week 1|Static Physician All
Global Assessment Week 2|PsoSat Questionnaire
Measure Initial Objective response|Relative change in

tumor burden compared to baseline|Lesion response All
compared to baseline|Progression free survival (PFS)
12-month freedom from recurrent atrial fibrillation|All
atrial arrhythmia recurrences|Change in Canadian
Cardiovascular Society Severity of Atrial Fibrillation
Scale (CCS-SAF)|Change in Atrial Fibrillation Effect on
Quality of Life Questionnaire (AFEQT)|Multiple
procedure success|Relative reduction in atrial fibrillation
burden|Freedom from cardioversion for recurrent atrial All
arrhythmias|Freedom from repeat atrial fibrillation
ablation|Left Atrial Diameter (Size) as predictor of atrial
fibrillation recurrence|Left Ventricular Ejection Fraction
as predictor of atrial fibrillation recurrence|New York
Heart Association Functional Class as predictor of atrial
fibrillation recurrence
VTE incidence rate All
Six-Minute Walk Test (6MWT)|Ten-Meter Walk Test

(10MWT)|Kinetic and kinematic gait analysis using 3D
camera system|Electromyography recording of lower
All
extremity muscles|Gait Outcomes Assessment List
(GOAL)|Timed Up and Go (TUG)|Modified Ashworth and
Tardieu Scales|PROMIS Pediatric-49 Profile v2.0
Efficacy endpoint is the time to treatment success|Best
corrected visual acuity (BCVA)|Central subfield thickness All
(CST)|Number of ranibizumab injections
Medication-free intraocular pressure control|Intraocular
pressure change from baseline|Number of intraocular
pressure lowering medications|Time to introduction of
All
intraocular pressure lowering medications|Number of
adverse effects|Score at the Glaucoma Quality of Life -
15
Time to the presence of fusion|Neck disability|Neck and
arm pain|Incidence of sensory deficits|Incidence of All
motor deficits|Rate of Adverse Events
Strickland modified Total Active Motion (TAM) All
Sensitivity
Number ofofReported
AcousticUnanticipated
Angiography; Adverse
Breast Imaging
Events|
(percent of positive scans)|Specificity of
Percentage of patients completing CBT-I program| Acoustic
Angiography;
Change in EpworthBreastSleepiness
Imaging (percent of negative
Scale|Change in
scans)|Sensitivity of Acoustic Angiography; Thyroid
Insomnia Severity Index Scale|Change in Patient Health All
Imaging (percent
Questionnaire of positive
- 9|Change scans)|Specificity
in Pittsburgh of
Sleep Quality
Acoustic Angiography;
Index|Change in HamiltonThyroid Imaging
Rating (percent
Scale for of
Depression
negative
17 scans)|Area Under the Curve of Acoustic
Angiography (arbitrary units)|Radiologist preference
All
(Arbitrary units)|Sensitivity of acoustic angiography
compared to conventional ultrasound: Breast (arbitrary
units)|Specificity of acoustic angiography compared to
conventional ultrasound:
Participants Achieving Breast
Either (arbitrary
a Major units)|
Clinical Response
Sensitivity of acoustic angiography compared to All
or Partial Clinical Response (PCR) Defined by WHO
conventional ultrasound: Thyroid (arbitrary units)|
Specificity of acoustic angiography compared to
Rate
Change of seroma
conventional
in dietarydevelopment|Difference
ultrasound:
quality Thyroid
and intake in pain
(arbitrary
(Patientunits)
reported
between patients with and without abdominal
outcome).|Change in body weight (Measured by drains|
study All
Pain Medicine Utilization|Time to drain removal
staff)|Change in physical activity and sleep (Measured
by actigraphy)|Change in waist circumference
(Measured by study staff)|Change in muscle mass
(Measured by the D3 creatine dilution method)|Change All
in physical performance (Measured by study staff)|
Change in physical activity (Patient reported outcome)|
Change in quality
Defenseofand life Veterans
(Patient reported
Pain Rating outcome)|
Scale
Number of
(DVPRS)|Number Participants
Change in healthcare of days With Treatment
utilization
missed(Patient
from work Emergent
reported
due to All
Adverse
outcome)
lower back Events
pain.(TEAEs)|Number of Participants With
Body Temperature Abnormalities and/or Adverse
Change in apnea-hypopnea
Events|Reactogenicity Assessedindexby (AHI)|Change
Number of Solicitedin
minimum
Local
Changes inoxygen
vascular saturation
function (SaO2)|Change
Reactions|Reactogenicity assessed
with treatment in
by Number
measured of All
Inflammatory
Solicited
as Systemic
flowchanges biomarker|Change
Reactions|Proportion
with in
ultrasound dopplerof Diurnal blood
in Participants
response to
pressure
Achievingof
infusions a Serotype-specific
acetylcholine|Changes Anticapsular
in vascular function
Polysaccharide
with training measured as flowchangesIgG)
Immunoglobulin G (PS with ultrasound
Concentration
doppler dividedofby ??0.35
changes 쨉g/mL for ASP3772|Proportion
in blood pressure All
of Participants
measured with Achieving
intraarterial a Serotype-specific
canula, in response to
Anticapsular
infusions of isoprenaline|Changes inofvascular
PS IgG Concentration ??0.35 쨉g/mL
functionfor
PCV13|Proportion
with training measured of Participants Achieving
as flowchanges withaultrasound
Serotype-
specific
doppler Opsonophagocytic
The Hospitaldivided by changes
Anxiety Activity
in blood
and Depression (OPA) Antibody
pressure
Scale (HADS)|The Titer
??1:8 for ASP3772|Proportion of Participants Achieving Male
measured
General with intraarterial
Functioning 12-itemcanula,
subscalein response
(GF12) oftoThe
a Serotype-specific
infusions of sodium OPA Antibody Titer
nitroprusside|Changes
McMaster Family Assessment Device (FAD)|Health- ??1:8in for PCV13|
vascular
Geometric
function with
Related Quality Mean ofTiter
training (GMT)
Lifemeasured for as
Serotype-specific
(HRQOL)|Uptake flowchanges
of cascade OPA
with
for ASP3772|Geometric
ultrasound doppler
testing|Initiation divided
of risk Mean Titer
by changes
reduction (GMT) for Serotype-
in blood Image
behavior|Body
specific
pressure OPA for PCV13 All
instrument|Self-Esteem Scale|Decision Regretinscale|
measured with intraarterial canula, response
to infusions
Genetic of tyramine|Changes
Counseling in arterial
Satisfaction Scale compliance
(GCSS)|Children's
measured
Revised with ultrasound
Impact doppler divided byAdaptation
of Events scale|Psychological changes
in blood
to Geneticpressure measured
Information scale with intraarterialEducation
(PAGIS)|Health canula,|
Blood pressure|Vascular
Impact Questionnaire (heiQ)compliance|Vascular function
systolic blood pressure 24-hour load at baseline|
Ambulatory diastolic blood pressure 24-hour load at
baseline|Ambulatory systolic blood pressure awake load
at baseline|Ambulatory diastolic blood pressure awake
load at baseline|Ambulatory systolic blood pressure
asleep load at baseline|Ambulatory diastolic blood
pressure asleep load at baseline|Ambulatory systolic
blood pressure nocturnal dipping at baseline|
Ambulatory diastolic blood pressure nocturnal dipping
at baseline|Casual systolic blood pressure at baseline|
Casual diastolic blood pressure at baseline|Change in
pulse wave velocity with dietary Na+ intervention|
Change in augmentation index with dietary Na+
intervention|Change in pulse wave velocity with dietary
Na+ intervention while on allopurinol|Change in All
augmentation index with dietary Na+ intervention while
on allopurinol|Change in heart rate variability with
dietary Na+ intervention|Change in baroreflex
sensitivity with dietary Na+ intervention|Change in
heart rate variability with dietary Na+ intervention while
on allopurinol|Change in baroreflex sensitivity with
dietary Na+ intervention while on allopurinol|Change in
angiotensin-(1-7) with dietary Na+ intervention|Change
in angiotensin II with dietary Na+ intervention|Change
in klotho with dietary Na+ intervention|Change in
angiotensin-(1-7) with dietary Na+ intervention while
Acceptability of intervention
on allopurinol|Change assessed IIbywith
in angiotensin semi-
dietary
structured interviews|Recruitment
Na+ intervention rate|Completeness
while on allopurinol|Change of
in klotho
intervention|Adverse event rate|Device
with dietary Na+ intervention while on measured
allopurinol|ACE2
sedentary behaviour|Self reported sedentary behaviour
assessed using the Sedentary Behaviour Questionnaire| All
Verbal fluency assessed using the Controlled and Oral
Word Association Test (COWAT)|Perceived quality of life
using the EuroQol five-dimension questionnaire (EQ-
Daily cigarette consumption|Total
5D)|Pre-morbid intelligence puff volume|Risk
All
perceptions|Harm exposure
Binomial proportion of men on active surveillance
without treatment|Occurence of grade reclassification|
Rate of indolent pathology|Mean score per arm of
patient reported urinary function questionnaire|
Proportion of patients with changes from baseline in
urinary function exceeding Minimal Important
Differences (MID).|Mean score per arm of patient
Male
reported sexual function questionnaire|Proportion of
patients with changes from baseline in sexual function
exceeding Minimal Important Differences (MID).|Time to
biochemical recurrence (BCR)|Time to distant
metastases|Mean score per arm of health-related
quality of life (HRQOL)|Rate of adverse pathology at
prostatectomy|Rate of biochemical recurrence
Change in FLT uptake|Change in FDG uptake|Change in

apparent diffusion coefficient (ADC) on diffusion- All
weighted MRI (DW-MRI)
Determine number of treatment-associated of grade 1-
4 adverse
Change in eventsevaluated
as assessed by CTCAE v5.0|Examine
Adverse
the or pain
Severe
feasibility of adverse
using
through
events
fasting and
a Visual
associated
refeeding
Analog
with
in the All
Scale (VAS)
Intracavernosal administration of umbilical cord derived
treatment of stage 1 and 2 hypertension based on
Wharton's Jelly injection.|Immediate and
change in systolic blood pressure (SBP)|Examine the short-term
efficacy
feasibilityofofDualStim Therapy
using fasting andwith Wharton's
refeeding Jelly based
in the
on changesofinstage
treatment the International Index of Erectile
1 and 2 hypertension based on All
Function Questionnaire score compared
treatment acceptability|Examine the feasibility to baseline|
of using
Immediate
fasting and and short-term
refeeding in theefficacy
treatment of DualStim
of stage Therapy
1 and 2
with Wharton's Jelly compared to DualStim
hypertension based on food acceptability|Examine the Therapy
with salineofbased
feasibility usingon changes
fasting and in the International
refeeding in the Index
Male
of Erectile of
treatment Function
stage 1Questionnaire
and 2 hypertensionscore.|Sexual
based activity
on
improvement
dietary adhernece according to Sexual Encounter Profile
Questionnaire from baseline leading to optimal
penetration at follow-ups|Sexual activity improvement
Treatment
according to failure
Global Assessment Questionnaire from All
baseline leading to optimal penetration at follow-ups|
Sexual activity improvement according to Erection
Serum
Hardness concentration
Score from of inflammatory
baseline leading mediator
to optimal
interleukin-6
penetration at(IL-6).|Serum
follow-ups concentration of
All
inflammatory mediator High-sensitivity C-reactive
protein (hs-CRP).
Serum concentration of uremic toxin p-cresol sulphate|

All
Serum concentration of uremic toxins indoxyl sulfate
Change in total hip trabecular volumetric bone mineral
All
density (vBMD)
Incidence of motor block in each group|Number of

subjects with Instrumental delivery|Number of subjects Female
Staphylococcus
with Breakthrough aureus acquisition
pain|APGAR as determined by
score
surveillance cultures in short stay residents|
Carbapenem-resistant gram-negative bacteria
acquisition as determined by surveillance cultures in
All
short stay residents|Percentage
Participant recruitment|Proportionof high risk patients
of Richmond
correctly identified and
Agitation-Sedation Scaleplaced
(RASS)on contact
scores precautions|
in deep
Percentage of healthcare workers using personal
sedation range|Reliability of Richmond Agitation-
protectiveScale
Sedation equipment
(RASS) during high riskduring
measurements care routine
All
care in the ED|AdverseDepression
Montgomery-횇sberg Events|Duration
RatingofScale
mechanical
(MADRS)
ventilation|Duration
Pre-Post of stay
Change|Clinical in ICU|Duration
Global of stay in
Impression/Severity
hospital|Incidence
(CGI) of acute brain dysfunction
Pre-Post Change|Generalized (delirium
Anxiety Disorder, 7-
+ coma)|Mortality
item (GAD-7) Pre-Post Change|Montreal Cognitive
All
Assessment (MoCA) Pre-Post Change|Patient Health
2-hour blood glucose
Questionnaire, incremental
9-item (PHQ-9) Area Under
Pre-Post the
Change|
Curve (AUC)|2-hour blood insulin incremental AUC|
Temperament and Character Inventory (TCI) Pre-Post
Post-prandial
Change insulin sensitivity|Glycated haemoglobin
(HbA1c)|Glycaemic Variability (GV) over the 24-hr Male
period|Glycaemic Control (GC) over the 24-hr period|GV
during sleeping hours|Fasting Blood Glucose|Blood
Pressure
Rate of serious adverse events|Objective response rate|
All
Characterization of immune cells|PD-L1
Change in scoliotic curve as assessed by the Major

Curve Cobb Angle|Change in Patient Reported All
Outcomes
Safety and tolerability as measured by rate of treatment
emergent grade 3 or higher toxicities|Objective
response rate
Digitalized (ORR)
pain as measured
pressure by RECIST 1.1|
algometer|Western Ontario
Progression-free survival (PFS)|Change from baseline
and Mc Master Universities Osteoarthritis Index|36-Item to All
week
Short 3Form
in the number
Health of tumor infiltrating lymphocytes
Survey
after epicutaneous cryoimmunotherapy|Change from
baseline to week 9 in the number of tumor infiltrating
lymphocytes after epicutaenous cryoimmunotherapy
plus pemrolizumab|Change from baseline to 18 weeks All
in the number of tumor cells|Change in quality of life
as measured by the Dermatologic Quality of Life Index|
Portal
Changepressure measurement|Intraoperative
in quality of life as measured by theblood loss|
Functional
Packed red blood
Assessment cell transfusion
of Cancer rates|Change in
Therapy (FACT)|Objective
hemoglobin
response rateconcentration|Rate of acute kidney
as measured by measurement of 2injury All
(AKI) grade 2 or 3|Rate of new renal therapy
sentinel skin lesions|Objective response rate as
replacement
measured by photography-based estimates of body
surface area
Mortality|Mortality-suicide|Incidence of hospitalization
for respiratory failure of COVID-19's Patients-|Incidence
of al home professional psychiatric-psychological
interventions for mental disorder.|Incidence of mental All
disorder: Beck Depression Inventory-Second Edition
(BDI-II).|Incidence
Proportions od spleep
of subjects who disorder:Pittsburgh
achieved complete Sleep
wound
Quality Index to
closure.|Time (PSQI).
initial complete wound closure
between the 2 groups.|Changes in wound size
compared to baseline between the 2 groups.|
Proportions of subjects who achieved complete wound
All
closure between the 2 groups by the classification of
wound size.|Proportions of subjects who achieved
complete wound closure between the 2 groups by the
Agreement
classificationwith pregnancy
of location status|Agreement
of diabetic with
foot ulcer.|Durability
technician
of complete results|Comprehension
wound closure for theofadditional
instructions
24 for
weeks. Female
use|Ease of product use|Ability to read result
delay/variability of operative time|Costs|Level of stress|

Number of intraoperative mistakes|Number and severity All
of intraoperative complications
Percentage of participants in whom we successfully
apply CURATE.AI profile.|Patient adherence|Timely
delivery of CURATE.AI recommendations to the All
clinician|Physician adherence|Clinically significant dose
changes
Change in sphincter defect 3-point radial angle|Change
in sphincter defect Stark Score|Change in bacterial Female
fluorescence patterns|Change in wound dimensions
efficacy of block|failure rate All

Change in baseline aerobic exercise capacity|Change in
baseline ventilation during exercise|Change from
baseline in glucoregulatory status|Change from baseline
in serum lipids|Change from baseline in visceral
All
adiposity|Change in baseline forced vital capacity|
Change in baseline maximal voluntary ventilation|
Change in baseline forced expiratory capacity in the
Chest circumference measurement|Forced expiratory
first second
volume|Forced vital capacity|Forced expiratory volume /
Homeostasis model assessment of insulin resistance
Forced vital capacity|Peak Expiratory Flow|Maximal
(HOMA-IR)|HbA1C [mmol/mol]|Insuline [mU/ml]|Systolic All
Expiratory Pressure|Maximal Inspiratory Pressure|
and diastolic blood pressure [mmHg]|Pulse wave
Respiratory Muscle Endurance|Oxygen Saturation|Heart
velocity (PWV) [m/s]|Glucose, Total cholesterol (TC),
Rate|Respiratory Frequency
high-density lipoprotein cholesterol (HDL-C), low-
density lipoprotein cholesterol (LDL-C) and triglycerides
(TG) [mmol/l]|Irisin, Visfatin, Retinol-binding protein 4
Female
(RBP-4) [pg/ml]|Apelin [ng/ml]|C Reactive Protein
(hsCRP) [mg/l]|Interleukin-6 (IL-6), Interleukin-10 (IL-10)
[pg/ml]|Endothelial nitric oxide synthase (eNOS)
[ng/ml]|Muscle strength [kg]|Plantar stiffness [N/m]|
State of tension of erector spinae muscles [Hz]|Low
back pain intensity: questionnaire|Disability caused by
pain in the spine
caloric intake).|Daily fat intake (in g and as a percentage
of total caloric intake).|Nutritional status assessment|
Risk of undernutrition.|Basic biology.|Maximum
voluntary isometric strength of the quadriceps muscles
at 45째 (Nm).|Maximum voluntary isokinetic strength of
the quadriceps
Change in DXA muscles
score at at 2460째/s (Nm).|Maximum
months|Change in DXA
voluntary
score at 60 isokinetic
months|Hip strength
fractureof the quadriceps muscles
incidence|Radiologic Female
at 240째/s
bone (Nm).|Maximum voluntary isokinetic strength
formation
of the quadriceps muscles at 30째/s (eccentric
contraction) (Nm).|Maximum voluntary isokinetic
Volitional Ankle Control-Tapping Task Performance|
strength of the hamstring muscles at 60째/s (Nm).|
Ankle Spasticity-Ankle Clonus|Corticospinal tract
Maximum voluntary isokinetic strength of the
excitability-Motor Evoked Potentials|Low frequency
hamstring muscles at 240째/s (Nm).|Maximum voluntary All
depression|Spinal Cord Assessment Tool for Spastic
isokinetic strength of the hamstring muscles at 30째/s
Reflexes|Ankle Isometric Strength Test|Walking speed
(eccentric contraction) (Nm).|Endurance coefficient of
and walking pattern|Heart rate and %SpO2
the quadriceps muscles at 180째/s.|Endurance
coefficient of the hamstring muscles at 180째/s.|
Functional ratio|Mixed ratio|Maximum voluntary hand
grip strength (Kg).|Maximum voluntary pinch strength All
(Kg).|Hip passive joint range|Knee passive joint range.|
Ankle passive joint range|Lower and upper limb muscle
power assessment (MRC)|Statokinesigram surface area
(mm짼)|Stabilogram
Rate of retinal toxicity length (mm).|Maximal
of intravitreous deflection of
administration
(forward, backward left and right).|Velocity
melphalan versus topotecan assessed by CTCAE variations
v5.0|
(mm/s).|: Romberg ratio according
Relapse rate after IAC by melphalan only and IAC byto sway area|
Romberg
melphalanratio according to center
+ topotecan|Efficacy of pressure path
of intravitreous
length|:
topotecan compared to intravitreousarea.|Plantar
Plantar pressure ratio sway melphalan
pressure ratio length.|Walking
(number of injections to tumor clearance velocity (cm/s).|Cadence
in vitreous)|
(steps/min).|Step
Ocular survival (eye salvage rate)|Number of (cm)|Stride
length (left and right foot)
length (cm).|Single
participants support
with ocular (nontime left and
retinal) and right
systemicfoot (s).|
Double support time
toxicity assessed (s).|Swing
by CTCAE time (s).|Swing
v5.0|Quality of vision phase (as
a % of walking
assessed by visual cycle).|Stance
acuity|Incidence phaseof (asearly
a % (within
of walking
1 All
cycle).|Vo2max (maximal oxygen consumption)
month), intermediate (2-12 months) and late (> 12
(mL/Kg/min).|Maximum
months) ocular and systemic heart general
rate (bpm).|Maximum
adverse events
power (Watts).|Threshold power
during regular ophthalmological and clinical (Watts).|Threshold heart
rate (bpm).|Forced vital Capacity (L).|Forced
examinationassessed by CTCAE v5.0|Quantification of Expiratory
volume (L)|Tiffeneau
the cumulative radiationratioexposure
(%).|Ventilatory
during reserve
the IAC (%).|
Physical
procedures activity|Functional
by routinely used capacity
devices timed-up
(sub-study andlimited
go|
Functional capacity TDM6|Functional
to Lausanne) by B three thermoluminescent dosimeters| capacity Five
Times Sit to
Incidence of Stand test.|Functional
the occurrence capacitymalignancies
of secondary SPPB|
Functional capacity and
and/or metastases the long
mini-BESTest.|Functional
term sequelae
capacity
Number of subjects with adverse eventscapacity
Berg Balance Scale.|Functional and serious10-
meter
adversewalk test|Dyspnea|Perceived
events|Number of subjects exertion before,
with abnormal
during
physical and
Demographics|Labafter effort|Pain|Sarcopenia
examination findings|Number
data|Medication ofrisk|Social
subjects with
dosage|Cachexia
insecurity|Kinesiophobia|Quality
abnormal body temperature|Number
assessment|Inbody S10|Multidimensionalof life|: Balance
of subjects
Fatigue with
Scale
confidence
abnormal in performing
pulse rate|Number
(MFS):|Symptom various activities|Functioning
Distress Scaleof(SDS)|Exercise
subjects with abnormal All
in regards to
respiratory
Involvement activities
rate|Number
Scale ofofdaily
(EIS)|Visual living.|Exhaustion|
subjects
analogue withscale
abnormal
for dietary
Patient's
blood opinion
pressure|Number about
intake (VAS-DI)|PedsQL|ActiGraph their
of knee
subjects and
with associated
abnormal 12
problems|Patient's opinion about their
lead electrocardiogram (ECG) values|Number of subjects hip and
associated
with abnormal problems|Predicting discharge destination
hematology parameters|Number of
after totalwith
subjects joint arthroplasty.|Physical
abnormal function in
clinical parameters|Number of All
myositis patients|Quality of life in Parkinson's
subjects with abnormal urine analysis|Percentage of Disease|
Actimetry.
subjects achieving 50% reduction in OCS dose in
Weeks 20 to 24|Frequency of clinical significant
exacerbations|Mean change from Baseline in clinic pre
and post-bronchodilator forced expiratory volume in
one second (FEV1) at Week 24|Mean change from
Baseline in Asthma control questionnaire-5 (ACQ-5)
Examination (HINE) (under the age of 2 years)|Change
of Hammersmith Functional Motor Scale (HFMS) (2
years and older, non-ambulant)|Change of Impact on
Demographics|Knowledge
Participation and Autonomy of (IPA)
My 5(18 Moments
years and for older)|
Hand
Hygiene|Knowledge of My 5
Change of maximal voluntary isometric contraction (5 Moments for Hand
Hygiene
years and(Post-test)|Frequency
older) (Newton)|McGill of performing
pain questionnaire My 5 (12
Moments
years and for older)Hand Hygiene|Frequency
- Change of location, level of performing
and All
My 5 Moments for Hand Hygiene
characteristics of pain|Change of muscle atrophy (cm) (Post-test)|Attitude
on
andhand
The hygiene|Attitude
fattening
Reliable Change Indexon
(echo-intensity) in handbyMini
in hygiene
muscle Mental (Post-test)|
ultrasound|
Status
Change in
ATP testing|ATP Welch Emotional Connection Score|Change
Change
(MMS; of muscle
Folstein ettesting
fattening,
al., (Post-test)
1975)|The atrophy,
Reliable inflammation
Change Index and
in Maternal
fibrosis Caregiving
by qualitative Behavior Score (Acceptance
in Montreal Cognitive and quantitative
Assessment (MoCA; full body
Nasreddine muscle All
versus
MRI|Change Rejection)|Change
of muscle in Maternal Caregiving
et al., 2005)|The Reliablepower Change by muscle
Index inpower the Semantic
Behavior
measurements Score (Medical
(Sensitivity versus Insensitivity)|Change
(Morris et al., 1989) and Research
the Phonemic Council (MRC) scale)
(Thurstone,
in Maternal
(2 years Caregiving
and older)|Pulmonary Behavior Score
function (Consideration
1948) fluency|The Reliable Change Index(5inyears and
the Five-
versus
older) TestIntrusiveness)|Change
- change of forced vital in Maternal
capacity1982)|The Caregiving
(percentage
Point (Regard, Strauss, & Knapp, All
Behavior Score (Quality of Physical
predicted)|Pulmonary Contact)|Change - in
Reliable Change Indexfunction in the Trail (5 years
Making andTest older) (TMT;
Maternal ofCaregiving
change 1958)|The forced expiratory Behaviorvolume Score (Quality
in the of second
Vocal
Reitan, Reliable Change Index in first
the Stroop
Contact)|Change
Survival Rate in Maternal
of thepredicted)|Pulmonary
Implant|Development Caregiving Behavior
of Knee Score
Time to recovery|Change
(liter)(Stroop,
Test (percentage 1935)|The from baseline
Reliable Change in alanine
function
Index in (5joint
(Effectiveness
function|Development
aminotransferase
years andWisconsin
older) of Response of Oxford
-(ALT)|Change
change to peak
of Baby's
Knee
from Crying)|Right
Score| flow
baseline
expiratory and
in Nelson,
(liter
Modified
Cardiopulmonary Card
Exercise Sorting
Test|EvaluationTest (mWCST;of Respiratory All
Left Frontal
aspartate Mother & Infant
Intraoperative/surgery
aminotransferase
per second)|Pulmonary function EEG(5Synchrony|Heart
Data|Radiographic
(AST)|Change evaluation|
from Rate
baseline
1976)|The
Muscle Reliable Change
Endurance|Balance Index
Assesment inyears
California
will
and
be
older)
Verbal
evaluated
-
Variability
Rate
in of
change ofTest (HRV)
Serious
C-reactive Adverse
protein
vital(CVLT;
capacity Events
(CRP)|Change
(percentage from baseline
predicted)| in
Learning
with Mini-Balance Delis,
Evaluation Kramer,
Systems Ober, Test&(Mini-Kaplan,
creatinine|Change
PulmonaryReliable
1987)|The functionfrom (5 years
Change baseline and in
Index in d-dimer
older)Digit - Span
change andof the
BESTest)|Evaluation of Cardiovascular Disease Risk-1|
concentration|Change
peak cough
Corsi Blockof flow(H채rtig
Test from baseline
(liter peretsecond)|Pulmonary
al., 2000)|The in hemoglobin|
Reliablefunction
Evaluation Cardiovascular Disease Risk-2|Evaluation All
Change
Change from
(5 years Index
and older) baseline
in the in
- 15-item
change ofinternational maximal
version normalized
of the Bostonratio
expiratory
of Cardiovascular Functions|Arterial Stifness-1|Arterial
(INR)|Change
pressure Test
Naming from baseline
(cmH2O)|Pulmonary
(Kaplan et al., infunction
platelets|Change
1978)|Apathy (5 years
Evaluation from
and
Stifness-2|Cardiovascular Diseases Risk Factors
baseline
older) (AES;
Scale in total bilirubin|Change
- change of Biedrzycki, maximal inspiratory from baseline
pressure1991; in white
Knowledge Marin, Level|Evaluation
Continuously-Measured Home of&Autonomic
Firinciogullari,
PM2.5 (Fine Functions|
Particulate
blood cell
(cmH2O)|Pulmonary
German count Lueken
version: (WBC) with
function et al., differential|Change
(52006)|The
years andReliable older)in-
Hand
Matter) Grip
LevelsForce|Evaluation
Prior to of Activities
Intervention|Continuously- of Daily Living All
National
change
Change of Early
sniffin
Index Warning
nasal Score (NEWS)
Beckinspiratory
Depression pressure
Inventoryfrom(cmH2O)|
baseline|
(Beck et al.
Measured
Cumulative
Pulmonary
Arch Home
incidence PM2.5
function -1961)|The
Gen Psychiatry of (Fine
Grade
change ofReliable Particulate
3 and
diaphragm 4 Matter)
clinical
Change Levelsin
and/or
thickness
Index
Following
AngstIntervention|Continuously-Measured
laboratory
(mm)|Pulmonary
Beck adverse
Inventory events
function (BAI;-(AEs)|Cumulative
change&of
Ehlers diaphragm
Margraf, Home of
incidence
2007)|The
NO2
serious (Nitrogen
Reliableadverse
thickening Dioxide)
events
(ratio)|Pulmonary
Change Index in Levels
(SAEs)|Duration Prior to
function disease
Parkinson's - of Intervention|
changefatigue of
Continuously-Measured
hospitalization|Duration
diaphragm
scale excursion
(PFS; Brown, Home
of
(cm)|Change
Dittner, invasive
Findley, ofNO2 (Nitrogen
mechanical
Quality of2005)|
& Wessely, Dioxide)
life All
Level
(adult,
The Following
ventilation|Duration
18 years
Reliable ChangeIntervention|Spirometry-
of
and older) new
Index by non-invasive
in the SF36/RAND36|Change Forced
ventilation
PDQ-39|The Reliable Vitalor of
Capacity
high flow
Quality of
Change (FVC)|Spirometry-
oxygen
life (adult,
Index use|Duration Forced
18 years and older) by of Expiratory
new
in Barratt-Impulsiveness-Scale|NEO-FFI-30 oxygen Volume
use| in
One
DurationSecond
Individualized
(K철rner of al.,
et (FEV1)|Spirometry-
new ventilatorlocus
Neuromuscular
2008)|The Forced
or extracorporeal
Quality
of Control ofExpiratory
Life
Scalemembrane
(INQoL).|
(TheFlow IE-
(FEF)|Spirometry-Forced
oxygenation
Change
4 scale) (ofJulian (ECMO)
Quality of Life et
B. Rotter Vital
use|Duration Capacity
(pediatric, of
al., 1966)|The non(FVC)|Fractional
2-17 years invasive
Reliable old) by All
Exhaled Nitric
ventilation/high
PedsQL generic
Change Oxide
Index inquality flow (FeNO)|Asthma
oxygen
AST - Apraxia use|Duration
of life|Change Screen ofControl of
of Quality oxygen
TULIA|The of Life
use|Incidence
(pediatric,
Reliable 2-17ofyears
Change discontinuation
Index old) by PedsQL
in Rey-Osterrieth or temporary
neuromuscular
complex figure,
suspension
module
Copy (Duley ofetinvestigational
(NMM)|Change of range
al.,function|Autonomic therapeutics|Incidence
1993)|Electroencephalogram of motion of ankles
(EEG)| of
Cardiorespiratory function|
new
and non-invasive
elbows|Change
Near-infrared ventilation
of spine deformity
spectroscopy|The or Reliable
high flow oxygen(2
(degree)
Change use|
years
Index
Endothelial function|Hemodynamic function|
Incidence
and
in the sum of
older)|Change
of newthe oxygen
of Brooke
Unified use|Incidence
and
Parkinson's Vignos of
Disease new
scale (2
Rating years
Inflammatory profile|Inspiratory muscle strength|Muscle
Signs
ventilator
and
Scale of Anxiety
older)|Change
(UPDRS) Partand
or extracorporeal I +Depression|Levels
of Wong-Baker
UPDRS membrane
Part Faces
II +UPDRSofPainsubjective
oxygenation Scale
Part III (2 All
architecture (peripheral muscles)|Muscle architecture
sensation
(ECMO)
years
+UPDRS andPartrelated
use|Mean
older) to Hyperventilation
change in the
IV|Non Motor oxygenation|Functional ordinal Syndrome|Self-
Symptom Assessment Scale scale|
(respiratory muscles)|Tissue
evaluation
Participant's
for Parkinson's ofclinical
breathing|Respiratory
status atSEIQoL-DW
disease|The Day 15Motion|Breath-
by ((Schedule
ordinal scale| for
capacity|Mortality
holding
Percentage time|Medical
of subjects History|Age|Gender|Weight|Height|
the Evaluation of Individual Quality of Life - Direct on
reporting each severity rating
Body
an mass ordinal
8 point
Weighting) index (BMI)|Level
scale|Subject of physical
14-day mortality|activity|Forced
vital capacity (FVC)|Forced
Subject 28-day mortality|Time to an improvement expiratory volume in theoffirst
second
one
Respiratory (FEV1)|Maximum
category using an ordinal
SOFA.|Need ofvoluntary
a high ventilation
scale|Time
dose ofto an(MVV)|
oxygen or All
Peak inspiratory
improvement
mechanical of flow
ventilation.|Changerate|Peak expiratory
two categories using
in oxygen flow
an ordinal rate|
saturation.| scale|
Inspiratory
Oxygen muscle or
Time to desaturation.|Change
discharge function|Expiratory
to a National in Quick Early muscle
SOFAWarning function|
score.| Score
Exercise
Myocardial infarction.|Stroke.|Acute kidney injury.| of
(NEWS) capacity|Level
of </= 2 and of heart
maintained ratefor variability|Level
24 hours,
arterial
whichever
Pulmonary bloodoccurs pressure|Minute
first|Time to recovery
thromboembolism.|Combined volume|Oxygen forendpoint Uptake|
participants All
Carbon
(stroke, dioxide|Respiratory
not on mechanical
myocardial ventilation infarction, exchange
(baseline
acute ratio|Respiratory
kidney ordinal
injury score
and of
rate|Attentional
4, 5, or 6) focus|Level
pulmonary thromboembolism.|Admission to ICU.| of fatigue|Level of dyspnoea
Invasive Mechanical Ventilation.|Hospital Length of
Stay.|ICU length of stay.|Death
BOLD Responses in the vmPFC-VS circuit|TBS Effects of
BOLD Response|Opioid Modulation Effects on BOLD All
Responses in the vmPFC-VS circuit
Incidence of AEs|Mortality|Death|Number of ventilator-

free days|Improvement of one category|7-point ordinal
scale|NEWS|NEWS of ??2|Sequential Organ Failure All
Assessment (SOFA)|Oxygen|Hospitalization|Incidence of
SAEs
Recruitment feasibility during pregnancy|Protocol

retention|Adherence to intervention|Acceptability of
Intervention|Physical activity levels|Maternal weight
status|Maternal body composition|Maternal blood
Female
pressure|Maternal insulin resistance|Maternal
endothelial dysfunction|Maternal postpartum
depression|Maternal mood|Mental Health|Infant body
composition|Infant birthweight
Assessment of safety by determining the number of

participants with any Adverse Events (AE) and Serious
Adverse Events (SAE)|Preliminary Efficacy: Recovery from
COVID-19 as determined by negative PCR or
asymptomatic by the NIH classification for the severity
of illness|Mortality|Preliminary Efficacy: To assess
prevention of respiratory deterioration associated with
COVID-19 by measuring the PaO2/FiO2 ratio|
Hospitalization|Life support|Clinical status by the new
All
NIH Patient Classification for the severity of illness|
Clinical status by NEWS2|Support measurements:
Change
percentage in pain sensitivity,
of subjects assessed
reporting eachthrough
severity pressure
rating on
pain
a thresholds.|Change
7-pointofordinal in
scale|Support pain intensity,
measurements: assessed
Number Participants Requiring Mechanical
through
improvement a 11 point numeric rating
on ascale (0 =ordinal
no pain,
Ventilation or of severity rating
Dying|Days 7-point
to Recovery|Duration of
10 = worst Clearance|Exploratory:
scale|Virus pain imaginable).|Muscular Serum strength
Hospitalization|Incidence of Death|Proportion of
assesses through a 1 repetition
cytokines/chemokines maximum (1RM)|Active
Participants Transferredand immunomodulating
to ICU|Change in Eastern factors|
shoulder range
Exploratory: complete of motion assessed with a universal
Cooperative Oncology blood Groupcounts|Exploratory:
(ECOG) Performance Histone
goniometer.|Body
and cell-free DNA composition
levels assessed through
Status Score|Incidence of Grade III-V Adverse Events|
bioelectrical impedance measurements.|Arm
Incidence of Secondary Bacterial or Viral Infections|
circumference
Walking in speed measured bilaterally at a single point
Change
Oxygenation Th1 Twith
Cell10
requirements
meter
during
walk test|Walking
Frequency|Change hospital in stay
Th17(oxygen
T Cell
30cm
Impact above
of
spatiotemporal thecharacteristics
patient styloid
activationprocess.|Physical
andwitheducation
GAITRite activity
alone
walkway|level
or
Frequency|Change
saturation in Interleukin-2
rates)|Oxygenation (IL-2)|Change
requirements during in
assessed
with
Motor through
physician
impairment the
activation international
on change
with(IL-2R)|Change
Fugl Meyer Lower physical
in skin activity
cancer
Extremity Female
Interleukin-2
hospital receptor
stay (supplemental in Interleukin-6
Oxygen)|Oxygenation
questionnaire
screening
Scale|Walking inand (IPAQ).|Health
health
endurance promotion related
6-minute walkof
quality
practices|Time
with (IL-7)|Change life
interval
test|Ankle
(IL-6)|Change
requirements Interleukin-7
during hospital stay (ventilator insupport)|
assessed
between through
a participant's
range of motion|Ankle the European
firstinnotice
motor Organisation
of a suspect
control|Balance for
with moleminior
Interleukin-8
Clinical (IL-8)|Change
improvement|Clinical Interleukin-10
status|Serial chest(IL-10)|
CT or X- All
Research
lesion
Balance and andthe Treatment
Evaluationsdate on of
which
Systems Cancer
a (EORCT)-C30
definitive
Testof diagnosis
(miniBESTest)|Aerobic quality
was
Change
ray in
of Interferon gamma-induced
ADAS-Cog|Frequency
findings|Time to clinical recovery|Time Protein
Falls|Change
to 10 of (IP- All
of life questionaire|Quality
made|Impact
capacity|Quality of an
of e-learning
Life with of life assessed
teledermoscopy
EuroQol-5D through
(EQ-5D)| program the
10)|Change
each items from
improvement in Macrophage
in Inflammatory
ADAS-Cog|Percentage
oxygenation Protein
at leastof48change
forOrganisation hours| 1alpha
of
breast
compared cancer specific
withModified
provision European
of print for
materials for Protein- All
Disability with
(MIP-1a)|Change
ADAS-Cog score in
4 or Rankin
Monocyte
more|TMT-A Scale|Community
Chemoattractant
Score|TMT-B Score|
Hospitalization
Research and period|Amount
Treatment of Cancerof time on Ventilator|
(EORCT)-BR23 All
identifying
ambulation
1 (MCP-1)|Change suspect
with lesions
wearable sensors|Serum
inQuestionnaire
Granulocyte brain
Colony-stimulating derived
Functional
Intensive Activities score|Activities of
quality
neurotrophicof Care stay|Quality
life growth
questionaire|Cancer
factor
of life (QoL)|All-cause
fatigue assessed
(BDNF)|Salivary samples for All
Factor
Daily (G-CSF)|Change
Living (ADLs) score|The
mortality|Temperature in Tumor Necrosis
Neuropsychiatric
measurements|Oxygen Factor (TNF)-
Inventory
saturation
through the Functional
brain derived neurotrophic Assessment
factor of Chronic
(BDNF)|Corticomotor Illness
alpha|Change
Questionnaire|Dementia
measurements|COVID-19 in Vasoactive Intestinal
Conversion Peptide (VIP)|
Rate|Single-task
Therapy
excitability (FACIT)
using fatigue QoL
-transcranial measurements
scale.|Mental
magnetic health assessed
stimulation|
Change
gait speed in Gene Expression
test|Dual-task gait Profile
speedoftest-naming
Regulatory T Cells
through
Cognitive the Major using
function Depression
Mini Index (MDI)
Mental Screening
(Tregs)|Change
animals in Gene Expression Profile of cluster of
Examination 8 (CD8)+Interferon Gamma (IFNg)+
differentiation
피험자 나이 피험자 수 연구 분류
18 Years and older (Adult, Older Adult) 107 Interventional
10 Years to 18 Years (Child, Adult) 40 Interventional
16 Years to 60 Years (Child, Adult) 32 Observational

18 Years to 65 Years (Adult, Older Adult) 80 Interventional
up to 18 Years (Child, Adult) 200 Interventional
25 Years to 40 Years (Adult) 30 Interventional
21 Years and older (Adult, Older Adult) 100 Observational

75 Years and older (Older Adult) 50 Interventional

18 Years to 85 Years (Adult, Older Adult) 300 Observational

5 Years to 17 Years (Child) 20 Interventional
18 Years to 60 Years (Adult) 150 Observational


Child, Adult, Older Adult 2200 Observational


up to 1 Year (Child) 3 Interventional


up to 14 Days (Child) 200 Interventional



65 Years and older (Older Adult) 90 Interventional

1 Year to 39 Years (Child, Adult) 24 Interventional

65 Years to 89 Years (Older Adult) 168 Interventional


15 Years and older (Child, Adult, Older

18 Observational
Adult)
65 Years and older (Older Adult) 100 Observational


Child, Adult, Older Adult 254 Interventional

up to 18 Years (Child, Adult) 500 Interventional


13 Years to 70 Years (Child, Adult, Older

120 Interventional
Adult)


200 Interventional
Adult)

6 Months to 18 Years (Child, Adult) 50 Interventional






56 Observational
Adult)
65 Years to 120 Years (Older Adult) 42 Interventional


34 Interventional
Adult)


60 Interventional
Adult)



up to 17 Years (Child) 50 Interventional

up to 30 Days (Child) 30 Interventional

40 Interventional
Adult)

240 Observational
Adult)

2063 Observational
Adult)

up to 23 Months (Child) 60 Interventional





9 Years to 14 Years (Child) 80 Observational








10 Years to 70 Years (Child, Adult, Older

20 Interventional
Adult)

12 Months to 15 Months (Child) 75 Interventional





3 Months to 11 Years (Child) 196 Interventional

up to 100 Years (Child, Adult, Older Adult) 20 Observational
up to 72 Hours (Child) 280 Interventional


임상시험 1차 평가변수 임상시험
임상시험 디자인
시작일 측정일 완료일
Allocation: N/A|Intervention Model: Single Group

Assignment|Masking: None (Open Label)|Primary Aug-20 Feb-21 Feb-22
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Jun-21 Dec-21
Purpose: Treatment
Allocation: Non-Randomized|Intervention Model:

Single Group Assignment|Masking: None (Open 1-Aug-20 1-Aug-21 1-Aug-21
Label)|Primary Purpose: Diagnostic
Observational Model: Cohort|Time Perspective:

3-Aug-20 25-Feb-21 25-Feb-21
Prospective
Allocation: Randomized|Intervention Model: Parallel

Assignment|Masking: Single (Participant)|Primary 15-Aug-20 30-Oct-20 31-Dec-20
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 1-Aug-21 1-Aug-22
Purpose: Prevention

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 30-Dec-21 1-Apr-22
Purpose: Treatment
Assignment|Masking: None (Open Label)|Primary Aug-20 Apr-21 Feb-22
Purpose: Treatment

Assignment|Masking: Quadruple (Participant, Care
Aug-20 Jul-21 Dec-21
Provider, Investigator, Outcomes Assessor)|Primary
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Oct-21 Dec-21
Purpose: Prevention

Assignment|Masking: None (Open Label)|Primary 3-Aug-20 30-Jun-21 31-Jul-21
Purpose: Other

Assignment|Masking: None (Open Label)|Primary 30-Aug-20 30-Jun-21 30-Jun-21
Purpose: Device Feasibility
Observational Model: Case-Only|Time Perspective:

25-Aug-20 25-Nov-20 25-Nov-20
Cross-Sectional

Assignment|Masking: None (Open Label)|Primary 5-Aug-20 31-Dec-22 31-Dec-23
Purpose: Prevention

Purpose: Treatment

Assignment|Masking: Double (Participant, Aug-20 Dec-20 Mar-21
Outcomes Assessor)|Primary Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Feb-21 Aug-21
Purpose: Supportive Care
Observational Model: Other|Time Perspective:

Aug-20 Jul-21 Jul-23
Prospective

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 31-Dec-20 1-May-21
Purpose: Treatment
Allocation: Randomized|Intervention Model:
Sequential Assignment|Masking: None (Open Aug-20 Jun-21 Dec-21
Label)|Primary Purpose: Other

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 31-Oct-20 1-Nov-20
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 1-Aug-21 1-Oct-21

Assignment|Masking: None (Open Label)|Primary 15-Aug-20 31-Dec-21 31-Mar-22
Purpose: Treatment

Assignment|Masking: Double (Investigator, Aug-20 Feb-21 Feb-22

Assignment|Masking: None (Open Label)|Primary Aug-20 Dec-21 Jun-22
Purpose: Prevention

Single Group Assignment|Masking: Single Aug-20 Dec-20 Dec-22
(Investigator)|Primary Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 31-Jul-22 31-Jul-22
Purpose: Prevention

Assignment|Masking: Single (Investigator)|Primary Aug-20 Aug-25 Dec-25
Purpose: Other

Assignment|Masking: None (Open Label)|Primary Aug-20 Sep-20 Dec-20
Purpose: Treatment

Assignment|Masking: Single (Participant)|Primary Aug-20 Dec-20 Dec-20
Purpose: Treatment
Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 31-Dec-23 31-Dec-23
Primary Purpose: Treatment

1-Aug-20 31-Aug-22 31-Dec-22
Prospective

Assignment|Masking: None (Open Label)|Primary 15-Aug-20 1-Feb-21 1-Aug-21

Crossover Assignment|Masking: Double (Participant, 3-Aug-20 30-Nov-20 15-Dec-20
Investigator)|Primary Purpose: Treatment
Observational Model: Ecologic or Community|Time

25-Aug-20 31-Aug-23 31-Aug-23
Perspective: Cross-Sectional

Aug-20 Jun-21 Jun-21
Purpose: Treatment
Aug-20 Feb-21 Feb-21
Purpose: Treatment

Aug-20 Mar-21 Mar-21
Prospective

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 1-Nov-21 31-Mar-22
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Aug-21 Aug-21
Purpose: Other
Aug-20 Dec-20 Jan-23
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Dec-21 Dec-21
Purpose: Other

Assignment|Masking: None (Open Label)|Primary Aug-20 May-21 May-21

Assignment|Masking: Single (Participant)|Primary Aug-20 Nov-20 Jan-21
Purpose: Treatment

31-Aug-20 1-Mar-21 1-Aug-21
Prospective

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 Mar-21 Dec-21
Purpose: Basic Science

Assignment|Masking: None (Open Label)|Primary Aug-20 Jun-22 Oct-22
Purpose: Treatment
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 30-Sep-20 31-Dec-20

Assignment|Masking: Single (Participant)|Primary 1-Aug-20 Dec-20 Dec-20
Purpose: Treatment

Purpose: Health Services Research

Purpose: Treatment

Aug-20 Aug-23 Aug-25
Prospective

Assignment|Masking: Single (Participant)|Primary Aug-20 Jul-23 Jul-24
Purpose: Treatment

Crossover Assignment|Masking: Single 15-Aug-20 31-Jul-21 31-Jul-21
(Investigator)|Primary Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Feb-22 Feb-22
Purpose: Treatment

Purpose: Diagnostic

Purpose: Diagnostic
1-Aug-20 31-Jan-25 31-Jan-27
Prospective

1-Aug-20 31-Oct-20 30-Nov-20
Prospective

20-Aug-20 20-Nov-21 20-Nov-21
Prospective

Assignment|Masking: Double (Investigator, Aug-20 Oct-21 Jun-22
Assignment|Masking: None (Open Label)|Primary 20-Aug-20 31-May-21 31-May-21
Purpose: Diagnostic

Parallel Assignment|Masking: None (Open Label)| Aug-20 Sep-20 Dec-20
Primary Purpose: Device Feasibility

Aug-20 Mar-21 Apr-21
Prospective

Assignment|Masking: Double (Investigator, 7-Aug-20 30-Jun-21 15-Oct-21

Purpose: Treatment

Assignment|Masking: Single (Participant)|Primary Aug-20 25-Dec-20 28-Dec-20
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 30-Nov-21 30-Nov-21

5-Aug-20 Dec-25 Dec-25
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Nov-20 Nov-20

Assignment|Masking: None (Open Label)|Primary Aug-20 Aug-22 Dec-22
Purpose: Treatment
1-Aug-20 1-May-24 Dec-25
Other

1-Aug-20 1-Oct-21 1-Nov-21
Retrospective

Assignment|Masking: None (Open Label)|Primary 13-Aug-20 Oct-20 Dec-20
Purpose: Treatment

Sequential Assignment|Masking: None (Open Aug-20 Aug-20 Aug-20
Label)|Primary Purpose: Device Feasibility

Single Group Assignment|Masking: None (Open 1-Aug-20 1-Apr-21 30-May-21
Label)|Primary Purpose: Device Feasibility

Assignment|Masking: Double (Participant, 1-Aug-20 1-Aug-22 1-Aug-25

Aug-20 1-Jun-21 1-Jun-21
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Apr-21 Jun-21
Purpose: Treatment
Aug-20 Dec-20 Dec-20
Cross-Sectional

31-Aug-20 31-Aug-27 31-Dec-27
Prospective

Aug-20 Sep-20 Nov-20
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Oct-20 Oct-20

1-Aug-20 30-Aug-20 30-Sep-20
Prospective

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 31-May-22 1-Jan-40
Purpose: Prevention

Parallel Assignment|Masking: Single (Outcomes Aug-20 Feb-21 Aug-21
Assessor)|Primary Purpose: Device Feasibility
1-Aug-20 1-Feb-21 1-May-21
Prospective

Assignment|Masking: None (Open Label)|Primary 3-Aug-20 15-Sep-22 15-Sep-22
Purpose: Diagnostic

Parallel Assignment|Masking: None (Open Label)| 15-Aug-20 31-Dec-21 31-Dec-22

1-Aug-20 31-Mar-24 31-Mar-24
Cross-Sectional

Assignment|Masking: Double (Participant, Care 18-Aug-20 31-Dec-20 31-Dec-20
Provider)|Primary Purpose: Other

Parallel Assignment|Masking: None (Open Label)| Aug-20 Jan-21 Jan-21
Primary Purpose: Basic Science

Assignment|Masking: None (Open Label)|Primary 21-Aug-20 31-Aug-21 31-Dec-21
Purpose: Treatment
Assignment|Masking: Triple (Participant, Care 1-Aug-20 Mar-22 Mar-22
Provider, Investigator)|Primary Purpose: Prevention

Aug-20 Feb-21 Jul-21
Purpose: Treatment

Parallel Assignment|Masking: None (Open Label)| Aug-20 Dec-20 Dec-20
Primary Purpose: Other

Assignment|Masking: None (Open Label)|Primary Aug-20 Jun-22 Jun-23
Purpose: Other

Purpose: Other

Purpose: Other

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 1-Aug-21 1-Aug-21

1-Aug-20 1-Feb-21 30-Mar-21
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Jan-21 Jan-21
Purpose: Treatment

Purpose: Treatment
Assignment|Masking: None (Open Label)|Primary 1-Aug-20 1-Feb-21 1-Feb-22
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 5-Aug-20 30-Dec-23

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 30-May-21 30-Jun-21
Purpose: Other

Parallel Assignment|Masking: Double (Participant,
Aug-20 30-Nov-22 30-Nov-22
Outcomes Assessor)|Primary Purpose: Device
Feasibility
1-Aug-20 1-Aug-22 1-Aug-22
Purpose: Treatment
Observational Model: Case-Crossover|Time

Aug-20 Jun-21 Dec-21
Perspective: Prospective

Single Group Assignment|Masking: None (Open Aug-20 May-21 Jul-21
Label)|Primary Purpose: Treatment

Parallel Assignment|Masking: None (Open Label)| 1-Aug-20 1-Jan-21 1-Jun-21

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 31-Jan-21 31-May-21
Purpose: Treatment

Purpose: Prevention
Assignment|Masking: None (Open Label)|Primary Aug-20 May-21 Nov-21

Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 15-Aug-20 30-Sep-21 30-Dec-21
Purpose: Treatment

Parallel Assignment|Masking: None (Open Label)| 11-Aug-20 Aug-21 Aug-21

Assignment|Masking: Double (Participant, 6-Aug-20 Sep-22 Sep-22

Assignment|Masking: Double (Care Provider,
1-Aug-20 1-Dec-21 1-Jan-22
Outcomes Assessor)|Primary Purpose: Supportive
Care


1-Aug-20 28-Feb-21 31-Aug-21
Cross-Sectional

Crossover Assignment|Masking: None (Open Label)| Aug-20 Apr-22 Aug-22

Assignment|Masking: Double (Participant, Care 1-Aug-20 31-Jul-21 31-Jul-21
Provider)|Primary Purpose: Supportive Care
Crossover Assignment|Masking: Single (Outcomes 18-Aug-20 30-Jun-24 30-Jun-32
Assessor)|Primary Purpose: Other

Sequential Assignment|Masking: None (Open 1-Aug-20 1-Oct-22 1-Feb-23
Label)|Primary Purpose: Treatment

Parallel Assignment|Masking: None (Open Label)| 1-Aug-20 30-May-24 30-May-24

10-Aug-20 18-Oct-20 1-Dec-20
Prospective

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 28-Feb-21 15-Apr-21
Purpose: Treatment

Crossover Assignment|Masking: None (Open Label)| Aug-20 Dec-20 Dec-20
Primary Purpose: Diagnostic

Assignment|Masking: Double (Participant, 1-Aug-20 1-Jan-22 1-Jan-22

7-Aug-20 31-Dec-20 31-Dec-20
Cross-Sectional
Assignment|Masking: Double (Participant,
1-Aug-20 30-Dec-21 30-Jun-22
Care

1-Aug-20 1-Oct-24 1-Oct-24
Prospective

Crossover Assignment|Masking: None (Open Label)| Aug-20 Dec-20 Dec-20

Crossover Assignment|Masking: Single (Outcomes 1-Aug-20 31-Dec-21 31-Dec-21
Assessor)|Primary Purpose: Treatment
Purpose: Treatment

12-Aug-20 1-Jun-21 1-Sep-21
Prospective

Purpose: Treatment

Assignment|Masking: Triple (Participant,
Aug-20 Jan-25 Jan-25
Investigator, Outcomes Assessor)|Primary Purpose:
Prevention

Assignment|Masking: Single (Outcomes Assessor)| 15-Aug-20 Dec-21 Apr-22

Purpose: Other

Assignment|Masking: None (Open Label)|Primary 3-Aug-20 May-21 May-22
Purpose: Other

Purpose: Treatment
Observational Model: Case-Control|Time

15-Aug-20 Aug-21 Aug-21

Purpose: Treatment
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Dec-21 Jun-22
Purpose: Diagnostic

Purpose: Treatment

Assignment|Masking: Double (Participant, 1-Aug-20 1-May-21 1-Aug-21

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 28-May-22 30-Jul-22
Purpose: Other

Purpose: Diagnostic

Purpose: Other

10-Aug-20 31-Mar-22 31-May-22
Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 May-21 Aug-21
Purpose: Treatment

Aug-20 Aug-21 Feb-22

Purpose: Treatment
Parallel Assignment|Masking: None (Open Label)| 25-Aug-20 Jun-22 Apr-24

Aug-20 Jun-22 Aug-22
Prospective

1-Aug-20 10-Jan-22 10-Jan-22
Prospective

Purpose: Prevention

Assignment|Masking: None (Open Label)|Primary Aug-20 Dec-21 Jan-23
Purpose: Treatment

Prospective

Assignment|Masking: Single (Participant)|Primary 15-Aug-20 31-Aug-20 31-Aug-20

Factorial Assignment|Masking: Single (Outcomes Aug-20 Jun-22 Jun-22
Assessor)|Primary Purpose: Prevention

Crossover Assignment|Masking: Quadruple
Aug-20 Oct-20 Oct-20
(Participant, Care Provider, Investigator, Outcomes

1-Aug-20 Feb-21 Feb-21
Prospective
Assignment|Masking: None (Open Label)|Primary Aug-20 Sep-22 Aug-23
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Apr-21 Aug-21

4-Aug-20 31-Dec-20 31-Mar-21

Assignment|Masking: Single (Participant)|Primary 1-Aug-20 1-Aug-23 1-Aug-23
Purpose: Treatment

Assignment|Masking: Double (Participant, 5-Aug-20 31-Dec-21 31-Dec-21
Outcomes Assessor)|Primary Purpose: Prevention

Assignment|Masking: Triple (Participant, Care 12-Aug-20 Oct-22 Oct-22
Provider, Investigator)|Primary Purpose: Treatment

Parallel Assignment|Masking: Single (Outcomes 10-Aug-20 1-Jun-24 1-Jun-24
Assessor)|Primary Purpose: Screening
Purpose: Prevention

Assignment|Masking: Double (Participant, 1-Aug-20 Dec-21 Dec-21

Assignment|Masking: Double (Participant, Care Aug-20 Aug-22 Sep-23
Provider)|Primary Purpose: Prevention

Purpose: Treatment

Purpose: Treatment
Purpose: Treatment

Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 7-Aug-20 31-Mar-21 31-Mar-21
Purpose: Treatment

Crossover Assignment|Masking: Single (Outcomes 29-Aug-20 30-Oct-20 31-Dec-20

Assignment|Masking: None (Open Label)|Primary Aug-20 Sep-21 Sep-21
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Jul-22 Jul-23
Purpose: Prevention

Purpose: Treatment


Assignment|Masking: Single (Outcomes Assessor)| 18-Aug-20 1-Dec-21 1-May-22

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Apr-25 Jan-26

Prospective
Assignment|Masking: Triple (Participant, Care 1-Aug-20 1-Aug-21 1-Aug-21

Assignment|Masking: Single (Participant)|Primary 1-Aug-20 10-Nov-20 1-Dec-20
Purpose: Diagnostic

Crossover Assignment|Masking: Double (Participant, 15-Aug-20 15-Oct-20 15-Nov-20


24-Aug-20 24-Aug-30 24-Aug-30
Prospective

1-Aug-20 31-Dec-22 31-Mar-23
Purpose: Treatment

Parallel Assignment|Masking: None (Open Label)| 4-Aug-20 Dec-25 Dec-25

Assignment|Masking: None (Open Label)|Primary Aug-20 31-Dec-21 31-Dec-22
Purpose: Other
Intervention Model: Sequential Assignment|

Masking: None (Open Label)|Primary Purpose: Aug-20 Dec-21 Dec-21
Treatment
Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 15-Jan-21 31-Jan-21
Primary Purpose: Prevention

Assignment|Masking: None (Open Label)|Primary Aug-20 Sep-21 Sep-23
Purpose: Treatment

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 1-Nov-20 1-Jan-21
Primary Purpose: Supportive Care

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 31-Mar-21 30-Sep-21

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Dec-20 Dec-20

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Mar-22 Mar-22
24-Aug-20 Aug-23 Aug-23
Prospective

1-Aug-20 1-Aug-30 1-Aug-40
Prospective

1-Aug-20 30-Aug-20 31-Dec-20
Prospective

Assignment|Masking: None (Open Label)|Primary 12-Aug-20 Mar-23 Aug-25

Assignment|Masking: None (Open Label)|Primary 20-Aug-20 Jul-22 Oct-22
Purpose: Diagnostic

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 1-Aug-21 1-Aug-21

Crossover Assignment|Masking: None (Open Label)| 31-Aug-20 May-21 May-21

Assignment|Masking: Double (Participant, 1-Aug-20 1-Aug-21 1-Aug-21

Assignment|Masking: None (Open Label)|Primary 28-Aug-20 Jan-21 Mar-21
Purpose: Diagnostic

Assignment|Masking: Double (Participant, 1-Aug-20 30-May-21 30-Aug-21
Outcomes Assessor)|Primary Purpose: Other

Crossover Assignment|Masking: None (Open Label)| Aug-20 May-21 Jul-21

1-Aug-20 31-Mar-22 30-Sep-22
Prospective

Purpose: Treatment

1-Aug-20 30-Dec-20 31-Dec-21
Prospective

19-Aug-20 1-Nov-22 1-Nov-22
Prospective

Assignment|Masking: Single (Participant)|Primary 15-Aug-20 1-Oct-22 1-May-23

Single Group Assignment|Masking: Single
15-Aug-20 28-Feb-21 28-Feb-21
(Participant)|Primary Purpose: Health Services
Research

Assignment|Masking: Double (Participant, 19-Aug-20 30-Jan-21 15-Feb-21
Outcomes Assessor)|Primary Purpose: Other

Assignment|Masking: None (Open Label)|Primary Aug-20 Oct-22 28-Feb-23
Purpose: Prevention
Assignment|Masking: None (Open Label)|Primary Aug-20 Aug-21 Nov-21
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Dec-20 Feb-21
Purpose: Other

1-Aug-20 30-Jul-22 30-Jul-23
Prospective

1-Aug-20 1-Jun-21 31-Dec-21
Perspective: Retrospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Nov-21 Nov-21

10-Aug-20 Aug-22 Aug-22
Prospective

Assignment|Masking: Double (Investigator, 1-Aug-20 1-Jan-24 1-May-24

Assignment|Masking: None (Open Label)|Primary 20-Aug-20 Nov-22 Nov-22
Purpose: Treatment

Purpose: Screening
Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 30-Apr-24 30-Apr-24

Assignment|Masking: None (Open Label)|Primary 17-Aug-20 30-Jun-21 31-Dec-21
Purpose: Treatment

Purpose: Diagnostic

Assignment|Masking: None (Open Label)|Primary 5-Aug-20 Jan-22 Feb-22
Purpose: Treatment
Assignment|Masking: None (Open Label)|Primary 11-Aug-20 15-Dec-20 30-Jan-21
Purpose: Treatment

Prospective

Prospective

Assignment|Masking: Triple (Participant, Care 25-Aug-20 30-Sep-21 30-Sep-21

Assignment|Masking: Single (Participant)|Primary 1-Aug-20 31-Dec-20 31-Dec-20

Purpose: Other

7-Aug-20 7-Dec-20 31-Jan-21
Purpose: Treatment

Crossover Assignment|Masking: Double (Participant, 17-Aug-20 31-Aug-21 1-Nov-21
Investigator)|Primary Purpose: Basic Science
Crossover Assignment|Masking: None (Open Label)| 5-Aug-20 15-Jul-21 1-Sep-21

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 1-Feb-21 31-Dec-21

Crossover Assignment|Masking: Double (Participant, 5-Aug-20 30-Sep-20 30-Sep-20
Assignment|Masking: Double (Participant, 15-Aug-20 1-Sep-22 31-Dec-22

15-Aug-20 14-Aug-21 14-Feb-22
Prospective

Crossover Assignment|Masking: None (Open Label)| 25-Aug-20 25-Oct-21 25-Feb-22

Assignment|Masking: Double (Participant, 15-Aug-20 30-Oct-20 1-Nov-20
Investigator)|Primary Purpose: Other

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 Aug-21 Aug-22

Crossover Assignment|Masking: None (Open Label)| 1-Aug-20 1-Aug-24 1-Aug-24

Crossover Assignment|Masking: Double (Participant, 1-Aug-20 31-Dec-20 31-May-21
Purpose: Prevention

Crossover Assignment|Masking: Double (Participant, 30-Aug-20 30-Nov-20 30-Dec-20

Assignment|Masking: Triple (Participant, Care
30-Aug-20 31-Jan-21 31-Jul-21
Provider, Outcomes Assessor)|Primary Purpose:
Prevention

Assignment|Masking: Double (Participant, Aug-20 Aug-23 Sep-23

Assignment|Masking: None (Open Label)|Primary Aug-20 Aug-21 Oct-21
Purpose: Prevention

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 31-Oct-21 31-Dec-21
Purpose: Other

Assignment|Masking: Double (Investigator, 1-Aug-20 1-Jan-23 1-Oct-23

Crossover Assignment|Masking: Single (Participant)| 15-Aug-20 15-Nov-20 30-Dec-20
Assignment|Masking: Double (Participant, 15-Aug-20 15-Jul-24 15-Nov-24
Outcomes Assessor)|Primary Purpose: Basic Science

1-Aug-20 1-Mar-24 28-Jun-24
Purpose: Treatment
Assignment|Masking: None (Open Label)|Primary Aug-20 Sep-21 Aug-22
Purpose: Treatment

Crossover Assignment|Masking: Single (Participant)| 20-Aug-20 2-Dec-20 14-Jan-21

Assignment|Masking: None (Open Label)|Primary 3-Aug-20 Aug-22 Aug-23
Purpose: Diagnostic

Crossover Assignment|Masking: Single (Outcomes 15-Aug-20 15-Feb-21 15-May-21
Assessor)|Primary Purpose: Supportive Care

Parallel Assignment|Masking: None (Open Label)| 1-Aug-20 1-Aug-22 1-Aug-30
Assignment|Masking: Double (Investigator,
Aug-20 1-Jan-22 1-Jul-23
Care

Assignment|Masking: Double (Participant, Care 25-Aug-20 15-Mar-21 15-Mar-21
Provider)|Primary Purpose: Prevention

Parallel Assignment|Masking: None (Open Label)| 24-Aug-20 24-Aug-24 1-Oct-24

Assignment|Masking: Single (Participant)|Primary 1-Aug-20 2-Feb-21 2-Feb-21
Purpose: Treatment

Aug-20 1-May-24 1-May-24
Treatment

Purpose: Treatment
Aug-20 Feb-21 May-21
Purpose: Treatment

Parallel Assignment|Masking: Single (Participant)| 1-Aug-20 Aug-21 Aug-21

Treatment

Crossover Assignment|Masking: Triple (Participant,
15-Aug-20 Jul-21 Jul-21
Treatment

Purpose: Treatment

Assignment|Masking: Double (Participant, 1-Aug-20 Nov-20 Dec-20
Investigator)|Primary Purpose: Other

Assignment|Masking: None (Open Label)|Primary Aug-20 Mar-21 Jun-21
Purpose: Treatment

4-Aug-20 31-Dec-20 31-Mar-21

Assignment|Masking: Single (Participant)|Primary 24-Aug-20 Dec-22 Jun-23
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 21-Aug-20 22-Aug-21 Dec-21
Purpose: Treatment

Aug-20 Feb-21 Mar-21
Prospective
26-Aug-20 26-Aug-20 26-Aug-20
Prospective

Assignment|Masking: None (Open Label)|Primary 20-Aug-20 1-Aug-21 1-Sep-21
Purpose: Treatment

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Jul-22 Nov-22

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 1-Jul-21 1-Jul-22
Purpose: Other

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 31-Jan-22 31-Dec-22
Purpose: Treatment

17-Aug-20 15-Mar-21 15-Dec-22
Treatment

Assignment|Masking: None (Open Label)|Primary 15-Aug-20 15-Jul-21 15-Aug-21
Purpose: Prevention
1-Aug-20 1-Feb-21 1-Feb-21
Prospective


Purpose: Treatment

Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Sep-25 Jan-26

Assignment|Masking: Single (Participant)|Primary Aug-20 Sep-21 Dec-21
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Nov-20 Mar-21
Purpose: Diagnostic

Purpose: Other

Assignment|Masking: Single (Participant)|Primary 30-Aug-20 30-Oct-20 30-Nov-20
Purpose: Other

Assignment|Masking: None (Open Label)|Primary 8-Aug-20 8-Nov-20 15-Nov-20
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 1-Jan-21 1-Jan-21
Purpose: Treatment

5-Aug-20 5-Aug-21 5-Oct-21
Prospective

Crossover Assignment|Masking: Double (Participant, 18-Aug-20 31-Dec-21 31-Dec-21

Crossover Assignment|Masking: Double (Participant, 1-Aug-20 31-Jul-21 31-Jul-21

4-Aug-20 30-Sep-21 31-Dec-21
Perspective: Other

Purpose: Treatment

1-Aug-20 1-Aug-21 1-Aug-21
Prospective

1-Aug-20 1-Mar-21 1-Sep-21
Prospective

Purpose: Treatment
Purpose: Treatment

Aug-20 Dec-20 Feb-21
Prospective

Parallel Assignment|Masking: None (Open Label)| 1-Aug-20 30-Oct-20 30-Nov-20

Assignment|Masking: None (Open Label)|Primary 2-Aug-20 Dec-21 Dec-22
Purpose: Treatment

Purpose: Other

Assignment|Masking: None (Open Label)|Primary 30-Aug-20 30-Aug-22 30-Jan-23
Purpose: Other

Aug-20 Aug-21 Sep-21
Prospective

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 1-Apr-21 1-Jul-21
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 1-Aug-21 1-Jan-22
Purpose: Treatment

15-Aug-20 15-Aug-22 15-Jan-23
Prospective

Aug-20 Sep-20 Oct-20
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Dec-20 Jan-21
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 31-Aug-22 29-Feb-24
Purpose: Treatment

Assignment|Masking: Double (Care Provider, 1-Aug-20 30-Jun-21 31-Jan-22

Purpose: Treatment

Crossover Assignment|Masking: None (Open Label)| 11-Aug-20 15-Oct-20 15-Oct-20

Assignment|Masking: Double (Participant, Aug-20 Oct-21 Oct-21

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 Feb-22 Feb-22

Assignment|Masking: None (Open Label)|Primary Aug-20 Nov-22 Dec-22
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 1-Jul-21 1-Sep-21
Purpose: Diagnostic

1-Aug-20 30-Dec-20 30-Dec-20
Retrospective

Prospective
Assignment|Masking: None (Open Label)|Primary 1-Aug-20 30-Jul-21 30-Oct-21
Purpose: Treatment

Prospective
Allocation: Randomized|Intervention Model: Single

Group Assignment|Masking: None (Open Label)| Aug-20 Dec-21 Dec-21

1-Aug-20 1-Sep-20 1-Nov-20
Prospective

Purpose: Treatment
1-Aug-20 31-Oct-20 31-Oct-20
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Jan-21 Jan-21
Purpose: Prevention

Purpose: Treatment
Assignment|Masking: Single (Investigator)|Primary Aug-20 Dec-20 Jul-21
Purpose: Prevention

Purpose: Treatment

Purpose: Treatment

30-Aug-20 30-Aug-22 30-Dec-22
Prospective
Intervention Model: Crossover Assignment|Masking:

Double (Participant, Care Provider)|Primary Purpose: Aug-20 Jan-24 Jan-25
Basic Science

Purpose: Treatment

1-Aug-20 30-Apr-23 31-Jul-23
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Jun-23 Jul-23
Purpose: Diagnostic

Cross-Sectional

Assignment|Masking: None (Open Label)|Primary Aug-20 Oct-20 Dec-20
Purpose: Treatment
Assignment|Masking: None (Open Label)|Primary 11-Aug-20 Apr-21 Apr-21
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 Mar-22 Jul-22
Purpose: Other

1-Aug-20 1-Apr-22 1-Apr-23
Prospective

6-Aug-20 Nov-21 Nov-21
Prospective

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 Mar-21 Dec-21
Purpose: Treatment

Purpose: Screening

3-Aug-20 Aug-21 Aug-21
Prospective

Assignment|Masking: Double (Investigator, 2-Aug-20 2-Jan-21 10-Jan-21
Outcomes Assessor)|Primary Purpose: Diagnostic

1-Aug-20 1-Nov-22 1-Dec-22
Purpose: Treatment

Purpose: Treatment
Aug-20 May-22 Sep-22
Prospective

1-Aug-20 Aug-21 Oct-21
Prospective

19-Aug-20 15-Mar-21 15-Mar-21
Prospective

Assignment|Masking: None (Open Label)|Primary Aug-20 Jul-21 Sep-21
Purpose: Treatment

Crossover Assignment|Masking: None (Open Label)| Aug-20 Jan-22 Jan-22

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Jan-23 Jan-25

Aug-20 Apr-22 Oct-22
Prospective

Purpose: Treatment

1-Aug-20 31-Mar-25 31-Mar-25

Group Assignment|Masking: Single (Participant)| 31-Aug-20 31-Oct-21 31-Dec-21

Parallel Assignment|Masking: None (Open Label)| Aug-20 Mar-21 Mar-21
Group Assignment|Masking: Single (Outcomes 11-Aug-20 1-Jan-21 30-Sep-21

1-Aug-20 25-Nov-21 25-Nov-21
Prospective

Group Assignment|Masking: None (Open Label)| 1-Aug-20 30-Jun-21 30-Sep-21

Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 15-Aug-20 1-Nov-20 1-Dec-20
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 26-Aug-20 Aug-21 Aug-21
Purpose: Diagnostic

Assignment|Masking: Double (Participant, Care Aug-20 Jan-21 Jan-21
Provider)|Primary Purpose: Supportive Care

Sequential Assignment|Masking: None (Open 1-Aug-20 31-Dec-21 31-Dec-21
Label)|Primary Purpose: Supportive Care

Purpose: Treatment

Aug-20 31-Aug-22 31-Aug-22
Prospective

1-Aug-20 15-Feb-21 20-Mar-21
Treatment

1-Aug-20 31-Aug-22 31-Aug-22
Prospective
Assignment|Masking: Double (Participant, Aug-20 Oct-20 Aug-21

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Nov-20 Dec-20


Aug-20 Dec-20 Feb-21
Prospective

Purpose: Prevention

Assignment|Masking: Single (Outcomes Assessor)| 7-Aug-20 Aug-22 Aug-22
Assignment|Masking: Double (Participant, 1-Aug-20 6-Apr-24 31-Jul-24

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Jan-21 Jan-22

Crossover Assignment|Masking: None (Open Label)| 1-Aug-20 1-Aug-23 1-Aug-23

Parallel Assignment|Masking: Double (Participant, Aug-20 Dec-22 Dec-22

Crossover Assignment|Masking: Double (Participant, 19-Aug-20 Mar-21 Apr-21


Other

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Nov-20 Dec-20

Aug-20 Oct-23 Jul-24
Prospective

21-Aug-20 21-Aug-21 21-Aug-22
Prospective

Assignment|Masking: Double (Participant, Aug-20 Jan-23 Dec-23
Assignment|Masking: None (Open Label)|Primary Aug-20 Nov-20 May-21
Purpose: Prevention

Assignment|Masking: Single (Participant)|Primary Aug-20 Aug-20 Oct-20
Purpose: Treatment

Assignment|Masking: Single (Outcomes Assessor)| 16-Aug-20 31-Dec-21 31-Mar-22

Single Group Assignment|Masking: None (Open 1-Aug-20 1-Jun-21 1-Aug-21
Label)|Primary Purpose: Prevention

Assignment|Masking: None (Open Label)|Primary 26-Aug-20 Jul-22 Aug-23
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 20-Aug-20 15-Apr-21 17-Apr-21
Purpose: Other

Assignment|Masking: Double (Investigator, 1-Aug-20 1-Dec-21 1-Dec-21
Purpose: Treatment

Crossover Assignment|Masking: Single (Outcomes Aug-20 Aug-23 Aug-23
Assessor)|Primary Purpose: Diagnostic

Crossover Assignment|Masking: Single (Participant)| Aug-20 Mar-21 Mar-21

Assignment|Masking: None (Open Label)|Primary Aug-20 Aug-22 Feb-23
Purpose: Treatment

Group Assignment|Masking: None (Open Label)| Aug-20 Oct-20 Oct-20
5-Aug-20 16-Feb-21 7-Apr-21
Prospective

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 28-Feb-25 28-Feb-25

Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 15-Sep-21 1-Dec-21
Purpose: Treatment

Assignment|Masking: Single (Outcomes Assessor)| 31-Aug-20 31-Aug-24 31-Dec-24

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 1-Jan-21 28-Feb-21
Purpose: Treatment

17-Aug-20 Jul-23 Jul-23
Treatment

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 1-Feb-22 1-Feb-22

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 31-Dec-22 31-May-24
Purpose: Treatment

11-Aug-20 31-Dec-23 31-Dec-24
Treatment

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 1-Aug-21 1-Sep-21

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Oct-24 Apr-25

1-Aug-20 31-Jul-25 31-Jul-25
Care Provider, Outcomes Assessor)|Primary
Purpose: Treatment

Assignment|Masking: Single (Participant)|Primary Aug-20 Oct-21 Nov-21
Purpose: Treatment

Purpose: Diagnostic
Assignment|Masking: Double (Participant, Aug-20 Aug-22 Aug-23

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 31-Jan-23 31-Jul-23
Purpose: Prevention

Crossover Assignment|Masking: None (Open Label)| Aug-20 Aug-24 Dec-24

Assignment|Masking: Single (Outcomes Assessor)| 1-Aug-20 30-Jul-24 30-Jul-24

Purpose: Treatment

20-Aug-20 Jul-21 Aug-21
Other
Assignment|Masking: Single (Care Provider)|Primary Aug-20 May-22 May-22
Purpose: Treatment

Parallel Assignment|Masking: None (Open Label)| 4-Aug-20 31-Dec-20 31-Dec-20

Single Group Assignment|Masking: None (Open Aug-20 Sep-22 Sep-22
Label)|Primary Purpose: Diagnostic

Assignment|Masking: Single (Participant)|Primary Aug-20 Dec-20 Feb-21
Purpose: Treatment

Assignment|Masking: Single (Participant)|Primary 1-Aug-20 1-Feb-21 1-Sep-21

Assignment|Masking: Triple (Care Provider,
1-Aug-20 31-Aug-23 31-Aug-23
Supportive Care

Assignment|Masking: None (Open Label)|Primary 25-Aug-20 Jun-22 Jun-22
Purpose: Treatment

Assignment|Masking: Double (Participant, Aug-20 Dec-21 Dec-21
Investigator)|Primary Purpose: Supportive Care

Sequential Assignment|Masking: Double
4-Aug-20 Sep-21 Sep-21
(Participant, Care Provider)|Primary Purpose:
Prevention

Assignment|Masking: Single (Participant)|Primary 1-Aug-20 1-Apr-22 10-Apr-23

Parallel Assignment|Masking: None (Open Label)| Aug-20 30-Jun-23 30-Jun-23
Primary Purpose: Health Services Research
Parallel Assignment|Masking: None (Open Label)| 30-Aug-20 Mar-24 Mar-24

Purpose: Other

Factorial Assignment|Masking: Single (Participant)| Aug-20 Jul-21 Jul-21
Crossover Assignment|Masking: None (Open Label)| Aug-20 Aug-23 Aug-23

Purpose: Other

Assignment|Masking: Double (Participant, 1-Aug-20 30-Aug-21 10-Dec-21

Purpose: Treatment

Assignment|Masking: Single (Participant)|Primary 1-Aug-20 31-Jul-22 31-Aug-22
Purpose: Treatment

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Jul-21 Dec-21

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 30-Jun-22 31-Oct-22
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 30-Jun-22 31-Oct-22
Purpose: Treatment
Assignment|Masking: Double (Investigator, 12-Aug-20 Apr-23 Apr-23

Assignment|Masking: Double (Participant, 10-Aug-20 31-Dec-21 31-Mar-22

Crossover Assignment|Masking: None (Open Label)| 1-Aug-20 31-May-21 31-Aug-21

Single Group Assignment|Masking: None (Open 1-Aug-20 30-Sep-21 31-Dec-21
Label)|Primary Purpose: Supportive Care

Prospective

Aug-20 1-Jan-22 1-Jan-22
Purpose: Prevention

Assignment|Masking: None (Open Label)|Primary Aug-20 Mar-22 Mar-22
Purpose: Treatment

Aug-20 Apr-23 Apr-23
Purpose: Treatment

Assignment|Masking: Double (Participant, 1-Aug-20 31-Jan-22 2-Aug-22

Assignment|Masking: None (Open Label)|Primary 31-Aug-20 30-Nov-22 31-Aug-24
Purpose: Treatment

24-Aug-20 Aug-21 Sep-21
Prospective
Assignment|Masking: None (Open Label)|Primary 15-Aug-20 1-Jun-21 30-Sep-21

Aug-20 Jun-22 Dec-22
Purpose: Treatment

Aug-20 Aug-20 Sep-20
Prospective

Group Assignment|Masking: None (Open Label)| Aug-20 Jan-22 Mar-22

Purpose: Treatment

30-Aug-20 Jul-21 Jul-21
Prospective

Assignment|Masking: Double (Participant,
Aug-20 Dec-20 Jan-21
Care

Factorial Assignment|Masking: Double (Participant, 31-Aug-20 31-Dec-24 30-Jun-25
Investigator)|Primary Purpose: Prevention

Assignment|Masking: Single (Participant)|Primary 15-Aug-20 15-Oct-20 15-Nov-20
Purpose: Other

Assignment|Masking: Single (Care Provider)|Primary 17-Aug-20 31-Dec-22 30-Jun-23
Purpose: Other

Crossover Assignment|Masking: None (Open Label)| 10-Aug-20 1-Dec-22 1-Dec-22

Assignment|Masking: None (Open Label)|Primary 27-Aug-20 Sep-30 Sep-31
Purpose: Diagnostic

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 31-Oct-25 31-Oct-25
Purpose: Treatment

Assignment|Masking: None (Open Label)|Primary Aug-20 31-Jul-23 31-Jul-23

Assignment|Masking: None (Open Label)|Primary 14-Aug-20 31-Aug-20 28-Feb-21
Purpose: Treatment

26-Aug-20 1-Sep-22 1-Sep-22
Prospective

Purpose: Prevention

Retrospective

31-Aug-20 31-Dec-20 1-Jul-21
Prospective

Single Group Assignment|Masking: Single 12-Aug-20 Dec-20 Aug-21
(Participant)|Primary Purpose: Prevention

Purpose: Prevention

Assignment|Masking: Double (Participant, 4-Aug-20 1-Nov-23 1-Nov-23

Treatment

8-Aug-20 30-Apr-21 30-May-21
Perspective: Cross-Sectional

12-Aug-20 15-Dec-20 28-Dec-20
Purpose: Treatment
Factorial Assignment|Masking: Double (Participant, 31-Aug-20 31-Mar-25 31-Mar-25
Investigator)|Primary Purpose: Basic Science

3-Aug-20 Jun-21 Jun-21
Purpose: Treatment

Purpose: Prevention

Assignment|Masking: None (Open Label)|Primary 1-Aug-20 Jan-21 Feb-21
Purpose: Prevention

Assignment|Masking: Single (Outcomes Assessor)| Aug-20 Mar-21 Sep-21
Assignment|Masking: None (Open Label)|Primary
Allocation: Randomized|Intervention Model: Parallel 1-Aug-20 Jul-22 Jul-22
Allocation:
Purpose: Randomized|Intervention Model: Parallel
Prevention None (Open Label)|Primary
Assignment|Masking: 31-Aug-20 31-Aug-21 31-Aug-21
Purpose: Treatment
Allocation: Randomized|Intervention Model: Parallel Aug-20 31-Dec-25 31-Dec-25
Provider, Outcomes
Allocation: Assessor)|PrimaryModel:
Randomized|Intervention Purpose:
Parallel
Assignment|Masking: Double (Participant, Care Aug-20 Feb-22 Feb-22
Treatment
Provider)|Primary Purpose: Treatment 1-Aug-20 31-Mar-22 31-Mar-23
Purpose: Treatment
임상시험 진행 지역 참고URL
https://ClinicalTrials.gov/show/NCT04059640
UPMC Lemieux Sports Medicine Complex,

CranberrySchool
Stanford Township, Pennsylvania,
of Medicine, United
Redwood City, https://ClinicalTrials.gov/show/NCT04378270
States|UPMC Aesthetic Plastic Surgery Center,
California, United States|Delta Waves Sleep
Pittsburgh,
Disorders andPennsylvania, United Colorado
Research Center, States
Springs, Colorado, United States|St Francis
Medical Institute, Clearwater, Florida, United https://ClinicalTrials.gov/show/NCT04482556
States|NeuroTrials Research, Inc., Atlanta,
Georgia, United States|Fort Wayne
Neurological Center, Fort Wayne, Indiana,
United States|Sleep Wake Disorders Center,
Bronx, New York, United States|CTI Clinical
Trial and Consulting Services, Cincinnati, Ohio,
United States|The Cleveland Clinic Foundation,
Cleveland, Ohio, United States|Ohio Sleep
Medicine Institute, Dublin, Ohio, United https://ClinicalTrials.gov/show/NCT04468204
States|Bogan Sleep Consultants, LLC,
Columbia, South Carolina, United States|Sleep
Therapy & Research
Metrohealth Medical Center,
Center, San Antonio,
Cleveland, Ohio,
Texas, United States https://ClinicalTrials.gov/show/NCT04500288
United States
Rehaklinik Zihlschlacht AG, Zihlschlacht,

Thurgau, Switzerland
UPMC Children's Hospital of Pittsburgh,

Pittsburgh, Pennsylvania, United States
Seoul National University Hospital, Seoul,

Other, Korea, Republic of
Prevention Point Philadelphia, Philadelphia,

Pennsylvania, United States
St. David's Medical Center, Austin, Texas,

United States
Universidade do Estado do Par찼, Bel챕m, Par

찼, Brazil
Weill Cornell Medicine, New York, New York,

United States
Cedars-Sinai Medical Center, Los Angeles,

California, United States
Kansas City Heart Rhythm Institute, Overland
Park, Kansas, United States
ProofPilot (Virtual Study:

https://p.proofpilot.com), New York, New https://ClinicalTrials.gov/show/NCT04471896
York, United States
University of Colorado, Hip Preservation

Center, Orthopedic Department, Boulder, https://ClinicalTrials.gov/show/NCT04516109
Colorado, United States
Stanford University Medical Center, Palo Alto,
California, United States|Yale University School
of Medicine, New Haven, Connecticut, United
States|Massachusetts General Hospital,
Boston, Massachusetts, United States|Duke
University Medical Center, Durham, North
Carolina, United States|MD Anderson Cancer
Center, Houston, Texas, United States
Barnes-Jewish Hospital, Saint Louis, Missouri,

United States
Peking University Shenzhen Hospital,
Shenzhen, China
Connecticut Children's Medical Center,

Hartford, Connecticut, United States
Bernafon AG, Bern, Switzerland https://ClinicalTrials.gov/show/NCT04374851
UPMC Magee Womens Hospital, Pittsburgh,

University of Minnesota, Minneapolis,

Minnesota, United States
Stanford, Stanford, California, United States https://ClinicalTrials.gov/show/NCT04471623

Yale-New Haven Hospital, New Haven,

Connecticut, United States|Mayo Clinic,
Rochester, Minnesota, United States|Duke https://ClinicalTrials.gov/show/NCT04468321
University Medical Center, Durham, North
Carolina, United States
Klick Inc., Toronto, Ontario, Canada https://ClinicalTrials.gov/show/NCT04529239

SF General Hospital, San Francisco, California,
United States|SF VA Health Care Center, San
Francisco, California, United States|UCSF
Medical Center, San Francisco, California, https://ClinicalTrials.gov/show/NCT04514861
United States|Rocky Mountain Regional VA
Medical Center, Aurora, Colorado, United
States
Mayo Clinic in Rochester, Rochester,
Mount Sinai West Hospital, New York, New

York, United States
Childrens Healthcare of Atlanta, Atlanta,

Georgia, United States
Hillel Yafe al Center, Hadera, Israel https://ClinicalTrials.gov/show/NCT04229316
University of Pennsylvania, Philadelphia,

Hospital, Albany, Georgia, United States|The
University of Kansas Medical Center, Kansas
City, Kansas, United States|MedStar Health
Research Institute (Baltimore), Towson,
Maryland, United States|Massachusetts
General Hospital, Boston, Massachusetts,
United States|Brigham and Women's Hospital
(Boston MA), Boston, Massachusetts, United
States|Michigan Heart, Ypsilanti, Michigan,
United States|Minneapolis Heart Institute
Foundation, Minneapolis, Minnesota, United
States|North Memorial Health Heart &
Vascular Center, Robbinsdale, Minnesota,
United States|Mayo Clinic (Rochester MN),
Rochester, Minnesota, United States|Missouri https://ClinicalTrials.gov/show/NCT04496518
Cardiovascular Specialists, Columbia, Missouri,
United States|Washington University School of
Medicine, Saint Louis, Missouri, United States|
Presbyterian Heart Group, Albuquerque, New
Mexico, United States|Huntington Hospital,
Huntington, New York, United States|Hudson
Valley Heart Center, Poughkeepsie, New York,
United States|WakeMed Health & Hospitals,
Raleigh, North Carolina, United States|
Northeast Ohio Cardiovascular Specialists,
Akron, Ohio, United States|The Christ Hospital
Health Network, Cincinnati, Ohio, United
States|University of Cincinnati, Cincinnati,
Ohio, United States|Geisinger Medical Center,
Geneva University Hospital, Geneva,
Switzerland
University Hospital Zurich /ID# 223035,

Zurich, Zuerich, Switzerland|Luzerner
Kantonsspital /ID# 223038, Luzern,
Switzerland
University Hospital Centre Zagreb,

Department of Orthopaedic Surgery, Zagreb, https://ClinicalTrials.gov/show/NCT04197284
Croatia
Vrouwenkliniek - Universitair Ziekenhuis Gent
(UZ Gent), Gent, Oost-Vlaanderen, Belgium|
Femicare VZW & Departement Verloskunde &
Gynaecologie - Regionaal Heilig Hart https://ClinicalTrials.gov/show/NCT04530201
Ziekenhuis Tienen, Tienen, Vlaams-Brabant,
Belgium|Gyn챕cologie-obst챕trique - CHU de
Li챔ge, Li챔ge, Belgium
Washington University School of Medicine,

Saint Louis, Missouri, United States
Panama Eye Center, Panama City, Panama https://ClinicalTrials.gov/show/NCT04524416
Dartmouth-Hitchcock Medical Center,

Lebanon, New Hampshire, United States
H척pital Princesse Paola, Aye, Belgium|CH
Alpes L챕man, Contamine-sur-Arve, France|
Hopital Renee Sabran, Hy챔res, France|
Clinique Basseres Kacem-Boudhar, N챤mes, https://ClinicalTrials.gov/show/NCT04349046
France|H척pitaux Du L챕man, Thonon-les-
Bains, France|CH Annecy Genevois, 횋pagny,
France
St. Peter's Hospital, Albany, New York, United

States|Samaritan Hospital Hildegard Medicus https://ClinicalTrials.gov/show/NCT04432727
Cancer Center, Troy, New York, United States
Stanford University, Stanford, California,

United States
The University of Texas Health Science Center

at Houston, Houston, Texas, United States
UZ Leuven, Leuven, Belgium https://ClinicalTrials.gov/show/NCT04225520
University of North Carolina at Chapel Hill-

Psychiatry Outpatient Clinic, Chapel Hill, North https://ClinicalTrials.gov/show/NCT04485455
Erasmus Medical Center, Rotterdam,
Netherlands
Haugesund Hospital, Haugesund, Norway|St

Olavs Hospital, Trondheim, Norway
Omaha VA Nebraska-Western Iowa Health

Care System, Omaha, NE, Omaha, Nebraska, https://ClinicalTrials.gov/show/NCT04337554
United States
Mayo Clinic in Florida, Jacksonville, Florida,

United States
Dartmouth-Hitchcock Medical Center Heater

Road Clinic, Lebanon, New Hampshire, United https://ClinicalTrials.gov/show/NCT04223570
States
Noguchi Memorial Institute for Medical
Research, University of Ghana, Legon, Accra, https://ClinicalTrials.gov/show/NCT04093076
Ghana
Saint Joseph's Medical Center, Stockton,
California, United States|Bay Area Cardiology
Associates PA, Brandon, Florida, United States|
Florida Heart Center, Fort Pierce, Florida,
United States|Baptist Health, Jacksonville,
Florida, United States|Iowa Heart Center, West
Des Moines, Iowa, United States|Minneapolis
Heart Institute Foundation, Minneapolis,
Minnesota, United States|North Memorial
Health Heart & Vascular Center, Robbinsdale,
Minnesota, United States|University of
Mississippi
RC2NB, Basel,Medical Center, Jackson,
Switzerland https://ClinicalTrials.gov/show/NCT04413032
Mississippi, United States|Cardiology
Associates of North Mississippi, Tupelo,
Mississippi, United States|Missouri
Cardiovascular Specialists, Columbia, Missouri,
United States|Lourdes Cardiology Services,
Voorhees, New Jersey, United States|Columbia
University, New York, New York, United
States|Cone Health, Greensboro, North
Carolina, United States|Doylestown Health
Cardiology a division of Doylestown Health https://ClinicalTrials.gov/show/NCT04480385
Physicians, Doylestown, Pennsylvania, United
States|Cardiology Consultants of Philadelphia,
Philadelphia,
Mayo Clinic inPennsylvania, United States|
Florida, Jacksonville, Florida,
Medical University of South Carolina, https://ClinicalTrials.gov/show/NCT04352140
United States
Charleston, South Carolina, United States|The
Stern Cardiovascular Foundation,
Germantown, Tennessee, United States|
University of Tennessee Methodist Physicians,
Memphis, Tennessee, United States|Tyler
Cardiovascular Consultants, Tyler, Texas,
Penn
UnitedState HersheyVirginia
States|West MedicalUniversity,
Center, Hershey,
Pennsylvania,
Morgantown, United States United States
West Virginia,
UF Health at the University of Florida,

Gainesville, Florida, United States|McKnight
Brain Institute--Fixel Center for Neurological
Diseases, Gainesville, Florida, United States
University Hospital of Heidelberg, Radiation
Oncology, Heidelberg, Germany
The First Affiliated Hospital of Xi'an Jiaotong

University, Xi'an, Shaanxi, China
University of Florida, Gainesville, Florida,

United States
The University of Texas Health Science Center

at Houston, Houston, Texas, United States
CloudCath Investigational Site, Lakewood,

Colorado, United States
Sharp Memorial Hospital, San Diego,

Hacettepe University, Ankara, Turkey https://ClinicalTrials.gov/show/NCT04014998
University of North Carolina at Chapel Hill,

Chapel Hill, North Carolina, United States
Better Health Clinical Research, Inc, Newnan,

Georgia, United States|Neuroscience Research
Center, LLC, Overland Park, Kansas, United https://ClinicalTrials.gov/show/NCT04341948
States|Ochsner Clinic Foundation, New
Orleans, Louisiana, United States
Montefiore Medical Center, Bronx, New York,

United States
AdventHealth Diabetes Institute, Orlando,
Florida, United States|Mayo Clinic, Rochester,
Minnesota, United States|University of https://ClinicalTrials.gov/show/NCT04016662
Pennsylvania, Philadelphia, Pennsylvania,
United States
Penn State Health Milton S. Hershey Medical

Center, Hershey, Pennsylvania, United States
Louis Stokes VA Medical Center, Cleveland,
OH, Cleveland, Ohio, United States
Medical College of Wisconsin, Milwaukee,

Wisconsin, United States
Beth Israel Deaconess Medical Center, Boston,

Massachusetts, United States
Rigshospitalet, Copenhagen, Denmark https://ClinicalTrials.gov/show/NCT04502654
Link철ping University Hospital, Link철ping,

Sweden|Skane University Hospital, Lund,
Sweden|횜rebro University Hospital, 횜rebro,
Sweden
Geisinger Medical Center, Danville,

Horizon Medical Center, Schaumburg, Illinois,

United States
Cleveland Clinic Fairview Hospital, Cleveland,

Ohio, United States
University of Louisiana Monroe College of

Pharmacy, Monroe, Louisiana, United States

United States|University of Colorado Denver,
Denver, Colorado, United States|Yale
University School of Medicine, New Haven,
Connecticut, United States|Atlanta Diabetes,
Atlanta, Georgia, United States|Joslin Diabetes
Center, Boston, Massachusetts, United States|
International Diabetes Center, Saint Louis https://ClinicalTrials.gov/show/NCT04476472
Park, Minnesota, United States|SUNY
Syracuse, Syracuse, New York, United States|
University
OHSU, Hospitals
Portland, Cleveland,
Oregon, UnitedCleveland,
States https://ClinicalTrials.gov/show/NCT04529655
Ohio, United States|Baylor College of
Medicine, Houston, Texas, United States|
Blanchfield
University ofArmy Community
Virginia, HospitalVirginia,
Charlottesville, (BACH),
Fort Campbell
United States North, Kentucky, United States
University of Arizona, Tucson, Arizona, United

States|University of Florida McKnight Brain https://ClinicalTrials.gov/show/NCT04018092
Institute, Gainesville, Florida, United States
University of Calgary, Calgary, Alberta,

Canada|GF Strong Rehab Centre, Vancouver,
British Columbia, Canada|Riverview Health
Centre, Winnipeg, Manitoba, Canada|
Dalhousie University, Halifax, Nova Scotia,
Canada|Parkwood Institute, London, Ontario,
Canada|Toronto Rehabilitation Institute -
University Health Network, Toronto, Ontario,
Canada|Sunnybrook Health Sciences Centre,
Toronto, Ontario, Canada
Mayo Clinic in Florida, Jacksonville, Florida,

United States
Innovation Research Center, Pleasanton,

Kantonsspital Baden, Baden, Switzerland https://ClinicalTrials.gov/show/NCT04480437

Shatin Hospital, Hong Kong, Hong Kong https://ClinicalTrials.gov/show/NCT04525924

Hazm Mebaireek General Hospital (HMGH),

Doha, Qatar
Iowa Methodist Medical Center, Des Moines,

Iowa, United States
Urology Partners of North Texas, Arlington,
Texas, United States
University of Rochester Medical Center,

Rochester, New York, United States
Sheba Medical Center, Ramat Gan, Israel https://ClinicalTrials.gov/show/NCT03708809
Department of Communication Sciences and

Disorders, ECU, Greenville, North Carolina, https://ClinicalTrials.gov/show/NCT03870217
United States
Duke University, Durham, North Carolina,

United States
Arizona State University, Tempe, Arizona,

United States|California Polytechnic University
San Luis Obispo, San Luis Obispo, California,
United States
Department of Clinical Pharmacology, Medical

University of Vienna, Vienna, Austria
Perry Community Hospital, Linden, Tennessee,

United States
CHU de Brest, Brest, France https://ClinicalTrials.gov/show/NCT04341350
Weill Cornell Medicine, New York, New York,

United States
Wake Forest Baptist Health, Winston-Salem,

North Carolina, United States
Ordination Dr. Petra Zieglmayer Vienna

Challenge Chamber, Vienna, Austria
Duke Eye Center, Durham, North Carolina,

United States
Shanghai Tongji Hospital, Shanghai, Shanghai,

China, China|Shanghai Oriental Hospital,
Shanghai, Shanghai, China, China|Renji
hospital, School of Medicine, Shanghai
Jiaotong University, Shanghai, Shanghai,
China, China
NYU Langone Health, New York, New York,
United States
USC Roski Eye Institute, Los Angeles,

NorthShore University Health System,
Evanston, Illinois, United States|Northwell
Health, New Hyde Park, New York, United
States|University of Pennsylvania, Philadelphia,
Pennsylvania, United States|MD Anderson
Cancer Center, Houston, Texas, United States
Department of Orthopaedics and Trauma
Surgery (DOTS)., Basel, Switzerland
Khoo Teck Phuat Hospital, Singapore,

Singapore|National University Hospital,
Singapore, Singapore|Ng Teng Fong General
Hospital, Singapore, Singapore|Sengkang https://ClinicalTrials.gov/show/NCT04511247
General Hospital,
Khoo Teck Singapore,
Phuat Hospital, Singapore|
Singapore,
Singapore General Hospital,
Singapore|National UniversitySingapore,
Hospital,
Singapore
Singapore, Singapore|Ng Teng Fong General
Hospital, Singapore, Singapore|Sengkang https://ClinicalTrials.gov/show/NCT04511234
General Hospital, Singapore, Singapore|
Singapore General Hospital, Singapore,
Singapore
Na Homolce Hospital, Praha, Czechia https://ClinicalTrials.gov/show/NCT04463121

OLV Aalst, Aalst, Belgium|Southlake Regional
Health Centre, Newmarket, Canada|University
Hospital Center Split, Split, Croatia|Nemocnice
na Homolce, Prague, Czechia|Ospedale https://ClinicalTrials.gov/show/NCT04524364
Generale Regionale "F. Miulli", Acquaviva
Delle Fonti (Bari), Italy|Vilnius University
Hospital, Vilnius, Lithuania
Rush University Medical Center, Chicago,

Illinois, United States
H척pital de la Fondation Rothschild, Paris,

France|Vall
Lucile d'Hebron
Packard University
Children's Hospital,
Hospital Stanford, https://ClinicalTrials.gov/show/NCT04236856
Barcelona, Spain
Palo Alto, California, United States|Lurie
Children's Hospital of Chicago, Chicago,
Illinois, United States|Massachussetts Eye and
Ear Harvard Medical School, Boston, https://ClinicalTrials.gov/show/NCT04322994
Massachusetts, United States|Cincinnati
Children's Hospital, Cincinnati, Ohio, United
States|The University of Virginia,
Charlottesville, Virginia, United States https://ClinicalTrials.gov/show/NCT04491136
Columbia University Irving Medical

Center/NYPH, New York, New York, United https://ClinicalTrials.gov/show/NCT04118764
States
General Hospital of Northern Theater

Command, ShenYang, China
Northwestern University, Chicago, Illinois,
United States
Rehab Abd Elraof Abd Elaziz, Alexandria,

Egypt
Luis Mendes, Paulista, Pernambuco, Brazil https://ClinicalTrials.gov/show/NCT04507490
University of Pennsylvania Abramson Cancer

Center, Philadelphia, Pennsylvania, United https://ClinicalTrials.gov/show/NCT04482855
States
Shirley Ryan AbilityLab, Chicago, Illinois,

United States
HIV/AIDS Clinical Research Unit / University of

Pittsburgh, Pittsburgh, Pennsylvania, United https://ClinicalTrials.gov/show/NCT04302896
States
Emirates Integrated Telecommunication
Company (Du), Headquarters Building., Dubai, https://ClinicalTrials.gov/show/NCT04403789
Dubai Internet City, United Arab Emirates
Providence Access Care, Providence, Rhode

Island, United States
sakarya University, Sakarya, Turkey https://ClinicalTrials.gov/show/NCT04445675
St Luke's Hospital, Bukit Batok New Town,

Bukit Batok, Singapore|Kwong Wai Shiu https://ClinicalTrials.gov/show/NCT04490655
Hospital, Serangoon, Singapore
University Hospital of the West Indies, Mona,

Kingston, Jamaica
University Hospital Zurich, Zurich, Switzerland https://ClinicalTrials.gov/show/NCT04373070

Adler Institute for Advanced Imaging,
Jenkintown, Pennsylvania, United States
University of California, San Francisco, San

Francisco, California, United States
MUW/AKH, Vienna, Austria|MUW/AKH,

Vienna, Austria
Cedars-Sinai Medical Center, Los Angeles,


United States
UCSF Tobacco Research Center, San Francisco,

California, United States|Zuckerberg San
Francisco General Hospital - CTSI, San
Second Hospital of Hebei Medical University,

Shijiazhuang, Hebei, China
Chu Clermont Ferrand, Clermont-Ferrand,

France
Yale University, New Haven, Connecticut,

United States
Rennes University Hospital, Rennes, Bretagne,
France
Virginia Commonwealth University, Richmond,

Virginia, United States
University of Nebraska Medical Center,

Omaha, Nebraska, United States
Azsintjan, Brugge, Belgium https://ClinicalTrials.gov/show/NCT03660891
University Hospital of Bonn, Bonn, Northrhine

Westfalia, Germany
The University of Denver, Frontier Hall,

Denver, Colorado, United States

Konya Education and Training Hospital,

Konya, Turkey
Christiana Care Health Systems, Newark,
Delaware, United States
Malcolm Randall VA medical center,

Gainesville, Florida, United States
UPMC Montefiore Hospital, Pittsburgh,

Behavioral Medicine Research Lab, Baltimore,

Maryland, United States
Moffitt Cancer Center, Tampa, Florida, United

States
Ohio State University Comprehensive Cancer

Center, Columbus, Ohio, United States
Edward Hines Jr. VA Hospital, Hines, IL, Hines,
Illinois, United States
London Health Sciences Centre, London,

Ontario, Canada

Westchester Research Center, Miami, Florida,

United States
Avant Sante Site 1, Monterrey, Mexico https://ClinicalTrials.gov/show/NCT04480138
UF Clinical Research Center, Gainesville,

Florida, United States
Medical Department of Hepatology and

Gastroenterology, Charit챕 University
Medicine, Campus Virchow Klinikum (CVK) https://ClinicalTrials.gov/show/NCT04500418
and Campus Charit챕 Mitte (CCM), Berlin,
Germany
Northeastern University, Boston,

Lucile Packard Children's Hospital Stanford,

Palo Alto, California, United States
Clinical Physiology Laboratory, Edmonton,

Alberta, Canada
Sansum Diabetes Research Institute, Santa
Barbara, California, United States|Stanford
University, Stanford, California, United States|
Joslin Diabetes Center, Boston, Massachusetts,
United States|Mayo Clinic, Rochester,
Minnesota, United States|Icahn School of
Medicine at Mount Sinai, New York, New
York, United States
Vue Optical Boutique, Jacksonville, Florida, https://ClinicalTrials.gov/show/NCT04494685

United States|Maitland Vision Center,
Maitland, Florida, United States|Tallahassee
Eye Center, Tallahassee, Florida, United States|
VisionPoint Eye Center, Bloomington, Illinois,
United States|ProCare Vision Centers,
Granville, Ohio, United States|EyeCare
Professionals of Powell, Powell, Ohio, United
States|Frazier Vision, Inc., Tyler, Texas, United
States
Cincinnati Children's Hospital Medical Center,

Cincinnati, Ohio, United States
Cleveland Clinic, Cleveland, Ohio, United

States
Sanglah General Hospital, Denpasar, Bali,

Indonesia
Department of Anesthesiology and Pain
Medicine, Yonsei University College of https://ClinicalTrials.gov/show/NCT04499222
Medicine, Seoul, Korea, Republic of
University of Waterloo, Waterloo, Ontario,

Canada
Odense University Hospital, Odense, Denmark https://ClinicalTrials.gov/show/NCT04460482
Scripps Poway Eyecare, San Diego, California,

United States|Golden Optometric Group,
Whittier, California, United States|Golden
Vision, Sarasota, Florida, United States|Kannarr https://ClinicalTrials.gov/show/NCT04449263
Eye Care, Pittsburg, Kansas, United States|
ProCare Vision Center, Granville, Ohio, United
States
Massachusetts General Hospital, Charlestown,
Atlanta VA Medical and Rehab Center,

Decatur, GA, Decatur, Georgia, United States
Lyndon Jones, Waterloo, Ontorio, Canada https://ClinicalTrials.gov/show/NCT04404725
The University of Alabama at Birmingham,

Birmingham, Alabama, United States

Department of Orthopaedics, Molndal, V채stra

G철taland, Sweden|Sahlgrenska University https://ClinicalTrials.gov/show/NCT04350255
Hospital, Gothenburg, Sweden
St. Jude Children's Research Hospital,
Memphis, Tennessee, United States
University of Michigan, Ann Arbor, Michigan,

United States
Penn Pain Medicine Center, Philadelphia,

Azsintjan, Brugge, Belgium https://ClinicalTrials.gov/show/NCT04170322
The Johns Hopkins Hospital, Baltimore,

Maryland, United States|Johns Hopkins
Hospital Bayview Asthma and Allergy Center,
Baltimore, Maryland, United States
First Affiliated Hospital of Xi 'an Jiaotong

University, Xi'an, Shaanxi, China
Vienna Challenge Chamber, Vienna, Austria https://ClinicalTrials.gov/show/NCT04532762
Culicchia Neurological Clinic, Marrero,

Louisiana, United States
El Paso Eye Surgeons, El Paso, Texas, United

States
Imperial College Healthcare NHS Trust,
London, Non-US/Non-Canadian, United https://ClinicalTrials.gov/show/NCT04529408
Kingdom
Perich Eye Center, New Port Richey, Florida,

United States
Research Institute for Complex Issues of

Cardiovascular Diseases, Kemerovo, Russian https://ClinicalTrials.gov/show/NCT04522609
Federation
Albany Medical Center, Albany, New York,

United States
Cancer Hospital, Chinese Academy of Medical

Sciences, Beijing, Beijing, China|The First
Affiliated Hospital of Fujian Medical
University, Fuzhou, Fujian, China|Sun Yat-sen
University Cancer Center, Guangzhou,
Guangdong, China|Henan Cancer Hospital,
Zhengzhou, Henan, China|Zhongda Hospital
Southeast University, Nanjing, Jiangsu, China|
The Second Affiliated Hospital of Soochow
University, Suzhou, Jiangsu, China|Shandong
Provincial Hospital, Jinan, Shandong, China| https://ClinicalTrials.gov/show/NCT04520906
Ruijin Hospital,Shanghai Jiao Tong University
School of Medicine, Shanghai, Shanghai,
China|Fudan University Shanghai Cancer
Center, Shanghai, Shanghai, China|Zhongshan
Hospital, Shanghai, Shanghai, China|Renji
Hospital, Shanghai Jiao Tong University
School of Medicine, Shanghai, Shanghai,
China|Zhejiang Cancer Hospital, Hangzhou,
Zhejiang, China|The Central Hospital of Lishui
City, Lishui, Zhejiang, China
Siperstein Dermatology Group, Boynton

Beach, Florida, United States
United States
University Hospital T체bingen, T체bingen,

Baden-W체rttemberg, Germany
National Taiwan University Hospital, Taipei,

Taiwan
University of Pittsburgh, Pittsburgh,

University of Virginia Center for Diabetes

Technology, Charlottesville, Virginia, United https://ClinicalTrials.gov/show/NCT04510506
States
University of Health Siences Diskapi Yildirim

Beyazit T&R hospital, Ankara, Turkey
University Hospital T체bingen, Department of

Radiation Oncology, T체bingen, Baden-W체 https://ClinicalTrials.gov/show/NCT04506476
rttemberg, Germany
Radboud university medical center, Nijmegen,
Gelderland, Netherlands
Palo Alto Medical Foundation - San Carlos

Center, San Carlos, California, United States
Seoul National University Hospital, Seoul,

Korea, Republic of
Ryan Zarzycki, Glenside, Pennsylvania, United

States
Tandem Diabetes, San Diego, California,

United States
Neuromotor Recovery and Rehabilitation Lab,

Pittsburgh, Pennsylvania, United States
Hvidovre University Hospital, Copenhagen,

Denmark
Harvard Eye Associates, Laguna Hills,

California, United States|Quentin Allen, Palm
City, Florida, United States|Quantum Vision
Center, Edwardsville, Illinois, United States
University of Manchester, Manchester,

Lancashire, United Kingdom|University of https://ClinicalTrials.gov/show/NCT04493775
Leeds, Leeds, West Yorkshire, United Kingdom
Institute of Progressive Medicine, South
Pasadena, California, United States
Neurological Associates of West Los Angele,

Santa Monica, California, United States
University of Michigan, Ann Arbor, Michigan,

United States
Orthop채dische Klinik der Medizinischen

Hochschule Hannover im DIAKOVERE https://ClinicalTrials.gov/show/NCT04468178
Annastift, Hanover, Niedersachsen, Germany
Duke University Medical Center, Durham,

North Carolina, United States
UCSF Sandler Neurosciences Center, San


Allegheny General Hospital, Pittsburgh,

Federal Research Clinical Center FMBA Russia,

Moscow, Russian Federation
The University of Texas Medical Branch,

Galveston, Texas, United States
King Saud University, Riyadh, Saudi Arabia https://ClinicalTrials.gov/show/NCT04449770

CHU Saint-Etienne, Saint-횋tienne, France https://ClinicalTrials.gov/show/NCT04439409
Northwell Health Comprehensive Wound Care

Center, Lake Success, New York, United States
AMA Eye Research Institute, Marysville, Ohio,

United States
Boston Children's Hospital, Boston,

Franciele Marques Vanderlei, Presidente
Prudente, SP, Brazil
Progressive Medical Research, Port Orange,

Florida, United States|Dr. Michael Zahavi, https://ClinicalTrials.gov/show/NCT04418505
Oshawa, Ontario, Canada
Helsinki Univeristy Hospital, Helsinki, Finland https://ClinicalTrials.gov/show/NCT04408482

UNC Hospitals, Chapel Hill, North Carolina,

United States
Geriatrische Klinik, Sankt Gallen, SG,

Switzerland
The Alfred Hospital, Melbourne, Victoria,

Australia
Kwong Wah Hospital, Hong Kong, Kowloon,

China|Queen Elizabeth Hospital, Hong Kong,
Kowloon, China|Tseung Kwan O Hospital,
Hong Kong, China
Emory University Hospital, Atlanta, Georgia,
United States
Nair Research, LLC, Jonesboro, Arkansas,

United States|University of Iowa Hospitals and
Clinics, Iowa City, Iowa, United States|Aultman
Hospital, Canton, Ohio, United States|Saint
Thomas Health, Nashville, Tennessee, United https://ClinicalTrials.gov/show/NCT04346537
States|Sentara Norfolk General Hospital,
Norfolk, Virginia, United States|PeaceHealth
Southwest Medical, Bellingham, Washington,
United States
Carilion Institute for Orthopaedics &

Neurosciences, Roanoke, Virginia, United https://ClinicalTrials.gov/show/NCT04339439
States

Mayo Clinic, Rochester, Minnesota, United

States|Washington University in St. Louis, https://ClinicalTrials.gov/show/NCT04322448
Clinical Hospital Centre Zagreb, Croatia,

Zagreb, Croatia
Hospital Alvorada Moema, S찾o Paulo, SP,

Brazil|Hospital Israelita Albert Einstein (HIAE),
S찾o Paulo, SP, Brazil|Hospital Municipal Dr.
Moyses Deutsch, S찾o Paulo, SP, Brazil
St Barbara Klinik, Hamm, Germany|Azienda
Ospedaliero-Universitaria Consorziale
Policlinico, Bari, Italy|Ospedale di Treviso, https://ClinicalTrials.gov/show/NCT04300075
Treviso, Italy|Azienda Sanitaria Universitaria
Integrata di Udine, Udine, Italy
Erasme Hospital, Brussels, Belgium https://ClinicalTrials.gov/show/NCT04262323
Elisabeth Bruy챔re Hospital, Ottawa, Ontario,

Canada
Tan Tock Seng Hospital Rehabilitation Centre,

Singapore, Singapore
Auckland City Hospital, Auckland, New

Zealand
Boston Children's Hospital, Boston,

Massachusetts, United States|Cincinnati
Children's Hospital Medical Center, Cincinnati,
Ohio, United States
Grady Health System, Atlanta, Georgia, United

States
Siperstein Dermatology, Boynton Beach,
Florida, United States
Centre Hospitalier de l'Universit챕 de Montr챕

al, Montr챕al, Quebec, Canada

UF Health Jacksonville, Jacksonville, Florida,

United States
Karolinska University Hospital, Stockholm,

Sweden
DHR Health Neuroscience Institute, Edinburg,

Texas, United States
VA Greater Los Angeles Healthcare System,

Los Angeles, California, United States|Ronald
Reagan UCLA Medical Center, Los Angeles,
Faculty of Medicine, Aexandria University,

Alexandria, Egypt
CMMR, Minneapolis, Minnesota, United States https://ClinicalTrials.gov/show/NCT03192007

Laboratory of Interdisciplinary Clinical
Neurosciences, Department of Psychiatry,
Federal University of Sao Paulo, Sao Paulo,
Brazil
University of Nove de Julho (UNINOVE), S찾o

Paulo, Brazil
Imam Abdulrahman Bin Faisal University,

Dammam, Eastern, Saudi Arabia
Emory University Hospital Midtown, Atlanta,

Georgia, United States|Emory University
Hospital, Atlanta, Georgia, United States|Grady https://ClinicalTrials.gov/show/NCT04416269
Memorial Hospital, Atlanta, Georgia, United
States
University of Virginia Center for Diabetes

Technology, Charlottesville, Virginia, United https://ClinicalTrials.gov/show/NCT04443153
States
Chang Gung Memorial Hospital, Taoyuan City,

Taiwan
University at Buffalo, The Center for Dental

Studies, Buffalo, New York, United States
Bezmialem Vak캇f University, Istanbul, Turkey https://ClinicalTrials.gov/show/NCT04352192
University of Oklahoma Health Sciences

Center, Oklahoma City, Oklahoma, United https://ClinicalTrials.gov/show/NCT04395274
States
City of Hope Comprehensive Cancer Center,

Duarte, California, United States
Universiti Sains Malaysia, Health Campus,
Kubang Kerian, Kelantan, Malaysia
Dongzhimen Hospital, Beijing, Beijing, China|

Institute of acupuncture and moxibustion,
Beijing, Beijing, China|Kyung Hee University https://ClinicalTrials.gov/show/NCT04509817
Hospital at Gangdong, Seoul, Korea, Republic
of
Walter Reed National Military Medical Center,

Bethesda, Maryland, United States
Brigham and Women's Hospital, Boston,

University of Miami, Miami, Florida, United
States
Emory Clinic, Atlanta, Georgia, United States|

Grady Health System (non-CRN), Atlanta, https://ClinicalTrials.gov/show/NCT04473430
Sunnybrook Health Sciences Centre, Toronto,

Ontario, Canada
Emory University Hospital, Atlanta, Georgia,

United States
Oslo University Hospital, Rikshospitalet, Oslo,

Norway
Department of Diabetes, Endocrinology,

Clinical Nutrition and Metabolism, Inselspital, https://ClinicalTrials.gov/show/NCT04361799
Bern University Hospital, Bern, Switzerland
VA Ann Arbor Healthcare System, Ann Arbor,

MI, Ann Arbor, Michigan, United States|John
D. Dingell VA Medical Center, Detroit, MI,
Detroit, Michigan, United States

Geisinger Medical Center, Danville,
Pennsylvania, United States|Geisinger
Wyoming Valley Medical Center, Wilkes-Barre,
Pennsylvania, United States|Geisinger South
Wilkes Barre, Wilkes-Barre, Pennsylvania,
United States
Tongji Hospital,Tongji medical college,HUST,

Wuhan, Hubei, China
Taipei Medical University-Shuang Ho
Hospital,Ministry of Health and Welfare, New
Taipei City, Taiwan|Taipei Medical University
Hospital, Taipei, Taiwan|Taipei Municipal
Wanfang Hospital - Taipei Medical University,
Taipei, Taiwan
Ordu University, Ordu, Turkey https://ClinicalTrials.gov/show/NCT04507009
Montefiore Medical Center - Einstein Division,

Bronx, New York, United States|Montefiore
Medical Center - Wakefield Division, Bronx,
New York, United States
Johns Hopkins Hospital, Baltimore, Maryland,

United States
Wake Forest University Health Sciences,

Winston-Salem, North Carolina, United States
Stanford University School of Medicine,

Stanford, California, United States
California, United States|University of
California Davis Medical Center, Sacramento,
California, United States|Mercy General
Hospital and Dignity Health Medical
Foundation, Sacramento, California, United
States|Stanford University Medical Center,
Stanford, California, United States|UCHealth
Medical Center, Fort Collins, Colorado, United
States|MedStar Georgetown University
Hospital and Medical Center, Washington,
District of Columbia, United States|Tampa
Cardiac Specialists, Tampa, Florida, United
States|AMITA Mercy Medical Center,
Naperville, Illinois, United States|Brigham and
Women's Hospital, Boston, Massachusetts, https://ClinicalTrials.gov/show/NCT04505163
United States|Beth Israel Deaconess Medical
Center, Boston, Massachusetts, United States|
Albert Einstein College of Medicine &
Montefiore Medical Center, Bronx, New York,
United States|Staten Island University
Hospital, Staten Island, New York, United
States|Bethesda North Hospital, Cincinnati,
Ohio, United States|Ohio Health Physician
Group, Columbus, Ohio, United States|St.
Thomas Heart, Nashville, Tennessee, United
States|Texas Cardiac Arrhythmia Institute & St.
David's Medical Center, Austin, Texas, United
States|Heart Center, Japan Red Cross
Yokohama City Bay Hospital, Yokohama City,
Universit채tsklinikum Carl Gustav Carus https://ClinicalTrials.gov/show/NCT04486859

Dresden Klinik und Polyklinik f체r
Augenheilkunde, Dresden, Germany|Universit
채tsklinikum
University of Klinik f체r Augenheilkunde
Washington, Seattle,
Freiburg, Freiburg, Germany|Hannover MHH https://ClinicalTrials.gov/show/NCT04467437
Washington, United States
Universit채tsklinik f체r Augenheilkunde,
Hannover, Germany|University Hospital of
Leipzig Department of Ophthalmology,
Leipzig, Germany|Klinikum der Stadt https://ClinicalTrials.gov/show/NCT04444492
Ludwigshafen Augenklinik, Ludwigshafen,
Germany|Universit채tsklinikum Gie횩en und
Marburg GmbH, Standort Marburg Klinik f체r
Augenheilkunde, Marburg, Germany| https://ClinicalTrials.gov/show/NCT04416724
Augenzentrum am St. Franziskus-Hospital M
체nster, M체nster, Germany|Universit채
tsklinikum Klinik f체r Augenheilkunde, M체
Allegheny Health Network, Pittsburgh,
nster, Germany https://ClinicalTrials.gov/show/NCT04388332
University of Florida, Gainesville, Florida,
United States
Medical University of South, Charleston, South

Univeristy of North Carolina Chapel Hill,

Cleveland Clinic, Case Comprehensive Cancer

Center, Cleveland, Ohio, United States
University of Alabama at Birmingham,

Birmingham, Alabama, United States|
University of Tennessee Health Science
Center, Memphis, Tennessee, United States
Mike O'Callaghan Military Medical Center,

Nellis Air Force Base, Nevada, United States
The University of Michigan, Ann Arbor,

Michigan, United States
PMG Research, Statesville, North Carolina,

United States
Department of Nutrition, Exercise and Sports,

UCopenhagen, Copenhagen, Denmark
Geisinger, Danville, Pennsylvania, United

States
Wake Forest University Health Sciences,
Cambridgeshire and Peterborough NHS

Foundation Trust, Cambridge, United https://ClinicalTrials.gov/show/NCT04464538
Kingdom
Center for Interdisciplinary Research on

Nicotine Addiction, University of Pennsylvania, https://ClinicalTrials.gov/show/NCT03699865
Philadelphia, Pennsylvania, United States
University of Michigan Rogel Cancer Center,
Ann Arbor, Michigan, United States

TrueNorth Health Center, Santa Rosa,

Universit채tsklinikum Heidelberg, Heidelberg,

Germany
University Medical Centre Ljubljana, Ljubljana,

Slovenia
University Medical Center ljubljana, Ljubljana,

Slovenia
Wake Forest University School of Medicine,
University of Iowa, Iowa City, Iowa, United

States|Cooper University Hospital/Cooper
Medical School of Rowan University, Camden,
New Jersey, United States
University of Iowa Health Care, Iowa City,

Iowa, United States
Atlantia Food Clinical Trials, Cork, Ireland https://ClinicalTrials.gov/show/NCT04529473
Hospital of the University of Pennsylvania,

Philadelphia, Pennsylvania, United States

Centre Hospitalier de l'Universit챕 de Montr챕

al (CHUM), Montr챕al, Quebec, Canada
Ambulatorio Telemedicina Giardino St Lucia,
Massa Lombarda, Ravenna, Italy
The N.1 Institute for Health, Singapore,

Singapore|National University Hospital, https://ClinicalTrials.gov/show/NCT04522284
Singapore, Singapore
Faculty of Medicine, Cairo, Egypt https://ClinicalTrials.gov/show/NCT04417179
Spaulding Hospital Cambridge, Cambridge,

Poznan University of Physical Education,

Pozna흦, Poland
AZ Nikolaas, Sint-Niklaas, Belgium https://ClinicalTrials.gov/show/NCT04511364
Shepherd Center, Atlanta, Georgia, United

States
Chu Clermont Ferrand, Clermont-Ferrand,

France
Wei Wen Wu, Taipei, Taiwan https://ClinicalTrials.gov/show/NCT04353063
Denver, Colorado, United States|University of
Florida Health - Shands Hospital - Division of
Infectious Diseases and Global Medicine,
Gainesville, Florida, United States|University of
Florida Health - Jacksonville - Department of
Emergency Medicine, Jacksonville, Florida,
United States|Emory Vaccine Center - The
Hope Clinic, Decatur, Georgia, United States|
Atlanta VA Medical Center - Infectious
Diseases
Radboudumc, Clinic,Nijmegen,
Decatur, Georgia,
Gelderland,United
States|Tripler https://ClinicalTrials.gov/show/NCT04478981
Netherlands Army Medical Center (TAMC),
Honolulu, Hawaii, United States|Northwestern
Hospital - Infectious Disease, Chicago, Illinois,
United
MorganStates|University
Stanley Children's of Hopspital,
Illinois at Chicago
New
Division of Infectious Diseases, Chicago, https://ClinicalTrials.gov/show/NCT04531618
York, New York, United States
Illinois, United States|Ochsner Medical Center
- Kenner - Department of Infectious Diseases,
Kenner, Louisiana, United States|Southeast
CHU Hopital
Louisiana Hautepierre,
Veterans Health Strasbourg,
Care SystemFrance
- https://ClinicalTrials.gov/show/NCT04199481
Section of Infectious Diseases, New Orleans,
Louisiana, United States|University of
Maryland School of Medicine - Center for
Vaccine Development - Baltimore, Baltimore, https://ClinicalTrials.gov/show/NCT04396405
Maryland, United States|Johns Hopkins
Hospital - Medicine - Infectious Diseases,
Baltimore, Maryland, United States|Walter
Reed National
University Military
Hospital Medical
Basel, Basel, Center,
Switzerland https://ClinicalTrials.gov/show/NCT04103255
Bethesda, Maryland, United States|National
Institutes of Health - Clinical Center, National
Institute of Allergy and Infectious Diseases
Laboratory Of Immunoregulation, Clinical https://ClinicalTrials.gov/show/NCT04464720
Research Section, Bethesda, Maryland, United
States|Massachusetts General Hospital -
Infectious Diseases, Boston, Massachusetts,
United States|University of Massachusetts
Medical School - Infectious Diseases and
Immunology, Worcester, Massachusetts,
United States|University of Minnesota Medical
Center, Fairview - Infectious Diseases and
International Medicine, Minneapolis,
Marlus
Minnesota,Karsten, Porto
United Alegre, Rio
States|Saint Grande Do
Louis
Sul, Brazil - Center for Vaccine Development,
University
Saint Louis, Missouri, United States|University
of Nebraska Medical Center - Infectious
Diseases, Omaha, Nebraska, United States|
University of New Mexico Clinical and
Brunel University
Translational London,
Science London,
Center, Middlesex,
Albuquerque,
United Kingdom
New Mexico, United States|Montefiore
Medical Center - Infectious Diseases, Bronx,
New York, United States|University of
RochesterdeMedical
Hospital Center - Vaccine
Alta Complejidad en RedResearch
El Cruce,
Unit, Rochester,
Florencio Varela,New York,
Buenos United
Aires, States|Duke
Argentina
Human Vaccine Institute - Duke Vaccine and
Trials Unit, Durham, North Carolina, United
States|Womack Army Medical Center -
Pulmonary and Respiratory Services, Fort
Bragg, North Carolina, United States|Kaiser
Bellefield Tower, Pittsburgh, Pennsylvania,
United States
St. Francis Medical Center, Lynwood,

Hadassah Medical Center, Jerusalem, Israel https://ClinicalTrials.gov/show/NCT04513470
Department of Health Science and

Technology, Aalborg University, Aalborg, https://ClinicalTrials.gov/show/NCT04509284
Northern Jutland, Denmark
City of Hope Comprehensive Cancer Center,
Duarte, California, United States
KGK Science
Emory Inc., London,
Saint Joseph's Ontario,
Hospital, Canada
Atlanta, https://ClinicalTrials.gov/show/NCT04465513
Georgia, United States|Emory University https://ClinicalTrials.gov/show/NCT04477330
Hospital Midtown, Atlanta, Georgia, United https://ClinicalTrials.gov/show/NCT04487886
States|Emory University
Beijing Tiantan Hospital,Hospital, Atlanta,China https://ClinicalTrials.gov/show/NCT04492241
Beijing, Beijing,

Ê Ë Ì Ì Ë Ê °ê ° Ì Ì Ì Í Ë Ë¡ Í Í © ('20.08)

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Ê Ë Ì Ì Ë Ê °ê ° Ì Ì Ì Í Ë Ë¡ Í Í © ('20.08)

Uploaded by

Copyright:

Available Formats

국내·외 의료기기 임상시험 등록현황

1. 의료기기 임상시험 단계별 진행 현황(총 512건)

험 단계별 진행 현황(총 512건)

PMCF Study of LiquiBand FIX8짰 OHMF Device Not yet recruiting

Validation of a Novel Foot Offloading Device Not yet recruiting

Comparison of the Q-NRG+ Indirect Calorimetry Device Versus the V(Max)

Wake and Sleep State Transitions on a Portable Electroencephalogram

Use of Novel Sinusonic Device for Prevention of Community Acquired

The Effect of Positional Therapy on Symptoms of Gastroesophageal Reflux

Structural Modification In Supraglottic Airway Device Not yet recruiting

User Acceptability of a Device-Based Opioid Overdose Intervention Recruiting

Efficacy of Different Anti-Thrombotic Strategies on Device-Related

Positional Device Aimed at Patients With Low Back Pain Recruiting

ROMTECH PortableConnect Rehabilitation Device Usage Post Unilateral

The Evaluation of External Thermomechanical Stimulation for Pain

Pressure Volume Loop Not yet recruiting

Treatment of Eustachian Tube Dysfunction (ETD) and Facial Pain With

Joovvin' for Your Skin Health Study Not yet recruiting

Remote Patient Management of CIEDs - Brady Devices Not yet recruiting

Pelvic Floor Muscle Training With a Digital Therapeutic Device to Standard

Improvements and Modifications of Devices for Hip Arthroscopy Enrolling by invitation

Application of a Perineal Protection Device in Vacuum-assisted Births Not yet recruiting

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast

Core Warming of COVID-19 Patients Not yet recruiting

Feasibility and Acceptability of the Propeller Monitoring System in Children

Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of

A Comparative Clinical Investigation of Two Hearing Instrument Digital

Screening for Atrial Fibrillation With Prolonged Continuous Single-lead ECG

Vestibular Nerve Stimulation Compared to Sham Control as a Means of

Hemodynamic Assessment of the Right Ventricle Using Pressure-volume

JuggerStitch Post Market Clinical Follow-up Study Not yet recruiting

Decentralized Trial in Atrial Fibrillation Patients Not yet recruiting

Effect of Wearable Devices on Patient-Reported Outcomes and Clinical

Safe Access for Bladder Entry in Transgender Men Following Penile

Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose

Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee

Warm and Humidified vs Cold and Dry Carbon Dioxide (CO2)

Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic

Early Ambulation to Reduce Hospital Length of Stay Not yet recruiting

Adherus??Dural Sealant in Spinal Procedures Not yet recruiting

Pilot Study of Esocheck in Eosinophilic Esophagitis Not yet recruiting

Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal

Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-

Determination of the Effectiveness of Certain Physical Methods in the

Elmo Respiratory Support Project - COVID-19 Not yet recruiting

Non-surgical Treatment of Peri-implantitis With and Without Erythritol Air-

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and

Efficacy of Whole-body Vibration on Balance Control, Postural Stability and

MINIject Global Long-Term Follow-up Study Recruiting

Early Feasibility Study of the Reia Vaginal Pessary Recruiting

Sacubitril/Valsartan in Left Ventricular Assist Device Recipients Not yet recruiting

MDR-JuggerKnot Mini Soft Anchor in Maxillofacial TMJ Not yet recruiting

Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30

Fabrication of Naso-alveolar Molding (NAM) Appliance in Cleft Lip and

Mechanical Dyssynchrony in CRT Not yet recruiting

iTBS for Adolescent Depression: An Open Label Study Evaluating Safety

PITA-HF: Feasibility, Safety, and Tolerability Not yet recruiting

The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare

Identification of Jaundice in Newborns Using Smartphones Recruiting

Exoskeleton Footwear to Improve Walking Recruiting

Visual and Electromyography Assessments in Response to Train-of-Four

Portable Measurement of Protoporphyrin IX in the Skin During

A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury